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Oral microbial disease is highly prevalent globally and is being associated with a multitude of 
systemic illnesses. There is a vast range of oral health products containing tooth hardening and 
antimicrobial agents yet the problem persists. The aim of this thesis was to chemically modify 
the anti-inflammatory vitamin E in order to introduce novel substantive antimicrobial activity 
giving it multifunctional activity to combat oral disease.  (+) Alpha tocopherol (α-T) was 
chemically modified by phosphorylation to generate (+) alpha tocopheryl phosphate (α-TP). 
(+) α-TP was observed to form nano sized aggregates with a µM critical aggregation constant 
when dispersed in Tris buffer. The addition of the phosphate group was found to introduce 
substantive antimicrobial activity as (+) α-TP retarded Streptococci biofilm growth, adhered to 
hydroxyapatite and inhibited salivary biofilm growth whilst (+) α-T did not. This activity was 
related to nanostructure architectures as (+) α-T formed spherical, non-surface adherent 
liposomes (563 ± 1 nm, -10.5 ± 0.2 mV) whilst (+) α-TP formed surface adherent, planar 
bilayer islands (175 ± 21 nm, -14.9 ± 3.5 mV). Tris facilitated (+) α-TP antimicrobial activity 
as when it was dispersed in phosphate buffer it did not penetrate, kill or retard biofilm bacterial 
growth. This was shown to be due to the presence of the ions affecting bacterial membrane 
packing, aggregate packing and aggregate charge. The small monolayer pressure increase of 
the (+) α-TP bilayer planar island interactions suggested the antibacterial mechanism was not 
likely to be simple lyses, but perhaps internalisation and enzymatic inhibition. The (+) α-TP 
bilayer planar islands swelled into micron sized aggregates when dispersed in cell culture 
media, selectivity killed macrophages and selectively inhibited monocyte chemoattractant 1 
production from human gingival fibroblast cells. The strategy of utilising phosphorylated 
vitamin E nanoaggregates as multifunctional agents in oral health described herein represents 
a potential technology platform worthy of clinical evaluation.  
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1.1 General introduction 
 
Poor oral health can lead to halitosis, tooth cavities, tooth pain, tooth loss and periodontal tissue 
destruction. These oral health issues are highly prevalent which suggests a usable solution to 
the issues in not commercially available. According to the World Health Organisation (WHO) 
worldwide, 60–90% of school children and nearly 100% of adults have dental cavities which 
often leads to pain and discomfort whilst gum disease (periodontitis), which may result in tooth 
loss and more serious systemic illness, is found in 15–20% of middle-aged (35-44 years) adults; 
Globally, about 30% of people aged 65–74 have no natural teeth proving that more research 
needs to be carried out in the field of oral healthcare to improve these figures (World Health 
Organisation., 2012). Some of the serious health problems that have been linked to 
periodontitis include dementia (Kamera et al., 2008; Abbayya et al., 2015) and heart disease 
(Meurman, et al., 2004; Ionel et al., 2016) and this has added an another aspect to the 
importance of maintaining good oral health.    
 
One consequence of this is that the oral healthcare market is growing. It was estimated that the 
oral healthcare consumer market was worth £833m in 2010, a 1% rise on 2009; toothpaste 
accounted for £353m, followed by toothbrush sales, which were worth £237m, however, 
mouthwash sales grew the most between 2005 and 2010, by 44% (Marketing magazine., 2011). 
One advantage of using a mouthwash compared to toothpaste is that the therapeutic liquid 
covers the entire mouth evenly and so removes some of the risk of the consumer not being 
thorough in their tooth cleaning. In June 2013 the market was worth almost £1 billion, growing 
4% in 2012 and is expected to have continued growth (Mintel., 2013). This vast market is 
driving research and development into new products to help maintain oral health and one key 
area is the prevention of plaque build-up in the mouth. 




Plaque generation correlates with oral disease as its formation means saliva can no longer 
penetrate to the tooth surface and maintain bacterial composition homeostasis which is needed 
to protect enamel and prevent gum disease (Marsh., 1994). Therefore preventing plaque 
formation or reducing its formation by mechanical and chemical removal has been the 
maintenance of good oral health to date (Loe., 2000). A good oral health regime is thought to 
include brushing teeth twice a day followed by flossing and rinsing with mouthwash. However, 
despite such a regime being shown to be effective to prevent plaque development, oral health 
remains to be a problem. 
 
One of the major issues that render it difficult to maintain good oral health in modern life is 
diet, in which there is a high sugar content. Bacteria can metabolise carbohydrates from sugar 
to produce acid deposits, which demineralise enamel and encourages the growth of select 
species of oral bacteria (Touger-Decker & van Loveren., 2003). It is unlikely that social 
attitudes to diet will change significantly to reduce the issue of sugar in the oral cavity and 
therefore oral health products need to be capable of tackling this issue. This leads to the second 
major issue in the fight against poor user compliance with oral health products. It has been 
found that oral care regimens that provide complete oral health care are among strategies that 
attract new customers and keep existing ones (GCI magazine., 2012). Current oral health 
products include active ingredients such as arginine which when metabolised in the mouth can 
increase pH, xylitol which is a non-fermentable sugar or include fluoride to strengthen tooth 
resistance to acid attack (Featherstone., 1999). These agents prevent/ protect against acid build-
up and therefore protects against enamel demineralisation (Marsh & Bradshaw., 1997).  
 
Chapter 1: Introduction   4 
 
 
The introduction of antimicrobial agents has greatly enhanced the ability to control plaque 
growth (Wilson., 1996) with chlorhexidine digluconate (CHX) and cetylpyridinium chloride 
(CPC) being capable of interacting with cell surfaces leading to cell death and also having tooth 
surface binding to give an enhanced retention time in the mouth leading to higher therapeutic 
effects (Elworthy et al., 1996). However, these products were also found to stain teeth and 
reduce taste sensitivity leading to poor user compliance (Sheen & Addy., 2003). Other ways of 
controlling plaque growth have included Lauroyl Arginate Ethyl (LAE) which prevents 
bacterial attachment to the acquired pellicle (Gallob et al., 2015).  
 
The search for new generation of antimicrobial agents to have comparable effects to CHX 
whilst not having the undesirable side effects has to date been unsuccessful. However, if a 
natural, multifunctional compound could be found to have similar antimicrobial properties it is 
likely that the side effects would be reduced and user compliance increased as natural products 
are perceived as being more beneficial. In addition, within the mouthwash market their appears 
to be a focus on antimicrobial agents with any reduction in inflammation incidents resulting 
from reduced bacterial loads but not influencing inflammatory processes directly, and so as 
gum disease is so prevalent it would seem beneficial to have a natural multimodal antimicrobial 
agent that also has inherent anti-inflammatory properties. In order to achieve this, a natural 
anti-inflammatory molecule could be chemically modified to incorporate antimicrobial activity 
and if needed improve hydrophilicity. However, there is a need to appreciate the oral 
microbiological environment, biofilm development, oral disease and the current range of 
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1.2 Oral microbiota  
 
The oral microbiota includes a vast range of bacteria with most of the organisms that colonize 
the mouth benefiting human health by adding to the defence against exogenous harmful 
species, however some of the microbiota are pathogenic and can, if not controlled, lead to oral 
health problems (Avila et al., 2009). 
 
Bacteria are present in saliva, but due to desquamation, accumulation on the soft tissue in the 
mouth is limited. This is exemplified by the fact that a robust biofilm is not formed in the oral 
cavity of infants until tooth eruption (Marsh., 2000). Bacteria can accumulate on tooth surfaces 
because they are hard non-shedding surfaces; some areas of the tooth are more prone to greater 
plaque depth due to physical protection e.g. fissures on occlusal surfaces, and the gingival 
margin (Marsh & Bradshaw., 1995). 
 
Teeth and the gingival margin create a subgingival environment that contains gingival 
curricular fluid (GCF), which is rich in nutrients and allows migrating bacteria from 
supragingival biofilms to form subgingival biofilms. However, it has been hypothesised that it 
is a shift in the subgingival microbiological composition from predominantly gram-positive 
bacteria to gram-negative bacteria that is the cause of gum disease (Berezow & Darveau., 
2011). This is a different process than observed with the formation of dental caries, which often 
occurs when there is a shift in microbiological composition within the gram-positive species to 
more cariogenic species, i.e. an increased in the population of Streptococcus mutans species 
(Marsh., 2000).   
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The difference between gram-positive and gram-negative bacteria is the number of cell walls 
an organism has which is determined through staining techniques; gram-positive species have 
one cell wall and gram-negative have 2 cell walls. Therefore antimicrobial agents will have 
varying efficacy on these categories depending on the mechanism of action (Neu & Gootz., 
1996; Silhavy et al., 2010). The compositions of these two categories and indeed species within 
these categories of bacteria vary in the mouth depending on a person’s health, diet and oral 
hygiene, but if they are not controlled they aggregate and form oral plaque.  
 
1.3 Oral plaque 
 
Some of the oral microbiota organisms are capable of adhering to tooth surfaces through long 
range interactions, which become covalent and hydrogen bonds. Other species of the 
microbiota adhere to bacteria already bound to a non-shedding surface through cell-cell 
interactions or through other organic and inorganic material in the extracellular matrix; this 
organized structure of microorganisms and their products is referred to as dental plaque due to 
its yellowish colour and represents a true biofilm (Chandki et al., 2011). Early stage colonisers 
are often gram-positive streptococci species whilst later colonisers in a mature biofilm are often 
gram-negative. However, the initial tooth surface bacterial attachment requires a pellicle layer 
on the enamel surface which consists of proteins and displays receptors for the early colonising 
bacteria to bind. This complex multi stage process of oral biofilm development will now be 
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1.3.1 Pellicle formation 
 
The tooth surface contains both calcium and phosphate groups and so is amphoteric and can 
bind both acidic and basic proteins despite its surface having a net negative charge (due to more 
phosphate group exposure at the surface) (Beachey., 1980). As a consequence the tooth surface 
eventually becomes coated with salivary proteins and other macromolecules including 
albumin, glycoproteins, acidic proline–rich proteins, mucins, sialic acids which provide 
receptors for pioneering bacterial colonisation (Kreth et al., 2009) (Figure 1.1). This layer can 
be at least partially removed by brushing with toothpaste but the pellicle layer is restored by 
proteins in saliva within minutes (Waaler., 2014). This protein layer is known as the acquired 
pellicle and is a major part of biofilm development as micro-organisms depend on this layer to 
adhere to the tooth surfaces. Despite the fact that the acquired pellicle allows biofilm formation, 
hence it can be viewed as a precursor to oral disease, it is thought to be beneficial to teeth due 
to the fact it forms a barrier protecting the enamel from abrasion and acid attack. However, as 
the yellowing of teeth is due to the staining of the acquired pellicle, from a cosmetic point of 
view, it is beneficial to completely remove it occasionally (Viscio et al., 2000).   
 
 




Figure 1.1. Selective interactions within an oral biofilm. (Kolenbrander et al., 2010). 
 
1.3.2 Pioneering/ primary colonisers 
 
Pioneering tooth colonising bacteria include streptococci species such as S. mitis, S. oralis, S. 
sanguinis and S. gordonii adhere irreversibly to different receptors on the acquired pellicle 
within 2-4 hours and then grow rapidly (Marcotte & Lavoie., 1998) (Figure 1.1). The reason 
why some species of streptococci bacteria successfully colonise the acquired pellicle is due to 
the expression of proteins on their surfaces which can interact with receptors in pellicle; this is 
an essential step in tooth surface colonisation and plaque development (Nobbs et al., 2009). It 
is thought that it is the fimbriae and fibrils proteins in the membranes of pioneering bacteria 
that have a strong affinity for pellicle receptors which gives them preferential binding after 
which the bacteria produce extracellular polymeric substance (EPS, predominantly alginic 
acid) which aids attachment (Huang et al., 2011). The pioneering bacterial colonizers then 
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allow the attachment of early colonisers through cell-cell surface interactions which in turn 
allows the colonisation of secondary colonisers. 
 
1.3.3 Secondary colonisers 
 
The secondary colonizers consist of gram-negative bacteria including Fusobacterium 
nucleatum, Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis 
(Kolenbrander et al., 2010) many of which are associated with gum disease. Like that of the 
pioneering bacterial colonisers (which require a bacterial surface protein to have a high affinity 
for a pellicle receptor), the secondary colonisers have varied surface proteins and 
lipopolysaccharide (LPS) that are recognised and have high affinity for certain early coloniser 
surface receptors or LPS. This selectivity for co-aggregation binding of secondary colonisers 
species to primary coloniser species can be seen in Figure 1.1.  
 
1.3.4 Plaque maturation 
 
Plaque structures are extremely complex and have multiple receptor binding sites on multiple 
co- adhered species of bacteria. The secondary colonizing bacterial species that adhere to the 
oral biofilm also produce EPS, it is estimated that once plaque has reached a mature state only 
5-25% of plaque consists of bacterial cells whist 75-95% consists of the glycocalyx (tangled 
polysaccharide fibres), which often encases the bacterial cells; the oral biofilm does however 
contain many porous layers and water channels to provide the bacteria with essential nutrients 
(Huang et al., 2011). As biofilms mature there is a proportionality change from streptococci 
species to more gram-negative species, which has been attributed as a risk factor for gum 
disease.  The risk factor is increased in mature plaque due to bacteria detaching from oral 
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biofilms as single cells or clusters; this dispersion has been explained by two hypotheses. 
Firstly as the biofilm matures, there is less nutrition available to bacteria or there is another 
undesirable change in the biofilm conditions (pH, oxygen tension and temperature) which 
result in some bacteria actively detaching in an attempt to find more favourable conditions. The 
second is that saliva flow which attempts to control plaque growth has an effect on passively 
dispersing surfaces of mature plaque through shear rate (Kaplan et al., 2010). The active 
dispersal of bacteria from oral biofilm to a planktonic state has been hypothesised as being a 
therapeutic target to reduce the proliferation of biofilm development (Filoche et al., 2010).  
 
1.4 Oral plaque initiating disease  
 
If oral plaque is left to proliferate and mature it is known to trigger oral health problems such 
as dental caries and gum disease. This is a consequence of a change in microbiological 
composition creating a disease risk biofilm hosting a high number of pathogenic bacterial 
species. The mechanistic causes and responses involved in both dental caries and gum disease 
will be discussed in the subsequent sub sections.  
 
1.4.1 Enamel demineralisation/ remineralisation and dental caries 
 
Enamel is the hardest substance in the human body. It coats the surface of teeth and is made up 
of 96% hydroxyapatite, 3% water and 1% organic matter. Tooth enamel is in a constant state 
of mineralisation and demineralisation; the tooth becomes mineralised via a controlled release 
of calcium and phosphate ions at neutral pH, but it can become mechanically eroded by attrition 
or demineralised by acid over time (Li et al., 2014). Acidic conditions can lead to the generation 
of white spot legions which can lead to cavity formation (Ferreira Zandoná et al., 2012). Below 
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the layer of enamel there is a material called dentin which has a lower composition of 
hydroxyapatite (70%) (Goldberg et al., 2011) and is therefore less resistant to abrasion and acid 
demineralisation (Mellberg, J. R. (1992). Cementum is the mineralised tissue that covers the 
entire root of the tooth and again has a lower composition of hydroxyapatite (50%) compared 
to enamel (Gonçalves et al., 2004). Proteins, in particular collagen are responsible for 
controlling the flux of ions into extracellular matrix, register signals that indicate when the 
mineralisation process should start and end and control the size to which the crystals will grow; 
collagen provides the template for mineral deposition in dentin and bone, without collagen the 
mineralisation process does not occur on a measurable time scale (Boskey., 2007). If the correct 
balance of oral bacteria is not maintained the tooth surfaces may become acidic (due to some 
bacteria’s acidogenic behaviour). On average once the pH on the surface of the tooth reaches 
below 5.5, enamel demineralization occurs at a faster rate than mineralisation, although this 
differs slightly between individuals due to other biological parameters (Bowen., 2013). Also 
dentin and cementum are more susceptible to caries than enamel as they contain a lower 
mineral content, hence dental caries are more likely to form in cases of gingival recession and 
periodontal disease. The chemical equation for the process of acid based enamel 
demineralisation can be seen in equation 1.1. 
 
Ca10(PO4)6(OH)2(s) + 8H
+(aq) → 10Ca2+(aq) + 6HPO42-(aq) + 2H2O(l) 
 
Equation 1.1. Acid based enamel demineralisation (Stoker., 2012). 
 
Harmful acid producing bacteria include Lactobacillus acidophilus and Streptococcus mutans. 
These bacteria are capable of breaking down sugars, such as sucrose via glycolysis to produce 
pyruvic and/ or lactic acid. However, when the numbers of these bacteria are kept in a healthy 
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number, the pH of the tooth surface is likely not to reach the ‘critical pH’ value of 5.5. It is 
only when there is debris, in particular sugar debris on the tooth surface that these harmful 
bacteria can produce more energy via glycolysis, resulting in more acid being produced and 
creating a lower pH environment that some beneficial bacteria cannot survive in but these 
bacteria multiply in. Hence a higher composition of harmful bacteria are produced which in 
turn produce more acid which in turn increase the number of cariogenic bacteria until the pH 
of the tooth surface reaches the critical pH value and demineralisation of enamel occurs. If the 
pH is not increased, then dental caries will form, this is the point at which tooth restructuring 
cannot occur (Islam et al., 2007). It has been noted that S. mutans in particular is capable of 
producing acid from metabolising sugars at a faster rate than other cariogenic bacteria, can 
survive and continue to produce acid at pH values that kill other streptococci species. S. mutans 
also produces three glucosyltransferases (GTFs) which catalyse the conversion of sucrose to 
glucans, a substance that is known to promote the adhesion of S. mutans to tooth surfaces. 
Hence S. mutans adhesion is sucrose dependent (Tao & Tanzer., 2002) and therefore research 
into GTF inhibitors is valuable. This section has illustrated the process of how cariogenic 
bacteria cause dental caries, a highly prevalent oral disease. However, gum disease is another 
prevalent disease caused by oral bacteria and will be discussed in the next section. 
 
1.4.2 Gingivitis and periodontal disease 
 
Gingivitis is a mild, reversible form of gum disease caused by an excess of gram-negative 
bacteria accumulated at the root of teeth as a result of supragingival plaque maturation. In 
particular S. oralis has been found to interact with common periopathogens such as P. 
gingivalis, allowing accumulation of gram-negative bacteria at supragingival levels and 
subsequent subgingival migration (Dziedzic et al., 2015). These bacteria produce 
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lipopolysaccharides (LPS), cytotoxic metabolites and immunoreactive molecules which irritate 
gingival tissue and result in an inflammatory response (Addy & Morann., 2000; Marsh et al., 
2009). Gingivitis can usually be reversed with daily brushing, flossing and mouthwash (Witt 
et al., 2006). However, if not treated, it can lead to periodontitis (inflammation around the 
tooth) which is a severe chronic condition (Pihlstrom et al., 2005).   
 
Inflammation is a biological response of vascular tissues to harmful stimuli and is a localised 
protective response to eliminate infection and to initiate healing (Handfeild et al., 2008). 
Microbiological composition change of subgingival plaque has the ability to induce a 
hyperimmune response which over time destroys gingival connective tissue; certain species of 
bacteria can also manipulate the immune response to their advantage (Ai et al., 2017). 
Periodontitis begins when supporting tissues of the teeth are attacked which can result in a 
breakdown of bone and connective tissue that hold teeth in place, the teeth may eventually 
become loose and have to be removed.   
  
Therefore gingivitis can initiate the periodontitis process if untreated (remove plaque).  
Periodontitis allows harmful bacteria to areas in the mouth that were previously inaccessible 
(Sagile et al., 1982). In periodontitis, the junction epithelium at the base of the gingival crevice 
migrates down the root of the tooth to form a deeper periodontal pocket (from 1-2 mm to ≤ 5 
mm) and is an ideal environment for the proliferation of microbes (Phaechamud & 
Setthajindalert., 2017). This pocket is highly anaerobic and preferentially attracts bacteria that 
do not metabolise carbohydrates but are proteolylic. As a result of this the pocket increases in 
pH to between 7.4-7.8 compared to a healthy value of 6.9 (the opposite of dental caries causing 
bacteria) (Marsh & Martin., 1992). This slightly basic condition allows periodontal pathogens 
like P. gingivalis to have enhanced growth (again opposite to dental caries causing bacteria). 
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Gingivitis is thought to affect every member of the human population at some stage and is the 
non-specific proliferation of the normal gingival crevice (Marsh et al., 2009). This is a common 
disease in developed countries and it is estimated that 5-10% of UK adults are particularly 
susceptible to periodontal disease and with an ageing population chronic periodontitis 
represents a significant healthcare burden with 85% of adults over 65 having periodontal 
destruction (Renz et al., 2007). These findings show that although antimicrobials are important 
in oral healthcare to prevent inflammation, anti-inflammatory agents are required to control the 
inflammatory response.  
 
Therefore periodontal bacteria cause destruction of gingival tissue in two ways. Firstly, in a 
direct action of bacterial enzymes and the cytotoxic products of bacterial metabolism. 
Secondly, in an indirect response by where tissue destruction is a side-effect of a subverted and 
exaggerated host inflammatory response to plaque antigens, this has been termed ‘bystander 
damage’ (Hasan & Palmer., 2014). This indirect response is made more severe by the proteases 
of P. gingivalis deregulating the host control of inflammatory response and evades the action 
of other components of the immune response (How et al., 2016). Some other periodontal 
bacteria can however inactivate the host antimicrobial pathways by degrading peptides and 
enzymes. The entire immune response is dependent on complex intercellular signalling 
networks mediated by cytokines which some periodontal bacteria can manipulate (Marsh et al., 
2009). Therefore the entire immune response is due to cellular signalling and so there appears 
to be two major ways of inhibiting this action. Firstly to use antimicrobial treatment so the 
inflammatory signals are not triggered and secondly to use an anti-inflammatory that is capable 
of inhibiting the signalling cascade and/ or have a selective toxic effect on recruited white blood 
cells in order to control the inflammatory response.   
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The initial response to bacterial irritation to the gingival margin is a humoral response, which 
is a non-cell mediated immune response and includes antibodies, proteins and small molecules 
(Cekici et al., 2014). During an inflammatory response gingival vasodilation also takes place 
due to vasoactive amine and prostaglandin release from cyclooxygenase enzymes whilst 
gingival cells generate intercellular adhesion molecule (ICAM-1) on their surfaces which 
complement adhesion molecules on the surface of polymorphonuclear leukocytes (PMN’s, 
white blood cells) on arrival (Page., 1991). Vasodilation is the widening of blood vessels that 
result in an increased blood flow to the infected area and increased vascular permeability which 
allows required diffusible components (PMN’s and monocytes) to the infected area. This leads 
to increased redness and gums that are more prone to bleeding. This mechanical process leads 
to the gum tissue parting from teeth and the jaw bone. Periodontal pockets are formed and thus 
accumulate bacteria; these bacteria can then initiate the destruction of bone structure leading 
to periodontal disease by producing toxins (direct response) that provoke further immune 
response (indirect response) (Cekici et al., 2014). The vasodilation which also allows peripheral 
white blood cells to access the infected area and engulf invading bacteria can also allow 




























Figure 1.2. The complex immune inflammatory response in periodontal disease (Cekici et al., 
2014). 
 
Any subgingival bacteria can be associated with contributing to tissue destruction via indirect 
pathogenicity, if the bacterium is provoking a host inflammatory response. Bacteria (usually 
from gram negative bacteria) can release antigens e.g. LPS from the bacterial cell wall and can 
penetrate crevicular epithelium stimulating humoral or cell mediated immunity  (Marsh et al., 
2009) as cell receptors recognise these compounds are produced by bacteria and indicate 
bacterial invasions and so the cells respond through cytokine release to signal for an immune 
response to eradicate the invading bacteria. 
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Humoral immunity also leads to the release of cytokines which then initiates a cell immunity 
including activated T-lymphocytes which regulate macrophage activity (ingest dying cells) 
(Silva et al., 2015). Activated macrophages can then release more cytokines including TNF-α 
(Tumour Necrosis Factor – alpha), IFN-γ (InterFeroN – gamma), interleukin and monocyte 
chemoattractant proteins (Madianos et al., 2005). Pro-inflammatory cytokines i.e. TNF-α, IL-
1 and IL-6 promote osteoclast activity causing bone resorption and can induce metalloprotease 
(MMP) activity which continue the degradation process (Heinz et al., 2015). Other proteolytic 
degradation enzymes include elastase and cathepsin-b which are both present in an inflamed 
gingival crevice and are likely to be derived from polymorphs, macrophages and fibroblasts 
(Eley & Cox., 1992). Mast cells can also gain access to periodontal pockets which release 
histamine and other vasodilator molecules as well as a range of chemokines and proteases 
(Sushma et al., 2013). Cells in the gingival crevice can contain protease inhibitors which are 
capable of inactivating proteases hence regulating the potential destructive forces of 
inflammation, however bacterial proteases are capable of degrading these regulators adding to 
‘bystander damage’ (Laugisch et al., 2012). 
 
Phagocytic cells form the main defence against periodontal pathogens but if not controlled can 
cause irreversible periodontal damage and some bacteria can evade the immune response all 
together. Strains of A. actinomycetemcomitans produce powerful leukotoxin capable of lysing 
human neutrophils, monocytes and lymphocytes whilst non-white blood cells i.e. epithelial and 
endothelial cells, fibroblast and erythrocytes are resistant, this allows periodontal pathogens to 
control (immunosuppressant) the host defences reducing tissue damage from the immune 
response but increasing it from the bacteria’s toxins (Aberg et al., 2015). Bacteria including A. 
actinomycetemcomitans, T. forsythia, P. gingivalis, and other pathogens may also evade the 
host defences by invading epithelial cells intracellularly (Tribble & Lamont., 2010). In addition 
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P. gingivalis possesses a capsule, which protects cells against phagocytosis (Singh et al., 2011). 
Therefore antimicrobial agents are required to reduce the risk of the gram-negative composition 
increasing (through direct effect or inhibition the initial growth of plaque). 
 
One cytokine often released is TNF-α which stimulates leukocyte (neutrophils, monocytes) 
adhesion through further causing monocytes/ PMN’s to express adhesion molecules on their 
surface to interact with ICAM-1 on endothelial cells. It also increases the synthesis of 
prostaglandins (PG’s), however, PG’s in particular PGE2 limit the destructive nature of 
excessive TNF-α and in this respect reduce inflammation response (Gitlin & Loftin., 2009). In 
addition it recruits more monocytes and PMN’s to the infected area. Other cytokines often 
generated from oral tissue upon bacterial irritation are interluekin 8 (IL-8) and monocyte 
chemoattractant-1 (MCP-1), these are key chemoattractants in neutrophil and monocyte 
recruitment respectively which if not controlled can lead to periodontal destruction (Fitzgerald 
& Kreutzer., 1995). IL-6 is another prominent cytokine in gingival inflammation and is 
responsible for the upregulation of antibodies, T (produce toxic granules) and B (produce 
antibodies) cell differentiation, increases vascular permeation and osteoclast (bone resorption) 
differentiation but can downregulate other pro-inflammatory cytokine expression (Nibali et al., 
2013). Therefore an anti-inflammatory agent is required to allow a measured immune response.  
 
1.5 Chemical prevention of oral disease 
 
It has been observed that the mechanical removal of plaque through the means of saliva flow 
and brushing of teeth is not enough to prevent oral disease. Brushing of teeth in particular is 
not done often/ thoroughly enough to inhibit plaque formation whilst extensive brushing can 
lead to enamel erosion. Therefore there are a number of commercial products including 
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dentifrices and mouthwashes that contain chemical means of preventing tooth demineralisation 
and gum inflammation. The chemicals used in these products include bacterial adhesion 
controlling agents, bacterial composition controlling agents, tooth hardening agents and anti-
inflammatories but to a large extent contain antimicrobial compounds.    
 
1.5.1 Antimicrobials to control oral plaque growth 
 
Antimicrobial agents have been used to treat disease for many years and can be classified as 
having bacteriostatic or bactericidal effects; a bacteriostatic effect refers to the agents ability to 
keep bacteria in a stationary phase of growth for an extended period of time whilst a bactericidal 
effect refers to an agents ability to kill bacteria, although in reality bacteriostatic agents 
commonly have some kill efficacy and bactericidal agents often do not kill the entire bacterial 
burden (Pankey & Sabath., 2004).  
 
There are several different types of antimicrobial agents including biocides which are 
substances that specifically destroy microbes, antibiotics that treat disease through specific 
cellular targets which require entry into metabolically active cells (often suffer from bacterial 
resistance), antiseptics used externally on living tissues to supress bacterial growth to prevent 
disease and disinfectants which are used on non-living tissue to destroy microorganisms 
(McDonnell & Russell., 1999). In oral healthcare, antiseptics are used to control oral plaque 
growth but there are a wide range of these antimicrobial agents employed in different product 
that have different physicochemical properties and various mechanisms of action. These will 
be discussed in the subsequent sub sections. 
 
 





Chlorhexidine is considered the most effective antimicrobial agent since the 1950’s and has 
been used in mouthwash since the 1970’s. It is a substantive, potent oral antiseptic that reduces 
the population of many bacterial streptococci species through its ionic interference with cell 
membranes (Balagopal & Arjunkumar., 2013; Ferretti et al., 1990). Chlorhexidine inhibits 
oxygen utilisation by bacteria and this induces a subsequent fall in cellular ATP levels that 
results in a loss of periplasmic enzymes (degrade compounds to a utilizable form) in the cell 
membrane (Barrett-Bee et al., 1994). It is chlorhexidine’s cationic charge that interacts with 
the negatively charged components in bacterial cell walls, which causes disruption. The agent 
is rapidly internalised bacteria and it interferes with osmosis. Once chlorhexidine hits the inner 
membrane, it ruptures it and this causes leakage of components leading to cell death. 
Chlorhexidine has been used in periodontitis in the form of a gelatine chip, which is placed in 
the gum pocket to destroy periodontal bacteria (Nair & Anoop., 2012). However, liquids 
containing chlorohexidine can have an unpleasant taste, deliver a burning sensation and it can 
stain teeth (Flotra et al., 1971). Therefore, it is typically recommended in many circumstances 
for only short-term use. 
 
1.5.1.2 Quaternary ammonium compounds  
 
Cetylpyridinium chloride is a less potent agent compared to chlorohexidine. It does not show 
a high degree of bio-retention and hence it is less effective against plaque and preventing 
gingivitis (Eley., 1999). Cetylpyridinium chloride still reduces bacterial adhesion, interferes 
with cell membranes and it has less side-effects compared to chlorohexidine (Sheen & Addy., 
2003). Cetylpyridinium chloride also has a more significant impact on gram-positive bacteria 
Chapter 1: Introduction   21 
 
 
over gram negative bacteria (Pitten & Kramer., 2001; Mcdonnell & Russle., 1999). This 
compound is used in Colgate Total Pro Gum Health Mouthwash® as an bacteriostatic and 
inflammatory prevention agent. CPC is an amphiphilic molecule that aggregates in aqueous 
vehicles (Mukhim et al., 2010).  
 
1.5.1.3 Triclosan  
 
Triclosan is a biocide agent that has been used in oral, dermal and other household products 
over the last 50 years. It is thought to have multiple mechanisms of action ranging from cell 
wall disruption to enzyme inhibition and hence it is useful in overcoming antimicrobial 
resistance (Yazdankhah et al., 2006). It has been found to be active against yeast, gram positive 
and gram negative bacteria. It has therefore been formulated with polymers to improve its 
retention time and other antimicrobials, i.e. metal salts, that have been shown to have a 
synergistic effect (Brading & Marsh., 2003). 
 
1.5.1.4 Metal salts 
 
Using metal ions as anti-plaque agents is desirable as they do not induce tooth staining or other 
undesirable side-effects (Harrap et al., 1983).  Perhaps one of the most commonly used 
antimicrobial metal salts is stannous fluoride (SnF2). This antimicrobial agent has been of great 
interest since the 1980’s and is still widely used today to improve oral health. The antimicrobial 
effectiveness of SnF2 has been tested on bacterial plaques in chronic periodontal disease and 
has been found to alter morphological groups (composition of different shaped bacteria i.e. 
rods, spherical) of subgingival and supragingival plaque bacteria. It has been found that by 
using 1.64% SnF2 causes a significant and sustained decrease in subgingival motile bacteria 
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and spirochetes, after six weeks bacteria was halved in concentration (Mazza et al., 1981). The 
antimicrobial active in SnF2 is thought to be fluoride not tin. However, the tin component 
allows fluoride to be present at effective antimicrobial concentrations in the mouth whilst 
remaining non-toxic. Fluoride as well as strengthening enamel also has been shown to reduce 
the number of bacteria in cariogenic plaque, it is thought to effect bacterial metabolism and 
viability. Fluoride antimicrobial effectiveness depends on the organism, type of compound, 
concentration, pH and retention time of the species. It has been found that fluoride can be 
effective in reducing plaque and gingivitis severity (Mazza et al., 1981). However, the activity 
of SnF2 in inflammatory conditions is debatable. One study found that 0.4% and 0.22% SnF2 
and sodium fluoride respectively resulted in no difference in gingivitis, bleeding or amount of 
bacteria when compared to a placebo group after 18 months of treatment (Wolff et al., 1989). 
However, a later study found that stabilising the SnF2 with sodium gluconate did reduce 
gingivitis after 6 months (Beiswanger et al., 1995).  
 
Another commercially tested antimicrobial metal is zinc. It has been found to adsorb to S. 
mutans and inhibit its ability to metabolise glucose to lactic acid, a process essential for the 
growth of bacteria. Zinc is also active against S. sanguinis and A. naueslundii through a similar 
mechanism. It is thought that zinc inhibits essential enzymes in the transport and metabolism 
of glucose including phosphotransferase transport system (PTS), sulphydryl enzymes and 
glyceraldehyde dehydrogenase. However, S. mutans can uptake glucose via two pathways, 
firstly, the PTS mechanism (which zinc inhibits) and secondly a metabolism driven by the 
energy of proton electro-chemical gradients (PMF, which zinc does not directly inhibit). PMF 
is important at low pH and although it is not inhibited by Zn2+ it is inhibited by Na+ (Cummins., 
1991; Devulapalle & Mooser., 1994). Inhibiting glucose metabolism has the consequence of 
inhibiting acid production. The inhibition of acid makes zinc a good bacteriostatic agent. As 
Chapter 1: Introduction   23 
 
 
zinc inhibits both plaque formation and acid generation it is able to prevent both gingivitis and 
dental caries whilst keeping a healthy composition of bacteria in the mouth.  
 
In addition to zinc inhibiting bacterial metabolism it is thought that it reduces bacterial 
colonisation by either modifying cell surfaces, altering cell proteins, inhibiting protease 
induced adhesion or attachment to cell membranes reducing negative charge (Cummins., 
1991). These zinc antimicrobial properties have a modest but significant effect on reducing 
salivary bacterial counts (Addy et al., 1980). Plaque growth is also inhibited both in vitro and 
in vivo dose dependently but efficacy is reduced if bacterial growth time is increased before 
treatment (Harrap et al., 1983). This suggests that zinc salts are unable to effectively penetrate 
mature plaque and so cannot be a replacement for the mechanical removal of plaque. Zinc 
oxide (ZnO) increases C. jejuni membrane permeability, induces membrane leakage and when 
internalised causes a large amount of oxidative stress resulting in reducing cell growth and cell 
death (Xie et al., 2011). It may also undergo transmetallisation with vital metals hindering 
bacterial metabolism and growth. However, using zinc salts have previously given variable 
results; this is likely due to varying concentration or interference of the counter ion (Harrap et 
al., 1983).  
 
1.5.1.5 Essential oils  
 
Essential oils derived from plants have been used for their antioxidant, anti-cancer and 
antimicrobial effects for decades, but they have become more popular in recent times due to 
consumer perceptions that natural therapeutic agents are favourable to molecules due to safety 
concerns (Seow et al., 2014). Essential oils including menthol, thymol, methyl salicylate, and 
eucalyptol have been found to have bacteriostatic and bactericidal effect though cell wall 
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disruption and enzymatic inhibition. They can only be used at low concentrations due to poor 
water solubility but they are used in the Listerine® products. Essential oils display an optimal 
anti-biofilm effect when formulated with alcohol (Erriu et al., 2013).  
 
1.5.2 Non-antimicrobial targets in oral health products 
 
In addition to the various bacteriostatic and bactericidal antimicrobial agents used to maintain 
good oral health there are other agents employed which inhibit oral disease by other means i.e. 
inhibiting bacterial attachment, making teeth harder and controlling biofilm pH which will all 
be discussed in the subsequent sub sections. 
 
1.5.2.1 Lauroyl arginate ethyl (LAE) inhibition of biofilm growth  
 
LAE inhibits plaque build-up by forming a physical barrier that prevents the adherence of 
bacteria to tooth surfaces. Through this mechanism it elicits its anti-plaque and anti-gingivitis 
effects. Delmopinol is thought to work in a similar manner to LAE but unlike delmopinol, LAE 
is not considered to have a have a bacteriostatic or bactericidal antimicrobial response and so 
can be considered a medical device rather than a drug which makes regulatory approval easier 
for products containing this agent (Gallob et al., 2015).   
 
1.5.2.2 Stronger teeth with fluoride 
 
Fluoride inhibits enolase (an enzyme containing two magnesium atoms, which catalyses 
fermentation of sugars to lactic acid) by binding to the active site instead of PG 
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(phosphoglycerate). Enolase is responsible for the penultimate (9th) step of glycolysis (Qin et 
al., 2006). Fluoride is perhaps more renowned for strengthening teeth against the acid 
dependent tooth demineralisation process. This is because fluoride can become a part of the 
enamel crystal structure, replacing the hydroxyl groups, generating fluorapatite (Ca10(PO4)6)F2 
which is a less acid soluble mineral than hydroxyapatite (Featherstone., 1999).  
 
1.5.2.3 Stronger teeth with zinc  
 
Zinc is also thought to have a role in biomineralisation, where it stimulates both bone growth 
and mineralisation and inﬂuences osteoclast activity. Retardation of bone growth in animals is 
commonly associated with conditions linked to zinc deﬁciency; also reduced bone density has 
been linked to a zinc-deﬁcient diet. Zinc is found naturally in saliva (0.0465 PPM to 0.244 
PPM) and plaque (7.86 PPM to 31.6 PPM) (Fatima et al., 2016). As zinc is naturally abundant 
in the mouth it is thought that a relatively large amount of zinc is incorporated into enamel 
prior to tooth eruption, however, after eruption the concentration of zinc in the surface of 
enamel increases. Therefore zinc is likely to be incorporated during the constant 
demineralisation and remineralisation of enamel. This is likely to be beneficial because enamel 
with zinc content has reduced acid solubility and may be more resistant to acid attack. 
However, zinc can inhibit the enamel remineralisation process but zinc adsorbed to enamel can 
be displaced by calcium or an overgrowth of newly deposited minerals takes place to minimise 
the negative effect of inhibited remineralisation. Therefore using zinc as an antimicrobial agent 
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1.5.2.4 Arginine in controlling cariogenic bacteria 
 
Oral bacterial biofilms consist of a variety of both acidogenic and arginolytic/ ureolytic  
bacterial strains which form part of the dynamic equilibrium between hydroxyapatite 
demineralisation influenced through acid generation, and remineralisation influenced through 
alkali generation which allows calcium and phosphate supersaturation. It is favourable to 
maintain conditions that promote arginolytic and to a lesser extent ureolytic bacteria in 
microflora because the acidogenic bacteria such as Lactobacillus casei and S. mutans ferment 
carbohydrates (which are in excess in modern diets) to generate acid and increase acidogenic 
bacterial composition (Wijeyeweera & Kleibergn., 1989; Sharma et al., 2014). Arginolytic 
bacteria including Streptococcus gordonii and Streptococcus sanguinis can catabolise arginine 
through the arginine deiminase system (ADS) producing ammonia, bacteria that express ADS 
maintain biofilm pH neutrality and are associated with dental health (Huang et al., 2016). 
Therefore, the use of arginine in oral health products has been reported to reduce the risk of 
dental caries by being a nutrient for non-cariogenic bacteria and raising plaque pH (Tada et al., 
2016). 
 
1.5.3 Anti-inflammatory agents to prevent and/ or treat gum disease 
 
When considering the high incidents rate of gum disease in people worldwide it is perhaps 
surprising to find that there are a limited number of anti-inflammatory agents used in 
mouthwashes compared to antimicrobials. Non-steroidal anti-inflammatory drugs (NSIAD’s) 
are frequently used as dentistry pain relief treatments but not to prevent periodontal disease. 
Therefore an approach to both prevent and treat gum disease simultaneously would be desirable 
to minimise the possibility of periodontal destruction but such a product does not yet seem to 
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exist with the potential exception of those that contain triclosan. Products that contain triclosan 
and diclofenac inhibit prostaglandins which are only one small part of the gum disease process. 
Subanitmicrobial dose doxycycline has been found to have a wider spectrum of oral anti-
inflammatory properties but appears to be the only one and therefore other anti-inflammatory’s 
should considered. The use of these oral anti-inflammatory agents will be discussed in the 




It is thought that some phenols are not only antimicrobials but also may prevent gum disease 
through anti-inflammatory properties. For example, triclosan inhibits COX, lipoxygenase 
pathways, cell mediated immunity, mRNA expression, translocation of NF-Kb (a protein that 
controls the transcription of DNA) and inhibition of IL-1β and IFN-γ. (Sreenivasan & Gaffar., 




Diclofenac an NSAID (Non-Steroid Anti-Inflammatory Drug) is found in mouthwashes such 
as Disoral®. It is known to inhibit the formation of prostaglandins and thromboxane which are 
pro-inflammatory molecules as well as having a stabilizing effect on cell membranes, allowing 
membranes to have a higher tolerance to pro-inflammation molecules (Segre & Hammarström., 
1985). Diclofenac is commonly used to treat gum inflammation and relieve pain in mouthwash 
but is not used to prevent it (Serafini et al., 2012). 
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1.5.3.3 Subantimicrobial doxycycline  
 
Doxycycline is a member of the tetracycline family. At subantimicrobial dosages doxycycline 
has been found to have anti-inflammatory properties on some biomarkers including IL-6, IL-8 
and TNF-α (Di Caprio et al., 2015). These non-antimicrobial anti-inflammatory properties also 
overcome the problem of encouraging antimicrobial resistance. In addition subantimicrobial 
doxycycline has been found to inhibit MMP and osteoclast activity, reducing gingival 
connective tissue destruction and periodontal bone resorption (Golub et al., 2009) but this is 
the only product to do so and by definition does not have antimicrobial properties. 
 
1.5.3.4 Vitamin E  
 
Naturally occurring vitamin E is a biologically active agent and a well-known anti-
inflammatory agent but is not currently used in oral health. It is found in vegetable oils such as 
corn, rapeseed, soybean and sunflower oil and was discovered in 1922 by Evans and Bishop as 
an essential nutrient for reproduction in rats (Gliszczyńska-Świgło et al., 2007; Zingg et al., 
2010). Since its discovery the importance of tocopherols (vitamin E) have increased in the 
pharmaceutical and food industries, this is due to their antioxidant properties inhibiting lipid 
oxidation and quenching reactive singlet oxygen species. Epidemiological tests indicate 
beneficial effects against atherosclerosis, cardiovascular disease, some cancers, Alzheimer’s 
and Parkinson’s disease as well aging process in general (Lienau et al., 2002). Vitamin E 
functions as a chain-breaking antioxidant that prevents the propagation of free radical reactions 
(Nishio et al., 2011). There has been increasing interest in the structural variations of 
tocopherols and this has led to additional applications of these agents in health including their 
use as anti-inflammatory agents.   
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1.5.4 Natural isomers of vitamin E and their anti-inflammatory properties 
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They also have the structure of non-ionic surfactants and have been found to self-assemble in 
aqueous environments (Wa & Gebicki., 1983). The small changes in the molecule architecture 
can make a profound difference to the aggregate architectures, bioactivity and biological 
function of each species. The tocotrienol isomers (Figure 1.4) have an identical Greek alphabet 
labelling system. However, in these cases three alkene groups can be found on the carbon ‘tail’ 
of the molecules, which makes these molecules non-chiral. 
 
It is widely recognised that tocopherols/ tocotrienols are antioxidant agents by acting as 
hydroxyl radical scavengers. They maintain cellular integrity via protecting polyunsaturated 
fatty acid moiety’s of phospholipids. Vitamin E has also recently been found to elicit anti-
inflammatory properties by inhibiting cytokine production leading to a reduction in IL-1β, IL-
6 and TNF-α production (Tahan et al., 2011). The anti-inflammatory activity of vitamin E is 
achieved by blocking the activity of NF-κB (proinflammatory gene regulator, controls 
glycoprotein mediating leukocyte-endothelial and marker of active inflammation, this is up 
regulated in inflammation) which leads to a decreased production of pro-inflammatory 
cytokines (Mirbagheri et al., 2008). In addition, it is thought that vitamin E reduces F2-
isoprostanes produced by COX.  
 
α-Tocopherol (α-T) is the most abundant form of vitamin E in nature, it generally has the 
highest biological activity and has signalling functions in vascular smooth muscle cells it 
decreases protein kinase C activity, increases phosphoprotein phosphatase 2A activation and 
controls expression of the α-tropomyosin gene that other forms of tocopherol with similar 
antioxidant properties cannot (Brielius-Flohe & Traber., 1999). α-T is thought to do this by 
affecting binding affinity between neutrophil and endothelial cells by decreasing the expression 
of adhesion molecules on endothelial cells (Mirbagheri  et al., 2008). 
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γ-T is found in nuts, seeds and vegetable oils and has been found to promote health and protect 
against disease predominantly defending against reactive nitrogen species (NOS). Furthermore 
it has been found to reduce inflammation, prevent certain types of cancer and activate genes 
that protect against Alzheimer’s disease. γ-T has anti-inflammatory properties as it inhibits 
COX-2, this is a property not shared with α-T. γ-T also acts as a powerful nucleophile that traps 
electrophilic mutagens. Thus γ-T may protect lipids, DNA and proteins from peroxynitrte-
dependent damage (Brielius-Flohe & Traber., 1999). This point demonstrates the sensitivity 
that the geometric structures of vitamin E have on their respective therapeutic properties. In 
this case one methyl group changes anti-inflammatory properties from decreasing binding 
affinity between neutrophil and endothelial (α-T) to the inhibition of COX-2 (γ-T) with the first 
acting as a signalling molecule and the second as an enzyme binding inhibitor.  
 
Recent studies have shown that the reason the α-T has the highest bioactivity is due to it 
preferentially appearing in plasma after passage through the liver. The reason for this is thought 
to be α-T is binding to the α-tocopherol transport protein (Brielius-Flohe & Traber., 1999). 
Although this is not directly relevant to oral healthcare it does show that the human body is 
preferentially increasing α-T in plasma for some reason, possibly because it is the tocopherol 
with the most beneficial properties. 
 
1.5.5 Stereo isomers of vitamin E 
 
In addition to the 8 geometric isomers of vitamin E listed in section 2 there are a further 8 
stereoisomers associated with each tocopherol isomer which can be seen in Figures 1.5 and 1.6 
(R symbols represent either H or Me depending on geometric isomer).    
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The stereochemistry of α-T has a direct effect on the bioactivity of the molecule and most likely 
affects aggregate architecture. It has been found that the RRR, d, (+) stereoisomer is the most 
bioactive. This is because the α-tocopherol transport protein as well as specifically binding α-
T also specifically binds the RRR α-T isomer and incorporates it into plasma lipoproteins. This 
is thought to be because this stereoisomer is most resistant to degradation (Brielius-Flohe & 
Traber., 1999). This is a significant factor for using tocopherols in oral healthcare products as 
if a higher retention time of the actives are required then the active chosen should have the 
most resistance to degradation, in this case RRR α-T.  
 
1.5.6 Ester derivatives of (+) α-T    
 
In addition to the 8 geometric isomers and the 8 stereoisomers of the tocopherols there can be 
more vitamin E generated by esterification of the alcohol functional group on the aromatic ring 








































Figure 1.7. Esterified derivatives of (+) α-tocopherol. 
(+) α-tocopheryl acetate 
(+) α-tocopheryl phosphate 
(+) α-tocopheryl polyethylene glycol succinate 
(+) α-tocopheryl nicotinate  
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In theory any functional group can be added to any species of vitamin E providing that the 
functional group being added can undergo an esterification reaction with an alcohol. This is 
significant as in theory each variation of functional group will change the molecules physical 
and chemical properties which will provide different aggregation properties for drug delivery 
and a variation of therapeutic effects. For example it is known that the esterified derivatives 
are more stable than there alcohol equivalents as they no longer behave as antioxidants because 
the hydroxyl group no longer exists and so can no longer act as a radical scavenger (Moddaresi., 
2010). This chemical modification would also likely effect aggregate architecture. 
 
In the case of some esterified derivatives the compounds become more water soluble compared 
to their alcohol precursors which are lipid soluble. This is of high importance in an oral 
healthcare product as the mouth retains water and so in order for a product to be successful the 
product must be water soluble. An example of this is α-TA (alpha tocopheryl acetate), in this 
case a study has been carried out to assess α-TA’s ability to accumulate in the gingival margin. 
The study verified that enriched vitamin E can be found in gingival tissue if treated with 
toothpastes containing α-TA. This is significant is showing that tocopherols can prevent or 
even cure gingivitis which is thought to affect 95% of all people (Lienau et al., 2002). However, 
it is known that α-T is the most biologically active form of vitamin E and α-TA is significantly 
less active than α-T. In comparison alpha tocopheryl phosphate (α-TP) shows relatively high 
levels of biological activity whilst still being water soluble (Thiele et al., 2005).  
 
1.5.7 Vitamin E phosphate biological activity 
 
Recently (2003) it has been found that there are significant amounts of endogenous α-
tocopheryl phosphate (α-TP) in animal and plant tissue as well as in some foods (chocolate and 
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cheese) and exhibits anti-inflammatory capabilities (Ogru et al., 2003). The reason why this 
has been a recent discovery is because during the purification of α-T there is a hydrolysis 
procedure to break any ester bonds. However, the phosphate group in α-TP is not hydrolysed 
by the conditions in this purification and instead forms a salt. Therefore, α-TP always remained 
in the aqueous layer during extraction and was never detected. It has since been discovered that 
ESMS (ElectroSpray Mass Spectrometry) is convenient for α-TP analysis (Ogru et al., 2003). 
 
Only small amounts of α-TP are found in endogenous tissue hence it is not likely to be a storage 
isomer (α-T reserves) but rather an active molecule in its own right. In fact α-TP is more potent 
than α-T as an anti-inflammatory in the signalling cascade. Therefore it is likely that this low 
level of α-TP is regulated by alkaline phosphatases and kinases to maintain a healthy level of 
α-TP, alkaline phosphatase removes the phosphate group and so converts α-TP to α-T with 












Scheme 1.1. Hypothetical function and regulation of α-TP (Negis et al., 2005). 
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Glibenclamide, an oral anti-diabetic drug and probenecid inhibit cellular internalisation of α-
TP. It is also known that Glibenamide and Probencid are Organic Anion Transporter (OAT) 
inhibitors. Therefore it is hypothesised that α-TP enters cells via OAT’s and not membrane 
diffusion (Negis et al., 2007). Interestingly α-tocopheryl succinate (α-TS) has also shown signs 
of having anti-inflammatory properties similar and as potent as α-TP suggesting that α-TS can 
substitute α-TP at cellular receptors (Gianello et al., 2005).  
 
α-TP has been shown to be a potent anti-inflammatory as it is capable of interacting in both the 
humoral or cell mediated immunity inflammatory immune response. This is due to α-TP’s 
ability to act as a mediator for modulating signal transduction (interaction with cell mediated 
inflammation) and gene expression (interaction with humoral mediated inflammation). 
Firstly, the way in which α-TP acts as a mediator for signal transduction is that α-TP inhibits 
the generation of pro-inflammatory cytokins and markers including IL-1β, IL-6, plasminogen 
activator inhibitor-1, TNF-α and C-reactive protein (Nishio et al 2011). α-TP is also effective 
in inhibiting smooth muscle cell, monocyte and smooth muscle proliferation, inhibition of 
oxLDL (oxidised low density lipoprotein) uptake and the scavenger receptor CD36 (signals 
macrophages) (Munteanu et al., 2004). Secondly, the way in which α-TP acts as a mediator for 
gene expression is by increasing in stimulator-induced cyclooxygenase 2 mRNA expression 
and suppressing p38 MAPK phosphorylation reducing PGE2 synthesis (Kato et al., 2011). This 
shows that α-TP has a wide range of anti-inflammatory properties, inhibiting both damaging 
cytokines which in turn reduces immune destruction and also inhibits prostaglandins which 
reduce likelihood of bone resorption occurring (bone loss, release of minerals in advanced 
forms of periodontal disease).    
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Other uses for α-TP include reducing the risk of atherosclerotic (hardening of artery walls via 
a build-up of plaque resulting in an inflammatory response) cardiovascular disease (Libinaki 
et al., 2010) and a use in human skin care products as it can protect against skin damage caused 
by UVB radiation (prevents damaged cell formation and PGE2 synthesis). In fact α-TP has 
shown enhanced protection against inflammation markers in skin tissue compared to α-TA and 
glycyrrhizin acid which are known anti-inflammatory agents (Kato et al., 2011). Also the 
regulatory influence of α-T and α-TP on P13K/Akt activity could represent an import signal 
for neurons and so would have an essential role in preventing predominant neurological 
symptoms of severe vitamin E deficiency and other neurodegenerative diseases (Zingg et al., 
2010). This shows that α-TP is likely to have many therapeutic and essential roles in vivo in 
addition to the hypothesis of being an anti-inflammatory agent in the prevention of gingivitis.   
 
Interestingly it has been found that HGF’s (Human Gingival Fibroblast’s) are critical in 
sustaining inflammation in periodontal disease. This is because HGF’s are intolerable to LPS 
and generates prolonged, excessive responses of macrophages and monocytes (other cells are 
likely to be involved) (Ara et al., 2009). It has also been found that α-T is able to accelerate 
proliferation which increases the synthesis of bFGF (basic fibroblast growth factor) which 
results in more LPS intolerance and so pro inflammatory compounds are maintained (Nizam 
et al., 2014). This is an interesting contrast to α-TP which inhibits proliferation showing that 
perhaps in vivo α-T and α-TP regulate HGF proliferation. However, one hypothesis could be 
that periodontal bacteria hinder the production of α-TP resulting in no inhibition of 
proliferation of HGF’s and a down regulation in anti-inflammatory capabilities. Therefore in 
this case external α-TP would be required to maintain a homogeneous environment.    
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Therefore in the context of oral healthcare it can be seen that α-TP is an attractive anti-
inflammatory molecule and could be used to prevent gingivitis and periodontal disease. It has 
been seen that synthetic α-TP is soluble in water at high pH (9.5), inorganic solvents, aqueous 
THF (1:9 respectively, with 1% NH3) (Gianello et al., 2005)
 and ethanol and is likely to be 
soluble in any neutral – basic pH polar solvent due to the charged nature of the phosphate 
group. It is also soluble in organic solvents at low pH as the phosphate group is protonated 
(pKa of α-TP phosphate protons is predicted at 1.80 and 6.74, hence phosphate group should 
be mostly completely deprotonated at neutral pH) but its supramolecular chemistry effect on 
biological activity is yet to be investigated. α-TP has also been found as an endogenous form 
within animal/ plant tissue and some foods making it a suitable and relatively safe candidate 
for oral use.  In addition to this vitamin E toxicity is very rare and supplements are widely 
considered to be safe.  The Cosmetic Ingredients Review Expert Panel (CIREP, 2002) 
concluded that α-TP is safe as used in cosmetic formulations, with the understanding that the 
vitamin E used in cosmetic products is of similar grade to that used in food (Libinaki et al., 
2005). 
 
The major problem to date is the predicted poor tissue retention time of α-TP due to its 
physiochemical properties: this is because α-TP is negatively charged and does not interact 
readily with the negatively charged membrane surfaces. However, studies need to be carried 
out to prove this and if necessary improve tissue resonance (Nishio et al., 2011). 
Hypothetically, these physiochemical properties could be altered by formulating α-TP with 
different electrolytes so that the α-TP aggregate architecture is transitioned. This should result 
in good uptake of α-TP and so would gain improved/ controlled retention time and perhaps 
accumulation of this active could be achieved resulting in an improved oral hygiene.  
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1.6 Nanomaterials in oral health 
 
Nanomaterials largely consist of rigid nanoparticles and amphiphilic self-assembling 
molecules (i.e. synthetic surfactants and natural phospholipids) that can form micelles 
(spherical, ellipsoids, cylindrical), liposomes (small univalent liposomes, large univalent 
liposomes, multilamella liposomes) planar bilayers, disorganised globular structures and 
hexagonal conformation packing structures. It is often thought that it is ‘free’ soluble active 
molecules that are released nanomaterials lead to the greatest therapeutic effect but more 
recently it has been found that supramolecular structures with hydrophobic cores and 
hydrophilic surfaces are capable of penetrating hydrophilic tissue, releasing the active 
molecules at a desirable location, enhancing activity (Sutariya & Pathak., 2015). Nanoparticles 
can be engineered such that the hydrophilic actives adhere to their surfaces improving drug 
delivery whilst the self-assembling structures can be used to encapsulate hydrophobic actives 
to improve their delivery. 
 
Functionalising nanomaterial surfaces controls the surface chemistry and therefore controls the 
interactions between the nanomaterial and the biosystem in which it is applied to improve drug 
delivery and disease therapy providing a versatile platform in biomedical applications (Mout 
et al., 2012; Wang et al., 2009). In the case of nanoparticles the surface has been functionalised 
with small molecules, surfactants, dendrimers, polymers, and biomolecules (including anti-
bodies/ receptors) by covalent and non-covalent attachment. However, in the case of 
amphiphilic bioactives, they themselves aggregate though drug-drug interactions. These nano-
assemblies are commonly characterised by their critical micelle concentrations (CMC)/ critical 
aggregation concentrations (CAC) by where there is an abrupt change in the samples physical 
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properties i.e. surface tension, electrical conductivity, viscosity and light scattering with 
increasing molecule concentration.  
 
There are some examples of nanotechnologies being employed in the oral heath market. Zinc 
oxide (ZnO), copper oxide (CuO), titanium dioxide (TiO2) and silver (Ag) nanoparticles have 
been found to improve the consilient agents antimicrobial properties when administered as 
colloidal dispersions in aqueous vehicles. The nanomaterial form has been found to be have 
lower minimum inhibitory concentration (MIC) and minimum bactericidal concentration 
(MBC) values than chlorohexidine against S. mutans and S. sanguis (Ahrari et al., 2015). In 
addition the antimicrobial CHX has been found to have enhanced solubility and stability when 
formulated with nano carriers leading to an enhanced antimicrobial effect against C. albicans 
and S. mutans (Pupe et al., 2011). However, this is a new and rapidly growing area of research 
and therefore much investigation needs to be performed to fully exploit it. Interestingly 
supramolecular structures such as liposomes have been found to have enhanced biofilm 
penetration, tooth surface binding, deliver an encapsulated active or themselves being 
therapeutic (Nguyen & Hiorth., 2015). Vitamin E phosphate being a phospholipid is likely to 
aggregate and hence may have enhanced drug delivery. 
 
1.7 Aim and scope of the PhD 
 
Nanomedicines are increasingly being used for the improvement of oral health (Narang & 
Narang., 2015; Ozak & Ozkan., 2013). (+) α-T has been found to self-assemble in aqueous 
solutions and it is likely that the amphiphilic (+) α-TP will also form aggregates when in vivo. 
However, the introduction of the phosphate, that will be charged at physiological pHs will 
affect aggregate architecture, which may modify the agents biological response compared to 
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the parent compound (+) α-T. The tocopherols may function as both antimicrobial and anti-
inflammatory agents in the oral cavity according to the literature that describes these and 
similar compounds, but as yet these actions have not yet been systematically investigated. The 
aim of this project was to assess if (+) α-TP could be employed as a multi-functional 
antimicrobial and anti-inflammatory nanomedicine that could be used as part of an oral 
healthcare routine. In order to address this aim the following objectives were set: 
 
1. To develop a robust esterification method for synthesising high purity naturally 
derived (+) α-TP, spectroscopically characterise the product and assess its 
aggregation behaviour.  
 
2. To observe if (+) α-TP had enhanced anti-biofilm activity over (+) α-T against 
single bacterial species and multispecies salivary biofilms. Assess its 
hydroxyapatite binding and compare (+) α-TP’s antimicrobial potency with 
commercially available antimicrobial agents found in mouthwash.   
 
3. To investigate how the (+) α-TP nanostructure physical properties (conformation, 
size and charge) influence its ability to interact with bacterial membranes, penetrate, 
kill and inhibit the growth of oral biofilms..  
 
4. To compare (+) α-T, (±) α-TP and (+) α-TP nanostructure swellability upon delivery 
to the mouth, assess their toxicity on gingival cells and develop an inflammatory 
cell culture assay that closely resembles the in vivo conditions in order to assess 
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The name Vitamin E includes a range of different molecular isomers (tocopherols/ tocotrienols) 
(Figures 1.3, 1.4, 1.5 and 1.6). Their phosphorylated derivatives could be useful compounds 
for use in maintaining good oral health as they have been found to have anti-inflammatory 
efficacy (Ogru et al., 2003; Libinaki et al., 2010). However, only one phosphorylated vitamin 
E derivative is commercially available and that is the synthetic (±) α-TP racemic mixture (8 
isomers, Figure 1.5 and 1.6). The natural and most bioactive stereoisomer configuration of the 
vitamin E phosphate derivatives is the +, d, RRR tocopherols and so a phosphorylation method 
was required. The four natural (+) tocopherol geometric isomers (Figure 1.2) derived from 
plant extracts are commercially available and this in principle could provide a starting material 
for the synthetic production of the desired (+) isomers. However, the naturally sourced (+) 
tocopherol activity is also influenced by the geometric isomer in which it is used.  
 
Naturally occurring vitamin E is found in vegetable oils such as corn, rapeseed, soybean and 
sunflower oil and was discovered in 1922 by Evans and Bishop (Gliszczyńska-Świgło et al., 
2007; Zingg et al., 2010). Vitamin E functions as a chain-breaking antioxidant that prevents 
the propagation of free radical reactions (Nishio et al., 2011). The structures of vitamin E have 
recently had their therapeutic relevance expanded (Zhao et al., 2011; Mirbagheri et al., 2008), 
but not all of the structures have been synthesised in pure form. Variations of vitamin E include 
geometric changes on the aromatic ring, geometric changes on the hydrocarbon chain and 
stereochemistry changes on the hydrocarbon chain (Brigelus-Floshe & Traber., 1999). Alpha 
Tocopherol (α-T) is the most abundant geometric form of vitamin E in nature; it has the highest 
biological activity with the (+), d, RRR species being the most bioactive stereoisomer 
(Brigelus-Floshe & Traber., 1999) (Figure 1.5). In addition, only the (+) isomer has been found 
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in nature due to specific enantiomeric synthesis by photosynthetic organisms (Caretto et al., 
2010; Schulze-Siebert et al., 2000).   
 
(+) α-T has two major drawbacks for use in an oral health product. The first being it is highly 
lipophilic (Thiele et al., 2005) and hence would limit the concentrations that could be used in 
aqueous mouthwash products. Secondly, (+) α-T is known to be chemically unstable due to its 
sensitivity to light which could reduce its shelf life. The esterification of α-T is a method that 
has been used to overcome these issues (Moddresi., 2010). These esterification reactions have 
included formation of acetate, polyethylene glycol succinate, nicotinate and phosphate esters 
(Figure 1.7). In this project the focus will be on the potential use of (+) alpha tocopheryl 
phosphate (α-TP) to improve oral health.  
 
(+) α-TP has been found to be endogenous in animal and plant tissue (Ogru et al., 2003). 
Phosphorylation reactions are common in nature, and so the presence of small amounts of α-
TP in plants and animals, which have α-T in their diet, is unsurprising. However, it was 
surprising that α-TP has only recently been discovered in animal and plant cells. This was due 
to the pH dependent solubility of the compound in aqueous/ organic extractions (Gianello at 
al., 2005). The detection of α-TP in animal and plant tissue was missed for so long due to the 
fact that vitamin E extraction processes ended with a basic pH extraction into an organic layer. 
The basic conditions generated the water soluble α-TP salt which did not partition into the 
organic phase. The aqueous phase was not tested as the researchers at the time did not anticipate 
a water soluble form of the vitamin.  
 
Two reactions that can be used to phosphorylate α-T have been published.  One reaction used 
phosphorus oxychloride (POCl3) as the phosphorus source (Reaction 1) (Nishio et al., 2011) 
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whilst the other used phosphorus pentoxide (P4O10) (Reaction 2) (Gianello et al., 2005). 
Reaction 1 did not state product purity, but the researchers claimed to achieve a 47% yield of 
α-TP after purification by trituration with boiling ethanol. Reaction 2 claimed a pure product 
was produced but did not state a yield. This literature provided a starting point for the 
development of a synthetic route, but a more systematic approach to the synthesis and 
characterisation was required. In addition, as (+) α-TP is an amphiphilic molecule it can be 
reasonably assumed it will form aggregates when dispersed in polar solutions with a –ve charge 
due to the phosphate group. However, its critical aggregate concentration (CAC) and physical 
stability over time has not been reported, but would likely influence any potential biological 
activity in the mouth and so also needs to be studied.    
 
The aim of this Chapter was to synthesise, characterise the molecular aggregation and assess 
the chemical stability of (+) α-TP when in a vehicle suitable for topical use in an oral health 
product. This was because the most biologically active and only naturally occurring 
stereoisomer of α-TP (RRR, + or d) was not easy to extract from natural sources, a synthetic 
esterification method, which generated (+) α-TP from plant extracted (+) α-T, was developed. 
(+) α-TP from this synthesis was still classified as natural due to the natural origin of the starting 
material (Moddresi., 2010). Following the synthesis, it was considered necessary to analyse the 
physical characteristics of (+) α-TP in an aqueous vehicle suitable for application to the oral 
cavity as very little was known about the aggregation behaviour of this amphiphilic agent in an 
aqueous system and how this could influence antimicrobial activity. A 20% ethanol, 80% water 
mixture at pH 7.4 (Tris buffer) was selected as the vehicle for (+) α-TP as it was able to 
solubilise a good amount of the active and it could be used in an oral healthcare product as 
there are commercial products available with a similar alcohol content such as Listerine 
Original antiseptic mouthwash.  
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(+) α-T (Type VI, ~40% purity), phosphorus oxychloride (POCl3) (≥ 99%), tetrahydrofuran 
(THF) (anhydrous) (≥ 99.9%), triethylamine, trizma hydrochloride (Tris) (≥ 99%), 
trifluoroacetic acid (TFA) (≥ 99%), deuterated chloroform (CDCl3), C18 silica and (±) alpha 
tocopheryl phosphate (≥ 97%) were purchased from Sigma Aldrich, UK. Hexane fractions (60-
80), propan-2-ol, methanol, formic acid (FA), absolute ethanol, disodium hydrogen phosphate, 
monosodium dihydrogen phosphate, hydrochloric acid, sodium hydroxide and HPLC mobile 
phase membrane filters (nylon 0.2µm pore size 47mm diameter) were purchased from Fisher 
Scientific Ltd, UK. All chemicals without a purity displayed were reagent grade. De-ionised 
water was used from laboratory supply. Disposable clear dynamic light scattering cuvettes 
(macro, PMMA) and disposable folded capillary cells (DTS1070) where purchased from 




2.3.1 Nuclear Magnetic Resonance (NMR) spectroscopy  
 
1H, 13C and 31P NMR spectra were recorded using a DRX 400 instrument (Bruker, UK) using 
TOPSPIN software for data acquisition and analysis. Spectra were obtained in CDCl3 at 296 K 
using a 5 mm switchable broadband probe. Proton NMR parameters included a sweep width 
of 8250.825 Hz, an acquisition time of 4.0  sec, an interpulse delay time of 1 sec and 16 scans 
within a zg30 pulse program. Carbon NMR used a sweep width of 24038.461 Hz, an 
acquisition time of 1.4 sec, an interpulse delay time of 2 sec and 1000 scans all within a zgpg30 
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pulse program. Phosphorus NMR used a sweep width of 64724.918 Hz, an acquisition time of 
0.5 sec, an interpulse delay time of 2 sec and 16 scans all within a zgpg30 pulse program.         
 
2.3.2 Fourier Transfer Infer-Red (FTIR) analysis 
 
Deuterated chloroform (CDCl3) was employed in the infrared analysis of the (+) α-TP 
solutions. The samples were loaded into a demountable universal transmission cell system 
(Omni-Cell, Specac Ltd, UK) fitted with calcium fluoride (CaF2) windows and a 25 μm Mylar 
spacer (Specac Ltd., UK). All spectra were produced using 32 scans collected at a spectral 
resolution of 4 cm-1. The data was recorded using a Spectrum One spectrometer (Perkin-Elmer 
Ltd., UK) and analysed with Spectrum software (version 10, Perkin-Elmer Ltd., UK). 
 
2.3.3 Mass spectrometry 
 
Mass spectra were recorded using a micromass ZQ 2000 instrument (Waters, UK), operating 
in negative electrospray ionisation (ESI) mode. The sample was directly infused into the ESI 
source at a 20 μl/ min flow rate. The nebulization gas was N2, the capillary potential was 2.80 
kV, the drying gas was 500 l/ h and the RF lens was set to – 0.5 V. The sample cone voltage 
was set to -40 V and the source temperature was 100 °C whilst the desolvation temperature 
was set to 250 °C.  The sample concentration was 100 µg/ mL, prepared in 50% methanol, 50% 
water and 0.1% FA. 
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2.3.4 High Performance Liquid Chromatography (HPLC) 
 
The HPLC system used Millenium 32 software, which employed a p200 pump (Spectraseries, 
UK), autosampler (Waters 717 plus) and a photodiode array detector (Waters 996, UK). The 
column (Phenomenex, Luna C8(2), UK) had a pore size of 100 Å, a particle size of 5 µm and 
column dimensions of 4.6 mm x 250 mm. The mobile phase consisted of 70% propan-2-ol, 
30% water and 0.1% TFA and was filtered and sonicated (PS40A - 10 Litre Bath with Heater, 
Monmouth Scientific, UK) prior to use. The injection volume was 50 µL, the flow rate was 1 
mL/ min and a UV detection wavelength range of 214 - 350 nm was employed with run times 
of 14 minutes. 
 
2.3.5 Elemental analysis 
 
(+) α-TP samples were submitted to Medac Ltd, UK, for further proof of identity and purity 
confirmation by elemental analysis. Carbon and hydrogen compositions were assessed by 
microanalysis. The technique used was based on the quantitative “dynamic flash combustion” 
method. The samples were held in a tin capsule, placed inside the autosampler drum 
(FlashEA®1112 Elemental Analyzer, UK) where they were purged by a continuous flow of 
helium and dropped at pre-set intervals into a vertical quartz tube maintained at 900ºC. When 
the samples were dropped inside the furnace, the helium stream was temporarily enriched with 
pure oxygen and the sample and its container melted with the tin promoting a violent reaction 
(flash combustion). Under these favourable conditions, even thermally resistant substances are 
completely oxidised. Quantitative combustion was then achieved by passing the mixture of 
gases over a catalyst layer. The mixture of combustion gases was then passed over copper to 
remove excess oxygen and to reduce the nitrogen oxides to elemental nitrogen. The resulting 
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mixture was then directed to a chromatographic column where the individual components were 
separated and eluted as carbon dioxide and water by the TCD signal, which fed the automatic 
workstation (EAGER300™, USA). The instrument was calibrated with the analysis of standard 
compounds using K factor calculations or the linear regression method incorporated in the 
EAGER300™ software. 
 
2.3.6 Circular dichroism (CD) 
 
QS cuvettes (0.5 mm, Starna Scientific Ltd, UK  or 10 mm, Hellma, UK ) were used for UV-
Vis and circular dichroism (CD) experiments. They were washed with water then ethanol and 
dried with nitrogen before use. Samples of either the (+) or (±) alpha tocopheryl phosphate 
(100 µM in 20% ethanol, 80% water, 25 mM Tris,  pH 7.4) were then added to cuvettes and 
were inserted into a spectrophotometer (Applied photophysics, Leatherhead, UK) for 
measurements using Chirascan plus software (version 4.2.15). The photodiode detector 
(Avalon, UK) CDDC channel used 1000 volts. Wavelengths were measured from 180 – 400 
nm taking a reading every 1 nm with a bandwidth of 2 nm. Measurements were completed at 
25 °C set by a temperature jack (Quantum northwest (TC-125), USA). Vehicle spectra were 
used as a blank for background subtraction.    
 
2.3.7 (+) α-TP aggregation analysis 
 
Molecular aggregation was analysed by photon correlation spectroscopy (Malvern Nanoseries 
Zetasizer, Malvern Instruments Ltd, UK). Detection of the light scattering signal was 
performed at 173 ° at 25 °C. Samples were placed in low volume disposable cuvettes. The 
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material refractive index was set at 1.59, the material absorbance at 0.01, the dispersant 
refractive index at 1.3469 and the sample viscosity (cP) at 2.143. The duration of experiments 
ranged from 60 - 100 second during which the measurement position and attenuation was 
automatically optimised by the machine. All the (+) α-TP samples were dissolved in 20% 
ethanol 80% water solvent systems buffered at pH 7.4 +/- 0.2 with Tris. Blank solutions 
(containing just solvent) and (+) α-TP (100 μM) solutions were assessed for aggregation over 
a 7 day period by monitoring the non-attenuated derived count rate (Kcp) and size (nm) in 
triplicate.  
 
Critical aggregation constant (CAC) data was calculated by monitoring the non-attenuated light 
scattering of 0.00512, 0.0062, 0.008, 0.01, 0.02, 0.1, 1, 10, 75, 300, 600, 900, 1200 and 1500 
μM solutions of (+) α-TP at 18 h and 164 h time points in triplicate. The CAC was calculated 
by finding the intersection of two log10 models applied to the (+) α-TP concentration verses 
non-attenuated light scattering plots. This was calculated by solving the two log10 equations of 
the models. The second log10 model was considered to start at the first (+) α-TP concentration 
that showed a significant difference in the non-attenuated light scattering signal when 
compared to the blank. The two data sets (18 h and 164 h) were also used to compare aggregate 
size and polydispersity index of the (+) α-TP concentrations to assess aggregate stability. 
Previous aggregate stability has been monitored over a 3 day refrigerated period and so a longer 
time course was selected (Correia et al., 2012). Sedimentation occurred at higher 
concentrations over time and hence all samples were re-suspended by vortexing (Whirlimixer, 
Fisherbrand, UK) prior to measurement. 
 
(+) α-TP aggregate zeta potentials were analysed by electrophoresis spectroscopy (Malvern 
Nanoseries Zetasizer, Malvern Instruments Ltd, UK). Detection of voltage signals were 
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performed at 25 °C. The disposable folded capillary cells material refractive index, material 
absorbance, dispersant refractive index and viscosity were set as per the light scattering 
experiments and the dielectric constant was set at 78.5. The Henry’s function (F(Ka)) to 
interpret the data was the Smoluchowski (1.5) option.  The duration of the equilibration time 
was set at 120 seconds with the experiment measurement positions and attenuations 
automatically optimised by the machine. The number of runs was set at a minimum of 10 and 
a maximum of 100. The measurements were carried out in triplicate. (+) α-T aggregates in Tris 
buffer (25mM) were used as a control to observe the effect of phosphorylation on the aggregate 
zeta potential values. 
 
2.3.8 HPLC chemical stability comparison of (+) α-T and (+) α-TP 
 
The chemical degradation rates of (+) α-TP and (+) α-T (20 µg/ mL, 39 µM) when dispersed 
in a 20% ethanol, 80% water at pH 7.4 (Tris buffer, 25 mM) vehicle was calculated over a 12 
week period. Samples were stored at 37°C in clear HPLC snap neck vials (1 mL) and the 
concentration was assessed every 4 weeks. The HPLC system was equilibrated (0.1 mL/ min 
flow rate) overnight prior to calibration/ sample testing and calibrated ((+) α-TP - 2, 5, 10, 20, 
50 and 100 µg/ mL) one day prior to sample testing to ensure the system was operating 
consistently allowing time points to be compared. The HPLC method used to generate each 
chromatogram was as described in section 2.3.5. Peak area was used to calculate sample 
concentration with the linear gradient of the data time points being used to calculate the 
degradation rate. The limit of detection (LOD) and limit of quantification (LOQ) were 
calculated using the LINEST function on the calibration curve data and were found to be 1.13 
and 3.78 µg/ mL respectively for (+) α-TP and 2.34 and 7.81 µg/ mL respectively for (+) α-T. 
The precision (CV/ relative standard deviation) and linearity (R2 value) for both the HPLC 
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calibration curves were found to be 2% and ≥ 0.99 respectively. These values showed the assay 
was ‘fit for purpose’. This assay allowed an assessment of the two molecules commercially 
viable in this formulation as the industrial chemical degradation tolerance is below 10% 
degradation of a 0.05% w/v (500 µg/ mL) solution over 12 weeks at 40°C. This assay also 
enabled an assessment as to how long (+) α-T and (+) α-TP laboratory formulations could be 
stored without affecting any potential biological activity. 
 
2.3.9 Data analysis 
 
All error values were expressed as their mean ± standard deviation (SD). Statistical analysis of 
data was performed using Levine’s homogeneity test and ensured all sample group data was of 
acceptable distribution (P > 0.05) before statistical significance between the sample groups was 
assessed by one way analysis of variance (ANOVA) tests with post-hoc Tukey analysis in 











Chapter 2: Synthesis, Characterisation, Aggregation and Chemical Stability of  56 




2.4 Results  
 
2.4.1 Synthesis and chemical characterisation of (+) α-TP 
 
The synthesis of (+) α-TP was performed according to Scheme 2.1 which was a modified 













Scheme 2.1. Chemical synthesis of (+) alpha tocopheryl phosphate from (+) alpha tocopherol. 
 
 
Over a period of 30 minutes (+) α-T (3.0395 g, 7.057 mmol) in anhydrous THF (25 mL) with 
triethylamine (2.854 mL, 20.47 mmol, 2.9 equivalence) was added to a solution of phosphorus 
oxychloride (1.973 mL, 21.17 mmol, 3 equivalence) in anhydrous THF (15 mL) under 
nitrogen, stirring, at room temperature (3 hours). Only a small trace of (+) α-T (Rf = 0.32) was 
detected using thin layer chromatography (TLC) analysis (9:1, hexane: ethyl acetate), 
compared to the (+) α-TP product (Rf = 0).  The white triethylamine hydrochloride (side 
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product) was removed (suction filtration). Distilled water (75 mL) was added to the mixture 
and allowed to stir for 24 hours. Hexane (75 mL) was added to generate a two phase system. 
The product preferentially partitioned into the hexane layer and was extracted from the hexane 
by shaking with disodium hydrogen phosphate (10 mM, 50 mL, pH 10.8). An aliquot of 
absolute ethanol (25 mL) was added to the product in order to eliminate foaming. The disodium 
hydrogen phosphate solution containing the product was then acidified with hydrochloric acid 
(2M, 20 mL) and the product was extracted for a third time using hexane (40 mL). This third 
hexane extraction was repeated and the combined hexane layers placed under vacuum to 
generate an off white flaky solid which was considered to be the crude (+) α-TP product (0.7221 
g, 50.1%). The crude product was purified using C18 silica packed glass column (30 cm x 3 
cm) with a 70% propan-2-ol, 30% water and 0.1% TFA mobile phase.  
 
(+) α-TP was obtained with a 27% yield. There was no (+) α-TP analytical standard to enable 
the calculation of the absolute purity of the product; hence an assessment of relative purity was 
performed using HPLC. A value of 99% was obtained by calculating the relative area of the 
(+) α-TP peak as a percentage of all other peaks in the liquid chromatographic run. Preliminary 
phosphorus NMR experiments found that sodium phosphate generated a peak at -0.05 ppm and 
phosphorus oxychloride generated a peak at 4.53 ppm. The phosphorus NMR analysis of the 
(+) α-TP product showed one signal at -1.27 ppm which matched the theoretical structure of 
the product (Figure 2.1).  With carbon NMR, 29 signals were observed, which matched the 29 
theoretical signals for the (+) α-TP product (Figure 2.2, see Table 2.1 for peak assignment). 
The proton NMR spectra contained numerous overlapping signals because the magnetic 
environments of protons on the hydrocarbon ‘tail’ are similar. However, the three aromatic 
methyl groups of (+) α-T and (+) α-TP were assigned (highlighted in Figures 2.3A and B) and 
they indicated that the conversion from (+) α-T to (+) α-TP was successful. This was because 
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the aromatic methyl group protons changed in the chemical environment when the hydroxyl 
group was converted to a phosphate ester. This resulted in a change in their H1 NMR chemical 
shift signals from two singlet peaks at 2.11 and 2.16 ppm (two peaks overlapping) for (+) α-T 
to three singlet peaks at 2.05, 2.07 and 2.11 ppm for (+) α-TP. This was also useful in ensuring 
there was no starting material was in the product because if both compounds were present 4 
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Figure 2.1. Phosphorus nuclear magnetic resonance spectra of the (+) alpha tocopheryl 
























Figure 2.2. Carbon nuclear magnetic resonance spectra of the (+) alpha tocopheryl phosphate 
naturally derived product in deuterated chloroform. 
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Figure 2.3. Proton nuclear magnetic resonance spectra of the (+) alpha tocopheryl phosphate 
naturally derived product (A) and the (+) alpha tocopherol starting material (B) in deuterated 
chloroform. The changes in aromatic methyl group proton environments caused by 
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Table 2.1. Assignment of naturally derived (+) alpha tocopheryl phosphate carbon nuclear 
magnetic resonance spectrum (Baker & Myers., 1991). 
Assignment  PPM 
C5   - CH3 12.2 
C8   - CH3 13.4 
C7   - CH3 14.3 
C4’  - CH3 20.3 




C12’ - CH3 23.2 
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The carbon NMR of the commercially available (±) α-TP isomers demonstrated that the three 
chiral carbon atoms had different chemical shift values which were dependant on the isomer 
stereochemistry configuration (Figure 2.4A). There are 8 variations of the chiral carbon 
arrangements (RRR, RRS, RSR, SRR, RSS, SSR, SSS and SRS) and so theoretically each 
chiral carbon would have had a different chemical shift for each isomer but as the chemical 
environment remained similar not all 8 peaks were resolved but did show multiplet like peaks 
(Figure 2.4A inset). However, the synthesised naturally derived (+) just had the predicted 29 
peaks for the 29 different carbon environments with the chiral carbons peaks being fully 
resolved singlets (Figure 2.4B inset) showing stereochemistry was retained throughout the 
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Figure 2.4. Carbon nuclear magnetic resonance spectrums of commercial (±) alpha tocopheryl 
phosphate (A) and naturally derived (+) alpha tocopheryl phosphate (B) aliphatic regions with 
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The FTIR confirmed the functional groups within the (+) α-TP structure (Figure 2.5). The 
absorption bands between 2959 - 2843 cm-1 are associated with the asymmetric and symmetric 
stretching vibrations of the CH2 and CH3 groups, the bands between 1462 - 1375 cm
-1 relates 
to the aromatic (C=C) stretching, CH3 asymmetric bending and CH3 symmetrical bending, the 
band at 1221 cm-1 results from the CH2 torsion mode and the band at 1090 cm
-1 is associated 
with the plane bending of phenyl (Silva et al., 2009). The band at 985 cm-1 results from the 
phosphate ester as this band is commonly seen in phospholipid esters i.e. phosphatidylcholine 



















Figure 2.5. Fourier transform infra-red spectra of the (+) alpha tocopheryl phosphate naturally 
derived product in deuterated chloroform. 
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The calculated M/Z of the (+) α-TP free acid is 510.4 g/ mol. The synthetic (+) α-TP showed a 
mass of 509.3 when assessed by negative mode ESI (Figure 2.6). The mass of the parent ion 













Figure 2.6. Mass spectrum of naturally derived (+) alpha tocopheryl phosphate (100 µg/ mL) 
in a 50% methanol, 50% water and 0.1% formic acid solvent system. 
 
The HPLC analysis of the (+) α-TP showed that the phosphorylation of (+) α-T (retention time 
10.8 min) resulted in the production of a new peak with a retention time of 7.9 min (Figure 
2.7). This reduction in retention time of the (+) α-TP compared to the (+) α-T was expected as 
(+) α-TP is more hydrophilic when compared to the reaction starting material. This data and 
the fact that no peak was observed at 10.8 min in (+) α-TP chromatograms provided further 
evidence that there was no starting material in the purified product. In addition, the peak 
observed at 2.9 min was found to be the solvent front as this was observed in the vehicle control 
injections.  
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Figure 2.7. High performance liquid chromatography chromatograms of (+) alpha tocopherol 
starting material and (+) alpha tocopheryl phosphate naturally derived product (100 μg/ mL, 
dispersed in 20% ethanol, 80% water, 25 mM Tris,  pH 7.4). C8 column, 50 µL injection 
volume, flow rate 1 mL/ min and 214 - 350 nm UV detection wavelengths, mobile phase; 70% 
propan-2-ol, 30% water and 0.1% Trifluoroacetic acid (v/v). 
 
The theoretical composition of carbon and hydrogen in (+) α-TP is 68.21 and 10.07% 
respectively. In the elemental analysis the compositions were found to be 68.25 and 10.30%, 
this showed a carbon match of 99.94% and a hydrogen match of 97.77%. This provided 
additional evidence that the phosphorylated product had been synthesised in high purity. 
The (+) and (±) α-TP were found to have UV absorption bands at 288 nm (n → π*), 219 and 
207 nm (n→π* and π→ π*) (Figure 2.8). However, in the CD the (±) isomer gave a flat line in 
both the 10 mm and 0.5 mm path length samples indicating that the different isomers were 
cancelling out each other’s rotation of light as expected (Figure 2.9A and B). The (+) isomer 
was found to have positive bands at 298, 240 and 207 nm and negative bands at 291, 231 and 
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217 nm in the 10 mm path length (Figure 2.9A). In addition when monitored in the 0.5 mm 
path length it was observed that there was a major peak at 207 nm (Figure 2.9B). For the (+) 
isomer the rotation bands appeared as differential signals but always first increased as 
wavelength decreases, this is denoted as positive (+) cotton effect (Person et al., 1995) and 
suggested aggregation could have been occurring (Cassim & Yang., 1967). Although there are 
three chiral centres in the α-TP molecule it is likely that the chiral centre within the pyran ring 
had the strongest influence on the aromatic electronic excitation bands of α-TP as the other two 
chiral centres were further away from the conjugated system. However, the pyran ring chiral 
centre was the most reactive chiral carbon for the stereochemistry to be altered as it had an 
oxygen atom bound making this chiral carbon more susceptible to nucleophilic attack. The 














Figure 2.8. UV absorption spectra with 10 mm path length (with annotated electronic transition 
bands) comparing the in house synthesised (+) alpha tocopheryl phosphate ( (+) alpha TP) (1 
isomer) and the commercially available racemic (±) alpha tocopheryl phosphate ((±) alpha TP) 
(8 isomers). Alpha TP concentrations were 100 µM dispersed in a 20% ethanol, 80% water, 25 
mM Tris vehicle at pH 7.4.  
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Figure 2.9. Circular dichroism spectra with 10 mm path length (A) and with 0.5 mm path 
length (B) comparing the in house synthesised (+) alpha tocopheryl phosphate ( (+) alpha TP) 
(1 isomer) and the commercially available racemic (±) alpha tocopheryl phosphate ((±) alpha 
TP) (8 isomers). Alpha TP concentrations were 100 µM dispersed in a 20% ethanol, 80% water, 
25 mM Tris vehicle at pH 7.4.  
A 
B 
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2.4.2 (+) α-TP Aggregation and Physical Stability Analysis  
 
Light scattering data demonstrated that (+) α-TP, when dispersed in 20% ethanol 80% water at 
pH 7.4 ± 0.2 (Tris buffer) generated aggregates (Figure 2.10 and 2.11). The attenuated derived 
count rate of the vehicle (blank) was 149 ± 59.4 kcps, but the (+) α-TP between 0.01 and 1.5 
mM resulted in an attenuated derived count rate increase which ranged from 1563 ± 36 to 6421 
± 87 kcps after 18 h. The CAC of (+) α-TP was found to be 5.5 ± 0.2 μM 18 h after preparation 
(Figure 2.10). The z-average diameter of the (+) α-TP (0.1 mM/ 0.005% w/v) aggregates was 
found to be 175 ± 21 nm; they had a slight negative charge of -14.9 ± 3.5 mV, a PDI value of 
0.359 ± 0.06 and a unimodal distribution (Figure 2.11). The z-average diameter of the (+) α-T 
(0.1 mM, 56044 ± 175 kcps) aggregates was found to be 563 ± 1 nm; they also had a slight 
negative charge of -10.5 ± 0.2 mV, a PDI value of 0.179 ± 0.03 and a unimodal distribution 
(Figure 2.12). 











Figure 2.10. Dynamic light scattering critical aggregate concentration calculation (CAC) of 
(+) alpha tocopheryl phosphate at 18 hours in 20% ethanol, 80% water at pH 7.4 ± 0.2 (25 mM 
Tris).  
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Figure 2.11. Aggregate size distribution (0.1 mM) (B) of (+) alpha tocopheryl phosphate at 18 
















Figure 2.12. Aggregate size distribution (0.1 mM) (B) of (+) alpha tocopherol at 18 hours in 
20% ethanol, 80% water at pH 7.4 ± 0.2 (25 mM Tris). 
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Reducing the concentration of (+) α-TP in the Tris vehicle increased aggregate sizes below 300 
µM (Figure 2.13) but this was likely an artefact due to the low derived count rate produced at 
low (+) α-TP concentrations. The (+) α-TP aggregates were found to be stable over an 8 day 
timescale as the size and polydispersity index of the aggregates remained the same (P > 0.05)  
(Figure 2.13 and 2.14). The CAC measured after 8 days was 8.4 ± 1.2 µM, just 2.9 µM higher 


















Figure 2.13. Dynamic light scattering size comparison at 18 Hours and 8 days of (+) alpha 
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Figure 2.14. Polydispersity index comparison at 18 hours and 8 days of (+) alpha tocopheryl 














Figure 2.15. 8 day critical aggregation concentration (CAC) calculation of (+) alpha tocopheryl 
phosphate (0.1 mM) in 20% ethanol, 80% water at pH 7.4 ± 0.2 (25 mM Tris).  
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2.4.3 Chemical stability comparison of (+) α-T and (+) α-TP 
 
The chemical stability studies demonstrated that (+) α-TP has a degradation rate of ~ 1.2 μg/ 
mL/ week indicating that chemical degradation did not influence the study’s results (Figure 
2.16). This data also demonstrated that the product was within the chemical degradation range 
to be commercially viable as the industrial chemical degradation tolerance is below 10% 
degradation of a 0.05% w/v (500 µg/ mL) solution over 12 weeks at 40°C. (+) α-TP was 
degraded by 14.4 µg/ mL over 12 weeks which corresponded to a 2.9% degradation of a 0.05% 
w/ v solution. Interestingly (+) α-TP was more chemically stable than (+) α-T, suggesting (+) 
α-TP may be less susceptible to oxidation. In addition (+) α-T failed the industry degradation 
tolerance test as it was calculated to be 11% but is likely higher than this due to the first time 
point being below the assays LOQ and so time points less than 4 week intervals would be 
needed to get this exact degradation rate of (+) α-T in this vehicle. The laboratory samples of 
(+) α-TP could be stored for 8 days before use but (+) α-T samples had to be freshly prepared 
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Figure 2.16. Chemical degradation rates of (+) alpha tocopheryl phosphate and (+) alpha 
tocopherol (20 µg/ mL, 1 mL) dispersed in 20% ethanol, 80% water at pH 7.4 (Tris buffer, 25 





α-TP is a water soluble derivative of the highly lipophilic α-T (Thiele et al., 2005). The natural, 
most biologically active structural isomer of α-TP, the (+) isoform, is not commercially 
available and so it was synthesised specifically for this project. Two reaction schemes that 
conserve the natural structural configuration, which is known to be the most biologically active 
form of (+) α-T (Brigelus-Floshe & Traber., 1999), have previously been reported (Nishio et 
al., 2011; Gianelo et al., 2005). As a prelude to this work both of these schemes were attempted, 
but neither was found to provide a suitable material for an oral healthcare product and hence 
modifications to the synthesis used by Nishio et al, 2011 were adopted. The chemical structure 
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of (+) α-TP was confirmed by NMR (phosphorus, carbon and proton), infra-red, mass 
spectrometry and elemental analysis. The adopted synthetic procedure generated a product that 
was of high purity (≥99%) according to HPLC in 27% yield.  
 
Each step of the synthetic process contributed to the loss of material. Firstly, not all the (+) α-
T starting material reacted with the POCl3, as indicated by TLC. A small trace of (+) α-T was 
still observed after the 3 hour reaction (Rf = 0.32). Secondly, when manipulating the pH 
dependent solubility of (+) α-TP for purification, there would have been losses of material at 
each of the three extractions as in immiscible solvent systems there is only a preferential 
partitioning of molecules, not an absolute partitioning. As an example, when the acidic water 
layer containing (+) α-TP was added to hexane, (+) α-TP being protonated and more 
hydrophobic, preferentially partitioned into the hexane layer but some (+) α-TP remained in 
the water layer. It would appear these two steps accounted for 50% of the material loss. The 
column chromatography purification of the crude (+) α-TP accounted for 23% loss of material. 
Apparently some of the (+) α-TP bound tightly to the C18 silica solid phase and could not be 
eluted. Attempts could be made to further optimise the reaction in order to achieve a higher 
yield. Perhaps the immiscible solvent (+) α-TP extractions could be removed and instead purify 
the 24 h water/ THF reaction mixture just using column chromatography.  
 
ICH guidelines state that the purity of new compounds should be calculated using an analytical 
standard. However, there was no analytical standard for (+) α-TP, only the (±) isomer was 
available which contained 8 isomers, which could have had an effect on the extinction 
coefficient and hence concentration based UV absorbance. Therefore the purity was calculated 
based the (+) α-TP peak areas as a percentage of all other peak areas in the HPLC 
chromatograms. The weakness of this approach is that any non UV active impurities present in 
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the sample would not be observed. However, elemental analysis of the (+) α-TP compound 
reinforced the purity value generated using our HPLC method as the % compositions of carbon 
and hydrogen were close to those of the theoretical values for the (+) α-TP structure. 
 
The chemical analysis of the product showed that the stereochemistry of (+) α-TP was retained 
as the carbon NMR generated 29 carbon peaks that closely resembled the 29 carbon peaks 
assigned by Baker &  Myers, 1991 for (+) α-T (whereas the commercial available (±) α-TP 
carbon NMR control was shown to have more than 29 peaks due to the presence of  the 8 
stereoisomers). 
 
The CD data generated from (+) α-TP gave confidence that the pyran chiral carbon remained 
at least predominantly in its R configuration throughout the reaction as (+) peaks were observed 
in the CD experiment and no peaks observed in the racemate mixture control. Again there was 
no (+) α-TP analytical standard to compare the (+) isomer CD peak intensities. The differential 
CD signals (Cotton effect) have been previously observed in dyes were the chromophoric 
groups acquired asymmetry through macromolecule interactions (Blout & Stryer L., 1959) and 
has been used for secondary, tertiary, quaternary structures and aggregation studies (Cassim & 
Yang., 1967). The ‘s’ shape signals in the CD suggested that (+) α-TP in this vehicle was 
interacting with other molecules and aggregating, which was having an influence on the 
aromatic electronic excitation bands by effecting molecular symmetry. 
 
The introduction of the hydrophilic phosphate group into (+) α-T generated an amphiphilic 
character. The (+) α-T (which only has a small non-charged hydrophilic domain) and the (+) 
α-TP aggregates possess different self-assembly characteristics i.e. the (+) α-TP nanostructures 
were smaller, more negatively charged and had a lower derived count rate. The (+) α-TP self-
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association generated nanostructures with a micro molar CAC, similar to the vitamin E 
derivative α- tocopheryl polyethylene glycol succinate 1000 (α-TS), which has previously been 
found to have a critical micelle concentration of 20 μM (Sadoqi et al., 2009; Muthu et al., 
2012). These initial aggregation studies showed that at concentrations relevant to its use as an 
oral health care product the (+) α-TP would likely form aggregates. The low CAC also 
suggested that the (+) α-TP aggregates should display a good physical stability (Wanga et al., 
2012). This was supported by the data derived in this study which showed the aggregates were 
found not to grow over time. The good physical stability was not surprising as high stability is 
common with phospholipid structures (Wu et al., 2010). Imaging techniques confirm the 
aggregate structures and are investigated in the next chapter.  
 
Drug aggregation can have a negative impact on antimicrobials, which often need to interact 
with the microorganisms to elicit their action as it can reduce the quantity of bioavailable 
substance (Balagopal & Arjunkumar., 2013; Ferretti et al., 1990). However, in the case of oral 
antimicrobials, which are required to enter biofilms to have their full effect on bacteria, the 
formation of nano-sized objects can be seen to be an advantage. For example, it has been shown 
that antimicrobial agents encapsulated in charged aggregates in the hundreds of nano meters 
size range (i.e. phospholipid liposomes and nanoparticles) can interact readily with biofilm 
surfaces, upon doing so the nanostructure is destabilised allowing the encapsulated 
antimicrobial to seep out into the biofilm and have an improved, targeted in vivo efficacy 
compared to the free drug (Meers et al., 2008; Drulis-Kawa & Dorotkiewicz-Jach., 2010). In 
this work it is envisioned that the (+) α-TP nanostructures themselves will have both the biofilm 
targeting and antimicrobial activity. 
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The chemical stability studies, which demonstrated that (+) α-TP has a degradation rate of ~ 
1.2 μg/ mL/ week indicated that chemical degradation would not influence future biological 
results and that it was a commercially viable molecule. Interestingly (+) α-TP was more 
chemically stable than (+) α-T, suggesting (+) α-TP may be less susceptible to oxidation 
(Sabliov et al., 2009). This is probably due to the mechanism of (+) α-T degradation starting 
with the formation of a free radical on the hydroxyl group. When phosphorylated this can no 
longer occur, and therefore the (+) α-TP must presumably be hydrolysed back to (+) α-T for 
the established vitamin E degradation pathways to be observed which would make degradation 




(+) α-TP was successfully synthesised using POCl3 as an intermediate. The product was shown 
to self-assemble into physically and chemically stable negatively charged nanostructures when 
dispersed in a polar vehicle at micro-molar CAC values. It was established that (+) α-TP is 
more chemically stable than (+) α-T. This material was used to investigate whether or not the 
addition of a phosphate group generates important biological properties, for example superior 
antimicrobial activity when compared to (+) α-T. In addition, it was considered to be important 
to understand if phosphorylation could provide substantive interactions with components of 
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Currently available substantive antimicrobial agents that can be used chronically to control the 
growth of oral micro-organisms, show undesirable side-effects, which limit their use in oral 
health products (Elworhy et al., 1996; White et al., 1997; Haps et al., 2008). Molecules 
displaying similar physicochemical properties to (+) α-TP have been found to have 
antimicrobial activity via membrane interactions (Cohen et al., 2000; Obando et al., 2007). In 
addition, organic phosphates, similar to (+) α-TP, are known to adhere to enamel surfaces 
strongly (Ganesan., 2008). Binding to enamel is desirable property for oral health actives as 
the continual bathing of the mouth with saliva makes it difficult to sustain the activity of locally 
administered agents (McBain et al., 2003; Tanomaru et al., 2008; Rao et al., 2001; Pan et al., 
1999). Therefore, (+) α-TP could be a promising substantive oral antimicrobial agent but its 
antimicrobial activity against relevant oral micro-organisms needs to be tested.  
     
In Chapter 2 (+) α-TP was shown to produce nanostructures. Interestingly, nanostructures can 
be engineered to control their size, shape, surface chemistry and functionality and this can 
influence an agents oral anti-biofilm properties including: biofilm penetration, biofilm 
dismantlement and bacterial kill. In addition, nanostructure properties can potentially be 
manipulated to maximise tooth surface adherence (Paula & Koo, 2016). Therefore, when 
testing the antimicrobial activity of (+) α-TP in biofilms the physicochemical properties of the 
nanostructures that it forms in water should be considered.  
 
The bacterial biofilms used for oral antimicrobial agent testing commonly include both single 
species biofilms and salivary biofilms to assess which bacteria are more susceptible to 
particular antimicrobial agents and how the agent affects salivary biofilm development to 
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prevent oral disease. When using the single species approach there must be some careful 
consideration of which species to employ. As streptococci species are early colonizers of the 
tooth surface and are thought to be fundamental to the formation of a biofilm, thus plaque, they 
are often used in single strain antimicrobial testing (Jakubovics & Palmer., 2013; Nobbs et al., 
2009; Catuogno & Jones., 2003).  
 
Streptococcus oralis is a highly proficient pioneering coloniser species, which is also known 
to produces glucan polymers, providing a surface that later bacterial colonisers can adhere to 
which is considered a major factor in the initialization of biofilm development (Dorkhan et al., 
2013; (Fujiwara et al., 2000). Therefore, limiting S. oralis growth, delays plaque maturation 
and is thought to inhibit the attachment of the later pathogenic colonizing bacteria which cause 
gum disease. A second streptococci species, which is prominent in the development of dental 
caries, that can be selected for antimicrobial susceptibility is Streptococcus mutans (Nobbs et 
al., 2009). S. mutans in particular is thought to be a major contributor to the prevalence of the 
dental caries disease due to its ability to metabolise and generate acids faster than other 
streptococci species and it has the ability to survive and continue to metabolise sugars even at 
pH levels that inhibit or kill other streptococci (Matsui & Cvitkovitch., 2010).  
 
The aim of this Chapter was to assess if (+) α-TP could bind to components in the mouth and 
provide a substantive effect on the growth of oral biofilms. To allow adequate (+) α-TP to be 
dissolved in solution for the antimicrobial testing a 20% ethanol, 80% water mixture at pH 7.4 
(Tris buffer) was selected as the vehicle to deliver the test agent. Streptococcus oralis and 
Streptococcus mutans were selected for single species biofilm growth studies. For the biofilm 
experiments the bacteria were only exposed to the test agents for 2 minutes because the 
application time of such agents in the mouth is relatively short. Following exposure the ability 
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of the tested agents to retard the exponential growth phase of the bacteria and their capability 
to inhibit the maximum population of bacteria were monitored. A charge neutralising agent 
was used after the test substances were applied to bacteria in several experiments to observe 
cell surface binding potential of the test agents. For the planktonic S. oralis and S. mutans 
experiments, a minimum bactericidal concentration (MBC) method was selected as the 
antimicrobial output as (+) α-TP aggregation would most likely result in turbidity and so the 
visible growth of bacteria could not be monitored in order to determine the minimum inhibition 
concentration (MIC) using a traditional methodology (Andrews., 2001). Binding studies 
between hydroxyapatite (HA) (majority composition of enamel) and (+) α-TP/ (+) α-T 
simulated the binding to the tooth in order to investigate the agent’s potential substantively in 
the mouth. However, it was also thought important to also test the test systems in biofilms 
produced from unsterilized whole mouth saliva (UWMS) grown on the treated hydroxyapatite 
as this more closely represented the situation in vivo. The application of (+) α-TP to HA was 
considered to be a close mimic to tooth surface conditions after brushing with toothpaste as the 
pellicle (salivary proteins) layer adsorbed to tooth surface is at least partially removed for a 
few minutes providing enamel exposure (Waaler., 2014).  
 
3.2 Materials  
 
 (+) α-T (Type VI, ~40% purity), trizma hydrochloride (Tris) (≥ 99%), Tween 80, lecithin, 
triflouroacetic acid (TFA) (≥ 99%), chlorhexidine digluconate (CHX) 20 % (w/v) in water, 
brain heart infusion (BHI) broth and glycerol were purchased from Sigma Aldrich, UK. 
Propan-2-ol, absolute ethanol, blood agar (BA) plates containing blood agar base no. 2 with 5 
% horse blood, hydrochloric acid, sodium hydroxide and sterile 0.2 μM nylon syringe filters 
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were purchased from Fisher Scientific Ltd, UK. All chemicals without a purity displayed were 
reagent grade. De-ionised water was used from laboratory supply. S. oralis NCTC 7864T and 
S. mutans NCTC 10449T were purchased from LGC standards, USA. Hydroxyapatite discs (5 
mm diameter x 2 mm thick) were purchased from Himed Inc, USA. Mica was purchased from 
Agar scientific, Elekron technology, UK. AFM cantilevers uncoated Si3N4 cantilevers with 
integrated pyramidal tips (Model: NSC15/noAl) were purchased from MikroMasch, Germany. 
Clear sterile polyester adhesive films were purchased from Starlab, UK. Live/ dead BacLight 




3.3.1 S. oralis and S. mutans biofilm antimicrobial growth retardation assay  
 
The deionised water, Tris buffer(aq) (0.5M), NaOH(aq)/ HCl(aq) (2M), and the 20%  ethanol, 80% 
water, Tris (150 mM) (pH at 7.4) vehicles used for test sample preparations were filtered 
sterilised using sterile 0.2 μM nylon syringe filters. (+) α-T and (+) α-TP stock solutions were 
prepared by weighing out the appropriate amount of each and dissolving in absolute ethanol 
for sterilisation. The stock solutions were then diluted with deionised water and Tris (0.5 M) 
to generate a 20% (v/v) ethanol, 80% (v/v) water solutions with Tris (150 mM) to control pH 
at 7.4 (adjusted if required).  Then a series of (+) α-T/ (+) α-TP dilutions were prepared in the 
Tris vehicle. CHX samples (positive controls) were prepared by serial dilutions of the CHX 
commercial solution (20% w/v in water) into deionised water with 20% ethanol. All samples 
were refrigerated when stored (maximum 8 days) and vortexed prior to use.  
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S. oralis NCTC 7864T and S. mutans NCTC 10449T aliquots were stored in brain heart 
infusion (BHI) broth with 10% glycerol at -70°C. When required for the experiments they were 
cultivated on blood agar (BA) plates containing blood agar base no. 2 and 5 % horse blood, at 
37°C under aerobic conditions. Plates were subcultured every 48 h and passaged no more than 
6 times. 
 
Aliquots of BHI broth (20 mL) were inoculated with 3-4 colonies of bacteria from plates that 
had been growing the bacteria for 24 h. After 18 h of planktonic growth, 20 μl of bacteria 
suspension were then transferred into fresh BHI broth (20 mL, 37 °C). Cell growth in this fresh 
BHI was monitored on a UV-Vis plate reader (iEMS Incubator/Shaker, Thermo Scientific, UK) 
until an optical density reading between 0.2-0.3 was obtained at 620 nm (ABS620). The bacterial 
cells were then washed twice by centrifugation (1614 g, 10 min, 25°C) with sterile saline (20 
mL), and resuspended in saline to provide an ABS620 reading of 0.16 measured with the UV-
Vis plate reader (200 μL aliquot). Aliquots (200 μL) of the cell suspension were transferred to 
the wells of a sterile 96-well microtitre plate, the plate was sealed and centrifuged for 60 min 
at 2046 g. The supernatant was removed by inverting the plate, and the wells were treated with 
200 μL aliquots of the test solutions for 2 min. The test solutions were removed and the cells 
washed twice with 200 μL aliquots of saline making sure to cause minimal agitation to the 
cells. Aliquots (200 μL) of fresh BHI were added to the wells. The plates were sealed and both 
bacterial strains were incubated in aerobic conditions at 37°C in the UV-Vis plate reader for 
24 hours, taking 620 nm absorbance readings every 15 minutes. The Richards model (Equation 
3.1.) was used to describe the growth curves (Dalgaard & Koutsoumanis., 2001). 
 
𝐴𝐵𝑆𝑡  =  𝐴𝐵𝑆𝑚𝑖𝑛  +  
𝐴𝐵𝑆𝑚𝑎𝑥 − 𝐴𝐵𝑆𝑚𝑖𝑛
[1 + 𝑒𝑥𝑝 ( − 𝜇𝐴𝐵𝑆∗𝑚∗(𝑡 – 𝑡𝑖)]1/𝑚
         [Equation 3.1.] 
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Where ABSt was the absorbance at time, ABSmin and ABSmax, were the asymptotic minimum 
and maximum absorbance’s, μABS was the maximum specific growth rate, t was the time (h), 
ti was the time to inflection, or time to the point at which the sign of the curve changes from a 
positive curvature to a negative curvature or vice versa, and m was the modifier for growth 
dampening. The growth curve data were entered into the Origin 9.1 software programme 
(OriginLab Corp., USA) and a nonlinear curve fit was performed on each growth curve to 
determine ti and ABSmax for each treatment run. The ti value was selected to measure lag phase 
whilst ABSmax was selected to measure post-growth maximum population density. Each 
experiment was performed in triplicate on three separate occasions.  
 
To understand if (+) α-TP was binding to the cell surfaces of S. oralis, the antimicrobial growth 
retardation assay was performed and the cells exposed to test solutions were washed twice with 
a neutralising rinse (200 μL) instead of saline. The neutralising rinse consisted of Tween 80, 
10% (v/v), lecithin, 0.5% (w/v), and phosphate buffer (281 µM pH 7.2 ± 0.2) in distilled water. 
The negatively charged phospholipids bind the positively charged CHX and the zwitterion 
phospholipids bind the negatively charged phosphate groups of (+) α-TP to inhibit 
antimicrobial substantive effects.  Each experiment was performed in triplicate on three 
separate occasions.   
 
3.3.2 MBC assay 
 
In order to assess if (+) α-TP had antimicrobial properties its MBC against S. oralis and S. 
mutans was assessed and compared with other established antimicrobial agents. Aliquots of 
BHI broth (20 mL) were inoculated with 3-4 colonies of bacteria from plates that had been 
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growing the bacteria for 24 h. After 24 h of planktonic growth the inoculated broth culture was 
then diluted to 4 x 105 CFU/ mL and plated at 100 μL/ well in 96 well plates. A series of (+) α-
TP concentrations (1024, 512, 256, 128, 64, 32, 16, 8, 4, 2, 1 and 0.5 μg/ mL) were prepared 
from the stock solution. The test solutions (100 μL) were then added to the wells providing 
final (+) α-TP concentrations of 512, 256, 128, 64, 32, 16, 8, 4, 2, 1, 0.5 and 0.25 μg / mL. 
Plates were sealed and incubated for 24 h at 37 °C, 100 μL aliquots from each well transferred 
to blood agar plates and the plates were incubation for 24 h at 37 °C. The blood agar plates 
were then assessed for colony formation with the first plate not to show any growth being 
considered to represent the minimum bactericidal concentration. A sterility (no bacterial 
inoculation) negative control and vehicle (no (+) α-TP) positive control were used. Each 
experiment was performed in triplicate on three separate occasions.    
  
3.3.3 Unsterilised whole mouth saliva biofilm growth inhibition 
 
HA discs pre-treated with (+) α-TP (0.15% w/v, 300 µL) or (+) α-T (0/15%w/v, 300 µL) 
statically for 10 minutes were washed with saline (600 µL, 2 min) and placed in UWMS from 
one donor (400 μL) (fasted for at least 8 h) in micro centrifuge tubes vertically and incubated 
at 37 °C for 18h (without supplements). The HA discs were then washed with saline (600 μL, 
2 min) and exposed to the live/ dead stain (200 µL) for 30 minutes followed by imaging. Live/ 
dead bacterial viability kit was prepared as per the vendors’ procedure. Biofilms were observed 
using 10x oil immersion objective and a Leica sp2 confocal microscope with 488 and 568 nm 
excitation and 500-530 nm (green fluorescence representing up take of Syto 9 by live cells) 
and > 620 nm (Red fluorescence representing up take of propidium iodide by dead cells) 
emission filters. Biofilm height was measured using the z-stacking tool taken each side of the 
HA discs. There was no cross over between emission spectra and excitation intensities were ≤ 
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31%. Biofilms grown on HA discs pre-treated with the vehicle were used as controls. 
Experiments were performed by measuring biofilm height once, each side of each HA disc and 
were performed in triplicate. All images were taken from the middle of each disc. 
 
3.3.4 Hydroxyapatite binding assay  
 
HA discs were placed into micro centrifuge tubes containing (+) α-TP or (+) α-T test solutions 
(0.01% w/v, 300 μL in 20% ethanol, 80% water, pH 7.4 with 150 mM Tris vehicle) statically 
for 10 minutes. Discs were then removed and placed in saline (600 μL) for 2 minutes. Vehicle 
(300 μL) was added to the 10 minute samples (1/2 dilution). This procedure was replicated 
with (+) α-TP and (+) α-T samples without the presence of HA as controls. Test solutions with 
and without HA disc treatments and saline rinse were tested via HPLC for the concentration of 
(+) α-TP and (+) α-T in triplicate.  
 
3.3.5 Characterisation of (+) α-T and (+) α-TP aggregates 
 
The packing parameter was used to predict aggregate structure. It was calculated from vo/aelo, 
where vo is the surfactant tail volume (Ǻ3), lo is the maximum tail length (Ǻ), and ae is the 
equilibrium area per molecule at the aggregate surface (Ǻ2). Values between ≤ 0 and 1/3 ≥ are 
predicted to be spherical micelles, ≤ 1/3 and 1/2 ≥ are predicted to be globular micelles or 
cylindrical micelles, ≤ 1/2 and 1 ≥ are predicted to be spherical bilayers (liposomes) and ≤ 1 
are predicted to form planar bilayers (Nagarajan., 2002). Equations 3.2 and 3.3 where used to 
calculate vo and lo (Tanford., 1972). 
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𝑣𝑜  =  27.4 +  26.9𝜂𝑐    [Equation 3.2.] 
 
lo  =  1.5 +  1.265ηc    [Equation 3.3.] 
 
Where ηc is the number of carbon atoms in the surfactant tail. The value of ae used was 54 Ǻ2, 
this is a value that has been experimentally determined for n-C8H17OPO3NaH (Chevalier & 
Chachaty., 1984) and has been previously used to predict the shapes of branched monoalky 
phosphate aggregates (Ravoo & Engberts., 1994).  
 
Height and phase images of the untreated mica, the Tris vehicle (20% ethanol, 80% water, 150 
mM Tris at pH 7.4), the (+) α-T (0.15% w/v) and the (+) α-TP (0.15% w/v) (dispersed in 20% 
ethanol. 80% water at pH 7.4 with and without 150 mM Tris) were obtained to assess the size 
and shape of the aggregates using atomic force microscopy (AFM; Bruker icon dimension, 
UK). All images were obtained in tapping mode using high resonance frequency (HRF = 320 
kHz) pyramidal cantilevers with uncoated Si3N4 tips having force constants of 46 N/m in air. 
Mica was chosen as a solid substrate on to which 2-3 drops of the test samples were placed, 
the samples were dried with nitrogen and then imaged. Scan speeds were set at 0.9 Hz.  
Measurements were recorded using the NanoScope 1.50 AFM image analysis software 
(Bruker, USA) and were analysed using Gwyddion 2.45, a free SPM data visualisation and 
analysis programme.     
 
3.3.6 Data analysis 
 
All error values/ bars were expressed as their mean ± standard deviation (SD). Statistical 
analysis of data was performed using Levine’s homogeneity test before statistical significance 
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between the sample groups was assessed by one way analysis of variance (ANOVA) tests with 
post-hoc Tukey analysis in Origin 2016. Statistically significant differences were assumed 




3.4.1 Substantive antimicrobial growth retardation effect of (+) α-T (+) α-TP 
against streptococci species 
 
Both single species bacterial biofilms used in this work were shown to have classical s-shaped 
growth profiles, with there being a bacterial growth lag phase at the early stage of the 
experiments followed by an exponential phase of bacterial growth and finally a plateauing of 
the curve at a maximum bacterial population. These growth profiles were fitted with a non-
linear fit model and this allowed two antimicrobial outputs to be monitored; the growth time 
inflection points (midpoint of exponential growth) and maximum population density (ABSmax) 
outputs as they monitor the delaying of growth and population limitation. Figure 3.1 shows the 
growth profile of S. oralis after treatment with (+) α-TP (0.51% w/v), indicating the two indices 
used to assess antimicrobial activity, growth time to inflection point and post-growth turbidity 
equilibrium (ABSmax). 
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Figure 3.1. Nonlinear fit growth curves of Streptococcus oralis measured by absorbance at 620 
nm every 15 minutes post 2 minute treatment with 0.51% w/v (+) alpha tocopheryl phosphate 




S. oralis was found to have a growth time inflection point at 2.2 ± 0.9 h when treated with 
water for two minutes (Figure 3.2 A). Treating S. oralis with Tris gave a growth time inflection 
point of 1.7 ± 0.2 h (Figure 3.2 A). These two results were not statistically different (p > 0.05). 
A dose dependent increase of the growth time inflection was observed when S. oralis was 
treated with the positive control, CHX, in the concentration range of 0.00125% w/v to 0.01% 
w/v (washed with saline). (+) α-TP was found to retard S. oralis bacterial growth to a maximum 
of 5.4 ± 1.3 h (Figure 3.2 A), but it did not generate a dose dependent effect (Figure 3.2 A). (+) 
α-T gave a statistically significant antimicrobial response (P < 0.05) against S. oralis, but this 
was much smaller in magnitude compared to (+) α-TP (P=0.002). 
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The maximum population of S. oralis post-growth after the treatment with (+) α-TP was 
reduced in a dose dependant manner. Each of the reductions was statistically different from 
each other, the vehicle and (+) α-T (Figure 3.2 B, p < 0.05). For CHX there was little effect on 
S. oralis post-growth population density for concentrations between 0.00125% and 0.005% 
w/v, however, there was a dramatic drop in post growth population density after using 0.01% 
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Figure 3.2. Time to inflection points of Streptococcus oralis biofilms treated then washed with 
saline (A) and (B) post-growth maximum population densities. Where CHX is chlorhexidine, 
Alpha TP is (+) alpha tocopheryl phosphate and Alpha T is (+) alpha tocopherol. Data 
represents mean ± standard deviation (n=3). (Tris (T) consists of 20% ethanol, 80% water (v/v) 
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When S. oralis was washed with a charge neutralising rinse instead of saline after the 
application of test solutions the time to inflection points and post-treatment maximum growth 
density profiles changed for both CHX and (+) α-TP. CHX no longer gave a dose dependent 
response and its activity appeared to be supressed. For example, the 0.01% w/v CHX solution 
displayed reduced time to inflection from 10.9 ± 3.9 h (Figure 3.2 A) to 3.5 ± 0.5 h (Figure 3.3 
A) upon use of the neutralising rinse and the post-growth maximum population densities of 
bacteria increased from 0.03 ± 0.02 (Figure 3.2 B)  to 0.33 ± 0.02 (Figure 3.3 B). Similarly, 
when the (+) α-TP treated bacteria were washed with the neutralising rinse the activity of the 
(+) α-TP 0.51% w/v solution reduced from 5.4 ± 1.3 h (Figure 3.2 A) to 2.7 ± 0.3 h (Figure 3.3 
A) in terms of time to inflection and increased from 0.09 ± 0.06 (Figure 3.2 B) to 0.34 ± 0.05 
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Figure 3.3. Time to inflection points of Streptococcus oralis biofilms treated then washed with 
neutralising rinse (A) and post-growth maximum population densities. Where CHX is 
chlorhexidine, Alpha TP is (+) alpha tocopheryl phosphate and Alpha T is (+) alpha tocopherol.  
Data represents mean ± standard deviation (n=3). (Tris (T) consists of 20% ethanol, 80% water 
(v/v) with 150 mM Tris made pH 7.4 ± 0.2) (Water (W) contains 20% ethanol). % 
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As (+) α-TP and CHX were effective in inhibiting S. oralis growth these two samples were 
also tested against S. mutans. When S. mutans were treated with CHX and washed with saline 
using the same concentration range as S. oralis the bacteria did not recover. However, when S. 
mutans were treated with the same concentration range of (+) α-TP and washed with saline the 
comparative growth time to inflection points between S. oralis and the S. mutans was reduced 
from 5.4 ± 1.3 h (Figure 3.2 A) to 3.0 ± 0.5 h (Figure 3.4 A) (0.51% w/v), but the S. mutans 
data was still statistically different from the vehicle (p = 0.01). There was also a reduced effect 
on the post-growth maximum population density when comparing the (+) α-TP effects on S. 
oralis and the S. mutans which were 0.09 ± 0.06 (Figure 3.2 B), and 0.22 ± 0.04 (Figure 3.4 B) 
respectively, but the S. mutans data was still significantly different compared to the vehicle (p 
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Figure 3.4. Time to inflection points of Streptococcus mutans biofilms treated then washed 
with saline (A) and (B) post-growth maximum population densities. Where Alpha TP is (+) 
alpha tocopheryl phosphate. Data represents mean ± standard deviation (n=3). (Tris (T) consists 
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3.4.2 Minimum bactericidal concentration of (+) α-TP against S. oralis and S. 
mutans 
 
(+) α-TP (in the Tris vehicle) when diluted in the broth culture resulted in turbidity and so the 
visible growth of bacteria could not be monitored in order to determine the minimum inhibitory 
concentration using a traditional methodology. However, the MBC could still be assessed and 
was found to be 1 μg/ mL (Figure 3.5) whereas the MBC against S. mutans was > 512 μg/ mL 
as the bacteria grew on all the blood agar plates even when incubated with the highest 








Figure 3.5. Photographs of grown Streptococcus oralis (100 µL aliquots) colonies when 
incubated on blood agar plates at 37 ̊ C after 24 h in the minimum bactericidal concentration 
assay. The aliquots were from planktonic bacteria (4 x 105 CFU/ mL)) that had been dispersed 
in brain-heart infusion (BHI) broth and incubated at 37 ̊ C with varying concentrations of (+) 
alpha tocopheryl phosphate (α-TP) for 24 h. The (+) α-TP was dispersed in 20% ethanol, 80% 
water with 150 mM Tris at pH 7.4 and diluted 1:1 with the bacterial inoculated BHI broth.   
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3.4.3 Unsterilized whole mouth saliva biofilm growth inhibition of (+) α-T and (+) 
α-TP 
 
Confocal imaging showed that discs pre-treated with the vehicle for 10 minutes (80% water, 
20% ethanol, 150 mM Tris at pH 7.4) followed by a 2 minute saline rinse produced a biofilm 
height of 76 ± 15 µm after 18 hour incubation with UWMS (400 μL) (Figure 3.6). Discs pre-
treated with (+) α-T (3 mM) resulted in a biofilm height of 58 ± 18 µm, which was not 
statistically different to the vehicle control (p > 0.05). HA discs pre-treated with (+) α-TP (3 
mM, 0.15 % w/v) resulted in a biofilm of 38 ± 7 µm in height, which was statistically smaller 
compared to the vehicle control (p = 0.0006) and (+) α-T (p < 0.05) pre-treated discs. These 
results suggested that the (+) α-TP bound to the HA and elicited an antimicrobial response even 











Figure 3.6. Height of oral biofilms formed on hydroxyapatite pre-treated discs after 18 hours 
incubation with unsterilized whole mouth saliva (10 x magnification, confocal microscopy, 
live/dead staining). Where (+) a-T was alpha tocopherol, (+) a-TP was (+) alpha tocopheryl 
phosphate and the vehicle is 20% ethanol, 80% water, 150 mM Tris,  pH 7.4. Data represents 
mean ± standard deviation (n=3).   
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3.4.4 Binding of (+) α-T and (+) α-TP to hydroxyapatite 
 
When (+) α-TP (200 µM, 0.01% w/v, 300 µL) was incubated with HA the concentration of (+) 
α-TP remaining in the incubation fluid was 25 ± 12 % of its initial concentration. This 
suggested that (+) α-TP were binding to the HA. Using the same concentration of (+) α-T, 99 
± 18% was found in the incubation solution, which suggested that it did not to bind to HA 
(Figure 3.7). The difference in (+) α-TP and (+) α-T HA binding was statistically different (p 
= 0.00006). Attempts to wash the (+) α-TP off the HA using saline were not successful, which 















Figure 3.7. Comparison of (+) alpha tocopheryl and (+) alpha tocopheryl phosphate remaining 
in solution after 10 minute exposure to hydroxyapatite discs inset (high performance liquid 
chromatography). Where (+) a-T was alpha tocopherol, (+) a-TP was (+) alpha tocopheryl 
phosphate and the vehicle is 20% ethanol, 80% water, 150 mM Tris,  pH 7.4. Data represents 
mean ± standard deviation (n=3).   
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3.4.5 (+) α-T and (+) α-TP biophysical analysis – Atomic Force Microscopy 
 
It has been shown that in Chapter 2 (+) α-TP formed Nano sized aggregates. Supramolecular 
aggregates can form a variety of shapes and transition into different structures depending on 
molecular characteristics and formulation conditions (Scheme 3.1). The ηc values for 
substantive antimicrobial (+) α-TP was 17 for vo and 13 for lo resulting in a vo value of 484.7 
Ǻ3 and a lo value of 17.945 Ǻ; its packing parameter was calculated to be 0.50. These indices 
suggested that (+) α-TP would form cylindrical micelles or spherical liposomes in the polar 
vehicle used in this work. AFM imaging showed (+) α-T formed liposomes with diameters of 
551 ± 43 nm  and heights of ~ 86 nm (Figure 3.8) and confirmed that the (+) α-TP structures 
were cylindrical in shape (Figure 3.9) with heights of ~ 22 nm when formulated in an ethanol, 
water mix. When (+) α-TP was formulated  in the Tris vehicle the shape transitioned from 
cylinders to planar bilayer islands with diameters < 500 nm and heights of ~ 4.6 nm (Figure 
3.10), the theoretical length of two (+) α-TP molecules, end to end, was calculated to be 4.4 
nm. The shape of the (+) α-T liposomes was not affected by the presence of Tris (Figure 3.11). 
Untreated mica and the Tris vehicle were imaged as controls and where found to have smooth 
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Figure 3.8a. Atomic force microscopy tapping height image (i), and cross-sectional profile (ii) 
of (+) alpha tocopherol. Samples were 3 mM dispersed in a 20% ethanol, 80% water, pH 7.4 
vehicle.  
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Figure 3.8b. Theoretical molecular packing of (+) alpha tocopherol aggregate structures (i), 
based on the AFM image in 3.8a, with enlarged head group (ii).  
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Figure 3.9a. Atomic force microscopy tapping height image (i), and cross-sectional profile (ii) 
of (+) alpha tocopheryl phosphate. Samples were 3 mM/ 0.15% w/v dispersed in a 20% ethanol, 
80% water, pH 7.4 vehicle.  
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Figure 3.9b. Theoretical molecular packing of (+) alpha tocopheryl phosphate aggregate 
structures (i), based on the AFM image in 3.9a, with enlarged head group (ii).  
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Figure 3.10a. Atomic force microscopy tapping height image (i), and cross-sectional profile 
(ii) of (+) alpha tocopheryl phosphate with Tris (150 mM). Samples were 3 mM/ 0.15% w/v 
dispersed in a 20% ethanol, 80% water, pH 7.4 vehicle.   
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Figure 3.10b. Theoretical molecular packing of (+) alpha tocopheryl phosphate aggregate 
structures when formulated with Tris (i), based on the AFM image in 3.10a, with enlarged head 
group (ii).  
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Figure 3.11. Atomic force microscopy tapping height image of (+) alpha tocopherol in the Tris 














Figure 3.12. Atomic force microscopy tapping height image of the untreated mica.  
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Figure 3.13. Atomic force microscopy tapping height image of the Tris (150mM) vehicle 
control. The samples were 20% ethanol, 80% water, pH 7.4 vehicle.  
 
 
Interestingly the phase images showed that the (+) α-TP planar bilayer islands where 
viscoelastic and adhered/ were attracted to the silicon nitride cantilever probe as the oscillation 
angle was delayed by ~ 22.4 ° when in contact with the islands (Figure 3.14) relative to the 
mica/ Tris coated surface controls (Figure 3.17 and 3.18). The (+) α-TP thread-like cylinders 
were found to have some adhesive properties with the silicon nitride probe as the oscillating 
angle was delayed by up to ~ 19.2 ° but this was not consistent across the structure (Figure 
3.15). The (+) α-T liposomes were not viscoelastic or adhesive relative to the mica and Tris 
surfaces as the oscillation angle delay was surprisingly reduced  to ~ -22.9 ° when in contact 
with the liposomes suggesting the liposomes repulsed the silicon nitride probe (Figure 3.16).  
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Figure 3.14. Atomic force microscopy tapping phase image (i), and cross-sectional profile (ii) 
of (+) alpha tocopheryl phosphate with Tris (150 mM). Samples were 3 mM/ 0.15% w/v 
dispersed in a 20% ethanol, 80% water, pH 7.4 vehicle.  
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Figure 3.15. Atomic force microscopy tapping phase image (i), and cross-sectional profile (ii) 
of (+) alpha tocopheryl phosphate. Samples were 3 mM/ 0.15% w/v dispersed in a 20% ethanol, 
80% water. 
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Figure 3.16. Atomic force microscopy tapping phase image (i), and cross-sectional profile (ii) 
of (+) alpha tocopherol with Tris (150 mM). Samples were 3 mM dispersed in a 20% ethanol, 
80% water, pH 
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Figure 3.18. Atomic force microscopy tapping phase image of the Tris (150mM) vehicle 
control. The samples were 20% ethanol, 80% water, pH 7.4 vehicle.  
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The S. oralis and S. mutans biofilm antimicrobial activity data showed that (+) α-TP was 
capable of retarding their growth time to inflection points and reducing their maximum 
bacterial population density in these studies. The maximum optical densities of the controls in 
these assays were comparable with previous work (Gan., 2010), which gave confidence that 
the test method was robust. The work carried out by Gan, 2010 found that zinc species 
increased the time to inflection points of S. oralis to ~ 4-9 hours depending on the formulation 
used and could reduce maximum population densities. It has been reported that histidine rich 
polypeptides are capable of increasing S. mutans lag phase by 4 h after a 1 hour pre-incubation 
(Mackay et al., 1984), in this study (+) α-TP increased S. oralis lag phase by ~3.5 h and S. 
mutans by  0.6 h after a 2 min incubation. In addition, other work assessing the growth 
retardation of another early stage tooth colonizer, Streptococcus sanguinis, a close relative of 
S. oralis (Zahner et al., 2011), was found to have a lag time of 8 hours when the 24 hour 
planktonic inoculum was treated with Listerine (1/2 dilution factor) for 15 seconds and was 
shown to have a dose dependent reduction in maximum population density (Fine et al., 1996). 
This shows that (+) α-TP had a mild antimicrobial efficacy as its effect on the S. oralis biofilms 
had ~ half the efficacy compared to a commercial product on planktonic with its potency 
against S. mutans being lower still. However, the (+) α-TP antimicrobial potency could perhaps 
be improved by changing the vehicle in order to provide weaker aggregates, providing more of 
the free drug. For example, the sensitivity of the (+) α-TP aggregates to electrolytes (in this 
case Tris) has been shown to transform the (+) α-TP nanostructure physical characteristics. 
 
The (+) α-TP antimicrobial activity against the pioneering tooth colonising species S. oralis 
was shown in the growth retardation assays to be at least in part related the phosphorylation of 
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the compound because in comparison to (+) α-T, it had a far superior effect. Antimicrobial 
activity against pioneering tooth colonising species is important in the maintenance of oral 
health as later bacterial colonisers depend on these species in order to form plaque (March., 
2000; Jakubovics & Palmer., 2013; Nobbs et al, 2009; Dorkhan et al., 2013). 
 
The response of the bacteria to the (+) α-TP in the S. oralis biofilm assays when the neutralising 
rinse was employed was similar to CHX, a known substantive agent (Elworhy et al., 1996). 
This suggested that the (+) α-TP did have the capacity to bind to biofilms in order to increase 
the oral cavity resonance. The ionic strength of the vehicle used for α-TP samples reduced 
electrostatic polar head repulsion (Nagarajan., 2002), therefore (+) α-TP aggregates interacted 
with the Tris buffer to form a more lipophilic structure. The Tris buffer also had the added 
advantage that it had previously been shown to enhance bacteria surface permeability and was 
thought to increase the chances of observing a (+) α-TP antimicrobial effect (permeability 
changed by ion pairing with phospholipids as Tris is predominantly positively charged at 
physiological pH (pKa: 8.1)) (Hamouda & Baker (Jr)., 2000; Irvin et al., 1981; Ban et al., 2012) 
and therefore may have allowed the bacterial surface interactions to occur synergistically with 
the cell surface permeability increase effect of Tris.  
 
CHX is known to primarily disrupt the cell membranes of bacteria by ion pairing to the 
negatively charged components on the membrane surface and hence altering the permeability 
of the cell (Koontongkaew & Jitpukdeebodintra., 1995). At low concentrations this results in 
low molecular weight substances, e.g. phosphates, leaking out of the cell and at high 
concentration CHX is bactericidal due to precipitation of cytoplasmic contents leading to cell 
death (Mohammadi & Abbott., 2009). In our planktonic studies we saw CHX being less potent 
against S. oralis than S. mutans. The increased susceptibility of S. mutans to CHX compared 
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to other streptococci species has been reported previously (Schaeken et al., 1994). (+) α-TP has 
been shown to have the opposite trend to CHX, this could be explained as S. mutans is known 
to be a more negatively charged species than S. oralis, with S. mutans (ATCC 25175) having 
a zeta potential of -75.52 ± 13.60 mV and S. oralis (ATCC 10557) having a zeta potential of -
58.13 ± 11.22 mV (Saito et al., 1997) enhancing the cationic antimicrobial effect of CHX whilst 
seemingly inhibiting the antimicrobial effect of anionic (+) α-TP. In addition there have been 
shown to be hydrophobic differences in the bacterial surfaces of S. oralis and S. mutans with 
the former being much more hydrophobic (Saito et al., 1997) which could explain differences 
in antimicrobial activity.   
 
CHX and CPC are both positively charged antimicrobial species that disrupt cell wall stability 
and cause cell lysis (McBain et al., 2003; Haps et al., 2008) and are considered antiseptics as 
they disrupt cell wall stability and cause cell lysis, negatively charged sodium lauryl sulphate 
micelles have been found to have bactericidal effects by solubilising cell membrane proteins 
again resulting in cell lysis (Wang et al., 2012; Mohamad., 2011). However, there is evidence 
from surfactant lipid preparations (SLP) that the aggregates can fuse with bacterial surfaces 
and become internalized whilst leaving the organism intact (Hamouda & Baker (Jr)., 2000) and 
hence had a bactericidal mechanism of action not caused by immediate cell wall/ membrane 
disruption; as (+) α-TP formed aggregates it is likely to have a similar mechanism especially 
in the presence of a cell membrane/ wall permeabiliser (Tris). In addition, (+) α-TP is 
endogenous in cells but appears to be highly restricted to only be present in ultralow 
concentrations and has been hypothesised as being a potent signalling molecule that targets 
enzymes including acid and alkaline phosphatases, adenosinetriphosphatase and 
diphosphopyridine nucleotidase to name just a few (Zingg et al, 2010) and or transcription 
factors (Gianelo et al., 2005). Moreover it has been suggested that (+) α-TP acts in a similar 
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way to thiamine di-phosphate in bacteria which directly binds and regulate mRNAs encoding 
enzymes involved in its biosynthesis controlling gene expression. Therefore if (+) α-TP was 
internalized at a high enough concentration it could become toxic.  
  
In order to assess how the (+) α-TP nanostructures antimicrobial activity compared with 
established antimicrobials, the MBC was tested against the pioneering tooth coloniser S. oralis 
and the cariogenic bacterium S. mutans. The MBC of (+) α-TP against S. oralis being 1 μg/ mL 
was found to be lower than CHX which has been reported to have an MBC of 7.8 μg/ mL 
(Wang et al., 2012)  suggesting a higher potency for the former. (+) α-TP also had a similar 
potency against this organism to cetylpyridinium chloride (7.8 μg/ mL) (McBain et al., 2004) 
and triclosan (5.2 μg/ mL) (Wang et al., 2012) which are two commonly used antimicrobial 
agents in the mouth. The MBC of (+) α-TP  being more potent than CHX was interesting as 
the nanostructures were a little less potent compared to the CHX treatments in the growth 
retardation assays. The dispersal of the (+) α-TP planer bilayer islands in the broth (containing 
sugars, salts and other bacterial nutrients) used for the MBC experiments, most likely disrupted 
the aggregates providing more of the free drug, which could explain reversal in potency across 
the two experiments. However, the aggregation characteristics (+) α-TP when dispersed in the 
broth could not be monitored by the zetasizer as it was as it was only available as a yellow 
solution and so would have led to inaccurate readings and could not be measured by AFM as 
the images would include the crystallised sugars, salts etc. that were in the broth. A potential 
way forward would be dispersing the (+) α-TP planar bilayer islands in a clear solution that 
closely resembles that of the broth. Additionally, (+) α-TP was found to have a much lower 
potency against S. mutans (≥ 512 µg/ mL) than S. oralis (1 µg/ mL). CHX in comparison has 
been found to have a more potent antimicrobial activity against S. mutans of 1 μg/ mL (Hwang 
et al., 2000). 
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The data showed that (+) α-TP pre-treated HA discs were capable of halving multispecies 
biofilm formation after 18 h even after washing supported the notion that the effect of (+) α-
TP would be substantive. The fact that (+) α-TP did not completely inhibit biofilm development 
was not considered to be a draw back as when developing new approaches to maintaining good 
oral health it is important to recognise that controlling the oral micro-organisms, rather than 
completely eradicating them, is the goal (March., 2000). When imaging close to the HA surface 
it was found that there was no bacterial infestation in the pellicle suggesting a sterile pellicle 
had formed. S. oralis, which has been shown to be susceptible to (+) α-TP’s antimicrobial 
properties would likely have been among the first species of bacteria to come into contact with 
any adhered (+) α-TP on the tooth surfaces and so presumably did not attach possibly due to 
HA controlled release of (+) α-TP or an increase in HA surface hydrophobicity, however, this 
confocal experiment would need repeating with just S. oralis to prove this. A healthy pellicle 
can also improve oral health as it acts as a barrier to acid attack and prevents enamel 
demineralisation (Baek et al., 2009). (+) α-T pre-treated discs did reduce biofilm formation but 
this was not statistically different from the control HA disc.  
 
The binding studies of (+) α-TP to HA suggested that the binding to teeth would also increase 
the oral cavity substantively of this molecule. It was surprising that the negatively charged 
aggregates interacted with HA to such a high degree as previous literature has shown poor 
adhesion of other negatively charged aggregates with HA with positively charged species 
having more adhesion (Nguyena et al, 2010) likely due to HA’s overall negative surface charge 
around a neutral pH (Beachey, 1980). However, HA has been reported to interact with organic 
phosphates molecules such as phytate and phosphoserine (Ganesan., 2008). This is because 
HA is a amphoteric material made up of calcium phosphate [Ca10(PO4)6(OH)2] and therefore 
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has two types of binding sites, positively charged (Ca2+) and negatively charged (PO4
2-). It has 
been shown that enamel crystals have domains of positive and negative charge which allow 
positive and negative species to bind to it despite its overall negative charge (Wallwork et al., 
2001). The (+) α-T did not bind to the HA and therefore the charged phosphate was responsible 
for the binding process. The chemical stability study in the previous Chapter indicated that 
chemical degradation did not influence the binding study’s results.  
 
In the previous Chapter it was seen that the introduction of the hydrophilic phosphate group 
into (+) α-T generated amphiphilic character, which reduced the nanostructures size, charge 
and derived count rate. Vitamin E derivatives such as α- tocopheryl polyethylene glycol 
succinate 1000 (α-TS) have been found to form spherical micelles with a critical micelle 
concentration of 20 μM (Sadoqi et al., 2009; Muthu et al, 2012). However, the (+) α-TP 
structures were thought to be cylindrical micellar or spherical liposomal because the packing 
parameter was calculated to be 0.50 and the aggregates were shown to be thread-like micellar 
by AFM. The (+) α-T was found to be spherical by AFM and so the introduction of the charged 
phosphate group increased polar head repulsion which transitioned the aggregates into thread-
like structures. The reason why (+) α-TP aggregate structures were not spherical like that of α-
TS was thought to a smaller head group whilst the transition into adhesive planar bilayer islands 
when formulated with a high ratio of salt (in this case Tris) was thought to be due to reduced 
head group repulsion (Nagarajan., 2002). This transition into planar bilayered structures may 
have also aided interactions with HA and bacteria as this would provide a greater surface area 
for the interactions to occur. The AFM phase images found that the whole of the (+) α-TP 
planar bilayer structures adhered uniformly to the silicon nitride probe (Si3N4), whilst the (+) 
α-TP cylinders had some adhesion but was not consistent across the structures. The (+) α-T 
spheres had no adhesion. Silicon nitride has similar physicochemical properties to 
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hydroxyapatite (Ca10(PO4)6(OH)2), in that both materials are overall charge neutral, both are 
hydrophilic and both have an overall net negative surface charge density (An & Friedman., 
2000). Therefore the AFM data supported the HA adsorption results in that the (+) α-TP planar 
bilayer structures were substantive whilst the spherical (+) α-T structures were not. This 




In this Chapter (+) α-TP has been shown to increase the growth time to inflection points and 
post-growth maximum population densities of S. oralis and S. mutans biofilms through cell 
surface interactions that were not displayed by (+) α-T. (+) α-TP was also found to adhere to 
HA and provide a substantive effect in inhibiting salivary biofilm growth over time that again 
was not displayed by (+) α-T. (+) α-TP self-assembled into adherent planar bilayer islands in 
aqueous Tris vehicles whilst (+) α-T generated non-adherent liposomes. Therefore these 
findings confirm that the chemically linked phosphate ester to (+) alpha tocopherol is critical 
for its substantive antimicrobial properties. The (+) α-TP potency was less than other agents 
that could be included in oral healthcare products, but as (+) α-TP showed the capacity to bind 
to hydroxyapatite it may prove more efficacious when used in vivo. In addition, the increase in 
potency in the MBC assay over CHX suggests that weakening the aggregate in biological fluids 
may improve potency. It is the effect of formulation counter ions which seems worthy of further 
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Bacteria often gain resistance to antimicrobial agents in biofilms as opposed to when they are 
observed in a planktonic state due to the incomplete penetration of the antimicrobial agents 
(Lewis., 2001). This biofilm resistance is a result of the bacteria producing extracellular 
polymeric substances (EPS), which often accounts for over 90% of the biofilm architecture and 
is responsible for biofilm cohesion (Flemming & Wingender., 2010). The EPS in oral biofilms 
is extensively negative charged which especially limits the penetration of cationic and anionic 
antimicrobials/ aggregates through the biofilms due to strong ionic interactions (electrostatic 
repulsion and attraction) at the EPS periphery (Shen et al., 2016). Neutral and zwitterionic 
phospholipid nanocarriers have been observed to penetrate biofilms and improve the drug 
delivery/ action of antimicrobials (Meers et al., 2008; Liu et al., 2016).  In Chapter 2, the self-
assembled anionic nanostructures of the phospholipid (+) α-TP were shown to have 
antimicrobial properties against S. oralis biofilms but the penetration depths were unknown. In 
addition, the large organic cation, Tris, was found to affect the shape and viscoelasticity of the 
anionic (+) α-TP nanostructures through ion-pairing giving the structure some zwitterionic 
character. Cationic Tris would also most likely interact with the negatively charged 
components in oral biofilms i.e. the EPS, dismantling the biofilms and neutralising there 
negative charge when applied in excess giving (+) α-TP access to potentially all the residing 
bacteria. Tris could therefore not only be influencing the (+) α-TP nanostructures 
physicochemical properties but also the physicochemical properties of the oral biofilms 
influencing the relationship between (+) α-TP interactions and biological activity on multiple 
levels. Therefore, the effect of Tris on the (+) α-TP nanostructures biofilm penetration required 
investigation to assess for (+) α-TP Tris synergisms.    
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Bacterial surfaces (cell wall and membranes) within oral biofilms also have net negative 
surface charges; therefore they have the ability to form ion pairs with positively charged 
species. Monovalent salt ion-pairing interactions have been shown to swell and modify the 
interactions between neighbouring membranes by reducing the electrostatic repulsion barrier 
and allowing coalescence (Petrache et al., 2006) and therefore could influence the interaction 
between bacterial membranes and the (+) α-TP planar bilayer islands. In addition, Tris has also 
been found to make the bacterial membranes more permeable (Vaara., 1992) because the 
positively charged species interacts with the phospholipid head groups causing the membranes 
to swell and as a consequence greater surface pressure membranes are more permeable due to 
their structure disruption. As a consequence this has been shown to improve the interaction of 
antibiotics with membranes and potentially improves diffusion uptake (Mecheri et al., 2004). 
However, it should be noted that the membrane is not solubilised when a positively charged 
species interacts with it unless the interacting species has detergent properties (Voss., 1967). 
Therefore, small positively charged organic non-surfactant molecules are not typically as 
antimicrobial alone but function to enhance the interactions of antimicrobial molecules with 
the bacterial membrane to increase antimicrobial potency, or perhaps, in some cases introduce 
molecular antimicrobial properties. Therefore, the effect of Tris on (+) α-TP nanostructure 
interactions with bacterial membranes should also be examined to understand the conditions 
required for achieving the maximum antimicrobial potency with the actual bacteria in addition 
to its biofilm penetration.    
 
The aim of this study was to assess the importance of simple electrolytes to influence the 
interaction and antimicrobial activity of (+) α-TP nanostructures with gram-positive bacteria 
and salivary biofilms. The ions used to manipulate the properties of the (+) α-TP nanostructures 
were negatively charged phosphate and positively charged Tris (pH 7.4) and their effects on 
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artificial gram-positive bacteria membranes were assessed using a Langmuir trough. The 
nanostructure structures were probed using fluorescence, aggregate size analysis and zeta 
potential in the presence of the two ions. Confocal microscopy was used to investigate salivary 
biofilm penetration of the aggregates and aggregate antimicrobial action. The aggregates were 
also applied to S. oralis biofilms as they were shown to be susceptible to the antimicrobial 
action of (+) α-TP in Chapter 3 and so showed differences in antimicrobial activity under 




Tris (≥ 99%), (+) α-T (Type VI, ~ 40% purity), phosphorous oxychloride (POCl3) (≥ 99%), 
tetrahydrofuran (THF) (anhydrous) (≥ 99.9%), trimethylamine (≥ 99%), trifluoroacetic acid (≥ 
99%), cetylpyridinium chloride (CPC) (99.0-102%),  brain heart infusion (BHI) broth and 
glycerol were purchased from Sigma Aldrich, UK. Absolute ethanol, propan-2-ol, hexane by 
fractions, disodium hydrogen phosphate, monosodium dihydrogen phosphate, blood agar (BA) 
plates containing blood agar base no. 2 with 5 % horse blood, 0.2 μM nylon syringe filters, 
hydrochloric acid and sodium hydroxide, were purchased from Fisher scientific Ltd, UK. De-
ionised water was used from laboratory supply. Hydroxyapatite discs (5 mm diameter x 2 mm 
thick) were purchased from Himed inc, USA. Live/ dead ® BacLightTM bacterial viability kit, 
for microscopy, was purchased from Life Technologies, UK. S. oralis NCTC 7864T was 
purchased from LGC standards, USA. 1-palmitoyl-2-oleoyl-sn-3-glycerophospho-1-glycerol 
(POPG) and 1-palmitoyl-2-oleoyl-sn-3-glycerophosphocholin (POPC) were purchased from 
Avanti polar lipids, USA. Chromatographic paper, 10 mm x 100 m was purchased Whatman, 
Maidstone, UK.  Plastic syringes (1 and 20 mL) were purchased from Terumo, Philippines. 
Syringe needles were purchased from Macrolance, Ireland. Disposable clear dynamic light 
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scattering cuvettes (macro, PMMA) and disposable folded capillary cells (DTS1070) were 
purchased from VWR, Germany. Clear sterile polyester adhesive films were purchased from 
Starlab, UK. Peptone Water (dehydrated) was purchased from BD Diagnostic Systems, USA. 
Human saliva was donated from volunteers that had fasted and had not used an oral hygiene 
product for a minimum of 8 hours.  Basic media and Phosphate Buffered Saline (PBS) were 
prepared in house at Johnson &Johnson, Skillman, USA. 96 well Nunc® Plate, Nunc® Peg 
Lid and Nunc® White Plate (Cat. No 236105) were purchased from VWR, USA. BacTiter-
GloTM microbial cell viability assay was purchased from Promega, USA. ATP reagents (Celsis 




4.3.1 (+) α-TP aggregate sample preparations 
 
For Langmuir trough monolayer interaction experiments (+) α-TP (3 mM) samples were 
prepared by dissolving the appropriate amount in ethanol. Water was then added to initiate (+) 
α-TP thread-like micelle self-assembly, followed by the addition of aliquots of Tris or 
phosphate (0.5 M stock solutions). The pH was then adjusted to 7.4 and the samples were made 
to the mark with water to give final vehicle compositions of 20% ethanol (v/v), 80% water 
(v/v), 150 mM buffer concentration. 
 
To compare the physicochemical properties of the different formulations the following process 
was developed; stock solutions of (+) α-TP (500 μM) was prepared by dissolving the 
appropriate amounts in ethanol. Water was then added to initiate (+) α-TP self-assembly, 
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followed by the addition of varied aliquots of Tris or phosphate (0.5 M stock solutions) to 
generate different ratios of α-TP: ion concertation and hence vary the amount of surface 
interaction of the nanostructures. The pH was then adjusted to 7.4 and the samples were made 
to the mark with water to give final vehicle compositions of 20% ethanol, 80% water with 
100μM α-TP formulated with either Tris or phosphate ions at various concentrations.  
 
For comparison of the different formulated aggregates on microbiology studies; α-TP stock 
solutions (4 mM) were prepared by dissolving the appropriate amounts in ethanol. 
Nanostructure development was then repeated as above with the exception that one ratio of α-
TP: ion concentration was selected (800 μM: 150 mM (1:187.5) and the water and stock 
solutions were filter sterilised through a 0.2 μM nylon syringe filters. All samples were 
refrigerated and stored for a maximum of 8 days. 
 
4.3.2 Bacterial membrane interactions  
 
A Langmuir trough (Nima technology equipment, Coventry, UK) with a circular Teflon trough 
(5 cm2, volume 20 ml) on a stir plate (Whatman stirrer, WC-303) was loaded with either a Tris 
or phosphate (10 mM, pH 7.4) and equilibrated until a stable surface pressure was obtained 
(drift in surface pressure, ≤ 0.2 mN/ m over 2 minutes using Nima TR516 software) (Figure 
4.1). The phospholipids used to mimic a gram positive bacterial membrane were POPG and 
POPC as they have been previously used to form monolayers to mimic gram positive bacteria 
membranes (Chenga et al., 2011). The POPC: POPG (3:1 mg/ ml, dissolved in chloroform) 
(lipid ratio was optimised in preliminary experiments) lipids were added to the subphase until 
a 30 mN/ m pressure was reached in the Tris subphase (as this is the pressure of a bacterial 
membrane (Erbe et al., 2009)) or the maximum pressure achieved for the phosphate subphase. 
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The lipid monolayer was allowed to equilibrate over 30 minutes at room temperature. The α-
TP samples (0.1 mL, 3 mM, in 20% ethanol, 80% water, 150 mM phosphate or Tris at pH 7.4) 
were injected into the subphase with pressure monitored over time at a constant surface area. 
Experiments were repeated in triplicate. Vehicle injections of 0.1 mL, 20% ethanol, 80% water 




Figure 4.1. Photograph of the Langmuir trough set-up. 
 
4.3.3 (+) α-TP aggregate characterisation   
 
To examine the ion interactions with the aggregates fluorescence emission spectra of (+) α-TP 
(195 µM) aggregate solutions were recorded using a fluorescence spectrometer fitted with a 
Xenon pulse lamp (Varian Cary Eclipse Fluorescence Spectrometer, Agilent Technologies, 
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UK). A fluorescence cell (Helima fluorescence cell 10mm, Helima UK Ltd., UK) with a 10 
mm path length was used. Excitation and emission slits were fixed at 5 nm. In all 
measurements, the excitation wavelength was set at 286 nm. The samples were scanned from 
250 to 450 nm at a wavelength scan rate of 120 nm/ min with a PMT detector gain of 600 V. 
The experiments were performed at a temperature of 25 °C.  Fluorescence emission intensity 
increases/ decreases at 310 nm were monitored and normalised as shown in equation 4.1. The 
normalised data points were then plotted against ion concentration (Tris or phosphate). 
Analysis of the spectra were conducted using OriginPro software (OriginPro version 2016, 
OriginLab Corporation, US) and the dose dependent analysis selected to assess trend patterns. 
 
𝐹𝑛(%) =  
𝐹𝑠 − 𝐹𝑚𝑖𝑛
𝐹𝑠 − 𝐹𝑚𝑎𝑥
𝑋100   [Equation 4.1.] 
 
Where Fn is the percentage normalised fluorescence, Fs is the sample fluorescence, Fmin is 
the minimum fluorescence and Fmax is the maximum fluorescence. The size of the aggregates 
(100 µM, n = 3) were analysed by photon correlation spectroscopy (Malvern Nanoseries 
Zetasizer, Malvern Instruments Ltd, UK). Detection of the light scattering signal was 
performed at 173 ° at 25 °C. The material refractive index was set at 1.59, the material 
absorbance at 0.01, the dispersant refractive index at 1.33 and the viscosity (cP) at 0.8872. 
Blank solutions (containing just solvent) were used as a control. The same instrument measured 
the zeta potentials using a dielectric constant of 78.5 and Smoluchowski (1.5) interpretation of 
the data with (+) α-T in Tris buffer (25mM) as a control. The chemical stability of the (+) α-
TP was attained as described previously. 
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4.3.4 HPLC chemical stability study 
 
The chemical stability of the (+) α-TP aggregates was as described in 2.3.9. 
 
4.3.5 S. oralis growth retardation 
 
S. oralis was cultured, treated and growth monitored as described in 3.3.1 
 
4.3.6 UWMS biofilm formation inhibition 
 
Pooled homogenized saliva (minimum 30 mL) was dispensed into clear 96 well Nunc® plates 
(175 µL/ well). Peg lids were placed in the plates containing saliva for 30 minutes, incubated 
at 35 oC aerobic to form the pellicle. Rows A and H, columns 1 and 12 (outer edges) of a second 
Nunc® 96 well plate were filled with 180 µl of water (to reduce the edge effect). Inoculum and 
media were prepared by mixing saliva and BM/ PBS (12mL PBS/ 100 mL BM) in a 1:1 ratio. 
This saliva BM/ PBS mixture were dispensed (120 µL) into each well except for rows A and 
H, columns 1 and 12 (outer edges). Samples were added by dispensing 60 µL of the treatment 
solution into each well (total volume in each well =180 µl, 1/ 3 sample dilution). A growth 
control consisting of 120 µl of saliva/ BM/ PBS mix + 60 µl of media was used. The wells 
were mixed 3 times using a multichannel pipettor. Each sample was plated in sextuplet (6 wells, 
1 column). After the 30 minute pellicle formation, the peg lid was placed into the growth plate 
and incubated aerobically at 35oC statically for 24 hours. The peg lid was transferred to a plate 
containing 200 µL/ well of a BactiterGlo (BactiterGlo bottle should be taken out of freezer and 
thawed out in warm water for 15 minutes)/ 0.1% Peptone water (dispersed in deionized water, 
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then filter sterilized) mix (1:1 ratio), and was left to sit statically for 5 minutes. Each of the well 
samples (10 µL) were aliquoted into the wells of a white Nunc® plate which was then placed 
into a suction filtration unit (Victor X, USA) and washed twice with PBS.  The wells of the 
white Nunc® plate had there ATP content measured by luminescence detection (Berthold 
Luminometer, USA). 
 
4.3.7 Biofilm penetration  
 
One hydroxyapatite (HA) disc was added vertically to a micro centrifuge tube containing 
UWMS (one donor, 400 µL) and incubated at 37 °C for 18 h. After the 18 h of incubation in 
unsterilised UWMS the HA discs were removed, added to a fresh aliquot of sterilised heat 
treated (10 min, 80 °C) UWMS (200 µL) incubated at 37 °C for 24 h, removed, washed with 
saline (600 μL) and treated with Live/ dead ® BacLightTM bacterial viability kits. Biofilms 
were observed with a confocal microscope (Leica TCS SP2, Leica microsystems, UK)  with 
488 and 568 nm excitation and 500-530 nm (green fluorescence representing up take of Syto 9 
by live cells) and > 620 nm (Red fluorescence representing up take of propidium iodide by 
dead cells) emission filters using the 63x oil immersion objective. Images were taken near the 
centre of the HA discs both sides. There was no cross over between emission spectra and 
excitation intensities were ≤ 31%. The biofilm growth was considered normal if they grew 30 
– 60 µM. Biofilm red / green ratios as a function of biofilm depth were measured using the z-
stacking tool at 63x magnification taking an image every ~1 µm. The HA discs were then 
completely submerged in one of the three different α-TP aggregate test solutions (200 μL) in 
new micro centrifuge tubes for 2 minutes before being washed with saline (600 μL). HA discs 
were then re-exposed to live/ dead staining for 1 h and imaged again. Changes in the ratios of 
the red/ green staining as a function of biofilm depth demonstrated each of the three samples 
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biofilm kill penetration. These studies were repeated in triplicate for each test solution. CPC 
was used as a positive control. Each HA disc was imaged on both treated sides in two different 
areas near the centre of the discs. As a sterility control, sterile saliva was incubated with a 
sterile HA disc and showed no biofilm growth. In some cases discs were only imaged once, 
after biofilm test sample exposure, to ensure kill was caused by antimicrobial activity and not 
by the dual imaging and staining process.    
 
4.3.8 Statistical analysis 
 
All data were expressed as their mean ± standard deviation (SD). Statistical analysis of data 
was performed using Levine’s homogeneity test and ensured all sample group data was of 
acceptable distribution (P > 0.05) before statistical significance between the sample groups was 
assessed by one way analysis of variance (ANOVA) tests with post-hoc Tukey analysis in 




4.4.1 Bacterial membrane interactions 
 
The Tris and phosphate subphases affected the phospholipid monolayer (gram-positive) 
maximum equilibration pressure and hence its lipid packing. The phospholipid monolayer was 
capable of reaching a maximum surface pressure of 38 ± 1.5 mN/ m when formed on a Tris 
subphase (at which point the addition of more POPG: POPC did not increase surface pressure 
further), but it was only capable of reaching a maximum surface pressure of 15.2 ± 8.5 mN/ m 
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when formed on a phosphate subphase (Figure 4.2). This demonstrated that the Tris was 
interacting with the monolayer, causing it to swell. When the (+)α-TP aggregates formulated 
with Tris where injected into the Tris subphase the monolayer equilibration pressure (set at 30 
mN/ m to replicate the pressure of bacterial membranes) was found to increase by 2.7 ± 1.8 
mN/ m (Figure 4.3). When (+) α-TP formulated with phosphate was injected into the phosphate 
subphase there was no increase in monolayer pressure showing no interaction of (+) α-TP with 
the monolayer. The injection of the vehicle alone was found to slightly reduce the monolayer 
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Figure 4.2. Gram positive bacterial membrane mimic surface pressure using a Tris or 













Figure 4.3. Surface pressure change when (+) alpha tocopheryl phosphate aggregates were 
injected into the Tris (30 mN/ m) supplying a gram positive bacterial membrane mimic or 
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4.4.2 (+) α-TP aggregate characterisation 
 
When (+) α-TP was dispersed in increasing concentrations of Tris the fluorescence emission 
intensity was found to increase (Figure 4.4). The converse was true when (+) α-TP was 
dispersed in a phosphate buffer solution (Figure 4.5), i.e., the fluorescence emission intensity 
was found to decrease. The (+) α-TP fluorescence signals are related to the ionic behaviour of 















Figure 4.4. (+) α-tocopheryl phosphate aggregates (195μM) (20 h) fluorescence emission 
intensity changes as a function of varying phosphate concentration at 25 °C. Samples were 
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Figure 4.5. (+) α-tocopheryl phosphate aggregates (195μM) (20 h) fluorescence emission 
intensity changes as a function of varying phosphate concentration at 25 °C. Samples were 
dispersed in a 20% ethanol, 80% water at pH 7.4. N = 1 results. 
 
There appeared to be no relationship between aggregate size and phosphate concentration 
(Figure 4.6), but increasing concentrations of Tris reduced (+) α-TP aggregate size, perhaps 
caused by head group conformation changes. (+) α-TP aggregates formulated with Tris were 
found to consistently have a less negative zeta potential values than when formulated with 
phosphate (p < 0.05) (Figure 4.7). As phosphate gave a dose dependent increase in negative 
surface aggregate charge it was assumed that the negative phosphate groups were associating 
with the aggregates through hydrogen bonding because this would allow the phosphate to 
interact with the aggregates in a manner that would not shield its charge. At the (+) α-TP: ion 
ratio used in the subsequent biological assessments (1:187.5), there was no statistical difference 
in nanostructure size across the two ion test systems (p > 0.05) and therefore any 
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microbiological activity differences would be due to aggregate charge variations and bacterial 













Figure 4.6. Comparison of (+) α-tocopheryl phosphate (0.1mM) (18 h) aggregate size when 
formulated with increasing concentrations of Tris or phosphate at pH 7.4 in 20% ethanol 80% 
water vehicles. The aggregate sizes for the selected ratio of (+) α-tocopheryl phosphate to ion 
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Figure 4.7. Comparison of (+) α-tocopheryl phosphate (0.1mM) (18 h) zeta potential when 
formulated with increasing concentrations of Tris or phosphate at pH 7.4 in 20% ethanol 80% 
water vehicles. The aggregate zeta potentials for the selected ratio of (+) α-tocopheryl 
phosphate to ion concentration (1: 187.5) for microbiology treatment solutions are highlighted. 
n=3 results. 
4.4.3 (+) α-TP chemical stability comparison of formulations 
 
The HPLC chemical stability study found that the different ions effected the (+) α-TP aggregate 
stabilities; in the Tris formulation the chemical degradation rate was 1.47 ± 0.31 µg/ mL/ week 
whereas (+) α-TP dispersed with phosphate ions was found to be more stable at 0.48 ± 0.27 
µg/ mL/ week (Table 4.1). All samples were still commercially viable because there chemical 
degradation was below 10% of a 0.05% w/v (500 µg/ mL) solution over 12 weeks at 40°C (as 
seen in Chapter 2).   
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Table 4.1: Chemical degradation rates of (+) alpha tocopheryl phosphate nanostructures 
dispersed in 20% ethanol, 80% water at pH 7.4 stored at 37 ̊C over 4 weeks when in formulation 
with different ions. 
 
4.4.4 S. oralis biofilm growth inhibition 
 
The (+) α-TP nanostructures formulated with Tris (-18.9 ± 2.6 mV, 718 ± 471 nm) displayed a 
3.34 ± 0.52 h bacterial growth inflection point, which was statistically different from the Tris 
vehicle (1.69 ± 0.17 h, p = 0.0001) (Figure 4.8 A). (+) α-TP nanostructures formulated with 
phosphate (-29.6 ± 2.4 mV, 392 ± 6 nm)  were found to give a bacterial infection time of 2.01 
± 0.30 h, which was not statistically different from the phosphate vehicle (1.81 ± 0.15, p > 
0.05). Interestingly all α-TP species regardless of the formulation reduced the post-growth 
maximum population density of S. oralis (p = 0.02 with controls) (Figure 4.8 B). This 
difference in lag time and maximum population density profiles with formulation showed Tris 
allowed instant antimicrobial effect on S. oralis as the lag time was increased where as in the 
phosphate formulation the antimicrobial response appeared to be delayed as only the maximum 
population density was affected suggesting less interaction and perhaps a slower uptake. This 
was in agreement with Langmuir experimental data.  
 
(+) α-TP (20 µg/ 
mL) pH 7.4 
vehicle 
T = 4 weeks 
(µg/ mL) 
Degradation 
rate (µg/ mL/ 
week) 
Degradation 
over 12 weeks 








18.08 ± 1.1 0.48 ± 0.27 5.8 ± 3.24 1.2 ± 0.6 
no buffer 
 
 15.18 ± 2.3 1.21 ± 0.57 14.50 ± 6.84 2.9 ± 1.4 
Tris (25 mM) 
 
14.17 ± 1.23 
 
1.47 ± 0.31 
 
17.64 ± 3.72 
 
3.5 ± 0.74 
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Figure 4.8. Growth time to inflection points (A) and post-growth maximum population 
densities (B) of Streptococcus oralis when treated with (+) alpha tocopheryl phosphate 
nanostructures formulated with phosphate or Tris. All treatments were dispersed in 20% 
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4.4.5 UWMS biofilm formation inhibition 
 
The salivary oral biofilms were found to develop to 5.95 ± 0.10 and 6.01 ± 0.14 relative light 
units (RLU, luminescence) when incubated in the presence of the media and water controls. 
The Tris and phosphate controls reduced biofilm attachment but the (+) α-TP nanostructures 
formulated with Tris (-18.9 ± 2.6 mV, 718 ± 471 nm) were found to inhibit the development 
of the oral salivary biofilms to 4.9 ± 0.25 RLU compared to the 5.55 ± 0.10 Tris vehicle control. 
The (+) α-TP phosphate formulations (-29.6 ± 2.4 mV, 392 ± 6 nm) were found not to inhibit 
the biofilms developments any more than the phosphate vehicle (Figure 4.9). The surfactant 
sodium lauryl sulphate (SLS) limited biofilm development to 4.53 ± 0.57 RLU which was none 












Figure 4.9. Salivary biofilm attachment to hydroxyapatite when the saliva was inoculated with 
(+) alpha tocopheryl phosphate nanostructures formulated with phosphate or Tris. All 
treatments were dispersed in 20% ethanol, 80% water vehicle at pH 7.4. n=3 results. Sodium 
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4.4.6 UWMS biofilm kill penetration 
 
The biofilm kill penetration depths were considered to be at point where the pre and post (+) 


















Figure 4.10. Unsterilized whole mouth saliva biofilm kill penetration depth of (+) alpha 
tocopheryl phosphate (0.8 mM, 0.04% w/v) nanostructures formulated with Tris (150 mM) 
monitored using a live/ dead viability assay via confocal microscopy (A), also showing an 
image at 4.2 microns showing a primarily dead biofilm layer (B) and an image at 15 microns 
showing a primarily live biofilm (C). Treatments were dispersed in 20% ethanol, 80% water 
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The (+) α-TP nanostructures formulated with Tris (-18.9 ± 2.6 mV, 718 ± 471 nm) where 
capable of penetrating the oral salivary biofilms and kill the bacteria to depths of 12.4 ± 3.6 
μM, whilst the CPC positive control demonstrated bacterial kill to a depth of 16.1 ± 4.3 μM. 
The Tris vehicle was found not to have any kill efficacy on the salivary biofilms. The (+) α-TP 
dissolved in phosphate buffer (-29.6 ± 2.4 mV, 392 ± 6 nm) was not capable of killing bacteria 

















Figure 4.11. Unsterilized whole mouth saliva biofilm kill penetration depths of (+) alpha 
tocopheryl phosphate nanostructures (0.8 mM) when formulated with phosphate (150 mM) and 
Tris (150 mM). Live/ dead stain confocal microscopy images at 4.2 micron depths. Cetyl 
pyridinium chloride (0.8 mM) with Tris was a positive control. All treatments were dispersed 
in 20% ethanol, 80% water vehicle at pH 7.4. n=3 results.   
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The set up to mimic gram-positive bacterial membranes were affected differently by the 
presence of the Tris and phosphate ions; the amount of phospholipids that can be applied onto 
a subphase before the surface pressure plateaus has been previously found to be influenced by 
the ions dissolved in the subphase and hence these phospholipid - ion interactions effect the 
monolayer architecture on which antimicrobial species come into contact with (Chou & 
Chang., 2000; Nowotarska et al., 2014). POPC is a zwitterion molecule, whilst POPG is anionic 
and hence the POPC: POPG (3:1) monolayer would have had a net negative charge. When this 
mixture of phospholipids was applied on the Tris subphase (25 mM), until the surface pressure 
plateaued, the maximum equilibrium surface pressure that could be achieved was higher 
compared to when this phospholipid mixture was applied onto the phosphate subphase (25 
mM). The ability of Tris dispersed in the subphase to increase the phospholipids maximum 
monolayer equilibrium surface pressure was due to the effect of the organic Tris cations 
interacting with the anionic POPG head groups through ion pairing, resulting in a change in 
the monolayer self-assembly process which enabled a higher maximum surface pressure to be 
reached. At low concentrations the phospholipids form islands before reaching a concentration 
where they become a monolayer; it would appear that Tris allowed this self-assembly process 
to accommodate more of the phospholipid molecules because of ion pairing destabilising and 
swelling the phospholipid supramolecular structures, creating ‘gaps’ in the monolayer to be 
filled by additional phospholipids ascertaining higher surface pressure.  
 
When the equilibration pressure of the monolayer on Tris was set to 30 mN/ m (that of bacteria) 
this meant there was ~8 mN/m capacity (gaps) for (+) α-TP molecules to exploit. When the (+) 
α-TP nanostructures were injected into the Tris subphase they instantly interacted with the 30 
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mN/ m monolayer but did not interact with the monolayers formed on the phosphate subphase. 
These observed interactions between anionic phospholipid species can be explained two fold, 
firstly by reducing the electrostatic repulsion, enabling the two species to interact and secondly 
due to the swelling phenomenon a potentially improved insertion into the membrane. There is 
evidence in the literature that when large organic monovalent cations, like Tris,  interact with 
bacterial membranes they become more permeable but the mechanism of action for this 
permeability is not stated (Hamouda & Baker., 2000; Irvin et al., 1981; Ban  et al., 2012;  Asbell 
& Eagon., 1966;  Vaara., 1992; Lambert., 2002; Angus Life Sciences., 2016). This work 
suggests the permeability mechanism is due to the ion pairing which enables the initial 
interaction due to reduced polar head electrostatic repulsion and causes the membranes to 
become disrupted and swell, creating a more porous membrane, increasing the uptake and 
potency of antimicrobials i.e. like that of the antibiotic tetracycline (Mecheri et al., 2004). 
However, proof of improved uptake via improved diffusion needs to be proved but the Tris ion 
pairing mechanism has been proven in the literature to be responsible for its permeabilising 
effect as it varied with pH; at pH 9 (predominantly neutral) the membrane of Pseudomonas 
aeruginosa has been shown to only have a 4.1 fold membrane permeability increase but at pH 
7.4 (predominantly cationic) it was 133 fold more permeable (pKa of Tris,  8.1) (Hancock & 
Wong., 1984). In addition, the work carried out in this study used 150 mM Tris concentrations 
at pH 7.4 and applied to bacteria with Nano sized antimicrobial aggregates. Interestingly high 
concentrations of Tris (≥200 mM) have been observed to cause enhanced membrane permeable 
to supramolecular species i.e. the enzyme lysozyme, and therefore the interaction between the 
sensitized bacterial membrane mimics and the (+) α-TP nanostructures in the Langmuir 
experiments and subsequent antimicrobial effect is supported by the literature (Hancock & 
Wong., 1984). Therefore when a high concentration of cationic Tris is applied onto anionic 
gram-positive bacteria, i.e. S. oralis, it is likely that the membrane would increase in pressure 
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by swelling due to the ion-pairing interactions allowing for enhanced antimicrobial interaction 
to occur. The POPC: POPG monolayer pressure increase of 2.7 mN/ m when the (+) α-TP 
planar bilayers were injected into the subphase was considered show that the structures were 
becoming inserted into the monolayer and not rupturing it. This is because 19 residue 
polypeptide chains that insert into membranes have been found to increase the pressure of 
POPG: POPC monolayers by ~ 3 mN/ m (Posada et al., 2014). 
 
In Chapter 3 (+) α-TP was found to form cylindrical micelles in water and planar bilayer islands 
when dispersed in Tris. This and the fluorescence studies  in this Chapter confirmed the data 
from the Langmuir experiments that the addition of the different electrolytes affect the 
architecture of self-assembled phospholipids, but on these occasions the changes were 
observed in the pure (+) α-TP aggregates as opposed to the POPC: POPG monolayers. The Tris 
ions were found to increase fluorescent emission intensity whilst phosphate decreased it. 
Changes in supramolecular species fluorescent emissions commonly correspond with 
structural conformational changes (Langner et al., 2000) which may have contributed to 
activity, however, unlike in Chapter 3 the shape of the (+) α-TP nanostructure dispersed in 
phosphate buffer could not be observed through AFM due to the presence of large phosphate 
precipitates when drying the phosphate containing samples. To overcome this Transition 
electron microscopy (TEM) could be employed as this does not require dry samples. In addition 
increases in fluorescence intensity when salts are added have been linked to decreases in 
aggregate electrostatic surface potential due to a decreased value of the dielectric constant in 
the phospholipid polar head group region related in turn to decreased water organisation within 
the aggregate interface. Tris ion pairing with the aggregates appeared to reduce water 
organisation whilst phosphate interactions appeared to increase it though increasing the 
aggregates negative charge but needs to be proved. These different physiochemical properties 
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of the aggregates also unsurprisingly effected chemical stability but were all still within the 
threshhold of commercially viable. 
   
The size of (+) α-TP aggregates when formulated with Tris or phosphate was similar, but the 
former was found to be capable of permeating the multispecies salivary biofilms to kill bacteria, 
increasing S. oralis biofilm growth time to inflection point and inhibiting biofilm development 
whilst the latter was not, which suggested in this case the nanostructures surface properties 
were more important than size in determining antimicrobial effects. The (+) α-TP dispersed in 
a phosphate buffer increased the aggregates negative charge and this reduced the interaction 
with the anionic bacterial monolayers due to greater electrostatic repulsion (Cherepanov et al., 
2003). Therefore the antimicrobial mechanism of action for (+) α-TP appeared not to be like 
that of SLS (cell wall lysis) as it would be expected to increase in potency with more negatively 
charged aggregates (Wang et al., 2012) by associating with the positively charged 
environments in the monolayer (choline groups) but did not. This electrostatic repulsion 
appeared to be responsible for (+) α-TP phosphate formulations having a complete loss of 
UWMS biofilm growth inhibition, bacterial kill efficacy in the UWMS biofilms and a reduction 
in S. oralis biofilm growth inhibition. However, the (+) α-TP nanostructures formulated with 
phosphate were found to have an antimicrobial effect later in the S. oralis biofilm growth 
profile by limiting the maximum population and this suggested the (+) α-TP in phosphate buffer 
interacted with the S. oralis bacteria in some way, but to a lesser extent when in the presence 
of Tris, which has been previously reported (Schwab et al., 1999). These antimicrobial 
characteristics were also observed in the UWMS biofilm formation inhibition assays. In 
addition, the (+) α-TP tris formulations were again observed to produce a mild antimicrobial 
effect (as seen in in Chapter 3), by reducing biofilm formation by 0.65 log units, a log reduction 
of 3 is observed for potent antimicrobials i.e. a 99.9% reduction.  
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It should also be mentioned that if (+) α-TP antimicrobial mechanism was via targeting and 
inhibiting enzymes containing phosphate binding sites that the formulations with phosphate 
could have inhibited its action if the inhibited enzymes were in the cell membrane. However, 
(+) α-TP has been found to be within mammalian cells with intracellular biological properties 
and hence it is likely its antimicrobial mechanism of action occurs intracellularly and not on 
the cell surfaces but this needs to be confirmed. In addition, the presence of excess phosphate 
ions may also inhibit (+) α-TP’s HA substantivity, seen in Chapter 3, as there would be less 
calcium binding sites.  
 
It was also observed that the presence of Tris allowed the (+) α-TP nanostructures to penetrate 
salivary biofilms and kill the residing bacteria. The negatively charged EPS (bulk volume of 
oral biofilms) has been shown to inhibit the diffusion of positively charged oral antimicrobial 
agents i.e. CHX though electrostatic interactions (Shen et al., 2016) and would presumably 
hinder the diffusion of negatively charged antimicrobials through electrostatic repulsion. 
Therefore the flooding of multispecies oral biofilms with cationic Tris would not only have the 
benefit of sensitizing bacterial membranes to antimicrobials but would have also presumably 
had a neutralising effect on the EPS, changing the biofilm architecture in a way that would 
allow charged antimicrobials the ability to penetrate the biofilms more effectively to reach and 
kill bacteria. However, the sample group for saliva donation in the biofilm penetration studies 
would need to be larger in order to confirm (+) α-TP’s antimicrobial potency on different 
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The combination of (+) α-TP nanostructures with the Tris facilitated interactions of (+) α-TP 
with the bacterial membranes, which inhibited S. oralis growth, inhibited biofilm development, 
facilitated biofilm penetration and killed the residing bacteria. The combination of the (+) α-
TP aggregates with phosphate reduced aggregate zeta potential and presented the aggregate 
with membrane/ biofilms architectures which inhibited active membrane interactions,  
inhibited biofilm penetration and reduced (+) α-TP antimicrobial activity and hence would 
affect its ability to prevent plaque build-up and oral disease. Therefore different species of 
electrolytes do influence the interaction and antimicrobial activity of (+) α-TP with gram-
positive bacteria and salivary biofilms. However, the oral soft tissue toxicity of (+) α-TP should 
be assessed for commercial viability, its aggregation properties probed further in an attempt to 
improve its biological activity further and assess if (+) α-TP could have additional therapeutic 
oral properties in addition to being a natural antimicrobial agent. Therefore the effect on α-TP 
aggregation characteristics, soft tissue toxicity and biological activity upon gum uptake will be 






Engineering of Swellable (+) Alpha 
Tocopheryl Phosphate Nanostructures for use 








Chapter 5: Engineering of Swellable (+) Alpha Tocopheryl Phosphate Nanostructures 150 
for use as Monocyte Control Agents to Treat Gingival Disease  






Both (+) α-T and (+) α-TP have anti-inflammatory properties (Cummings & Mattill., 1931; 
Libinaki et al., 2010), both self-assemble into nanostructures in aqueous environments and both 
could potentially treat gingival disease i.e. oral psoriasis, gingivitis and periodontal disease but 
their architecture will effect activity. The ability of nanostructures to swell can facilitate 
targeted delivery of agents (Paula & Koo., 2016; Singh & Singh., 2013; Socransky & Haffajee., 
2005; Loesche & Grossman., 2001). Nanocarriers i.e. liposome, polymeric micelles, 
dendrimers and nanoparticles have been designed to target inflammatory diseases responding 
to a change in the micro environment into which they are administered for example pH, oxygen 
and temperature (Shaji & Lal., 2013). In the mouth nanocarriers can penetrate oral biofilms, 
but once within oral tissues it is desirable for the nanocarriers to swell to release the active. 
This type of delivery profile lends itself to self-assembled nanostructures made of an active but 
this type of system has not been for developed oral health drug delivery.    
 
In Chapter 3, (+) α-T and (+) α-TP showed that they self-assembled into liposomes and planar 
bilayer islands. The non-water soluble (+) α-T, formed tight non-ionic liposomes, which were 
not sensitive to the presence of Tris and so probably have limited swellability properties. (+) 
α-TP is more water soluble, it formed anionic cylindrical micelles in water that transitioned 
into anionic planar bilayer island fragments in Tris buffered water and in Chapter 4 was 
structurally different when dispersed in phosphate buffered water. Therefore, its structure is 
sensitive to electrolyte environment change, which gives it potential to swell, and remove the 
individual molecular actives from the supramolecular structures in order to obtain higher 
concentrations intracellularly to inhibit cytokine responses more compared to α-T (Epstein-
Barasha et al., 2010; Libinaki et al., 2010; Zingg et al., 2010). 
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Thus far, attempts at formulating oral health agents in order to achieve a substantive action 
have focused on bio-retention polymer systems (Pan., 2006; Ishikado et al., 2010). For example 
the non-substantive oral hygiene anti-inflammatory agent Triclosan (cyclo-oxygenase 
inhibition) has been formulated with the copolymers of methoxyethylene and maleic acid to 
extend its residency time and hence biological activity (Eley., 1999). In Chapter 3 the (+) α-TP 
nanostructures themselves were observed to adsorb to both biofilms and teeth and hence this 
show good potential to have a sustained effect on maintaining good periodontal health, but the 
action of the agent must release from the planar bilayer islands to antagonise the cell surface 
receptors and/ or pass into the mammalian cells because for gingival health the inhibition of 
chemokines (i.e. MCP-1), which can be generated in human gingival fibroblast (HGF-1) cells, 
is of primary importance (Urnowey et al., 2006). These chemokines are responsible for cell 
migration of white blood cells (i.e. monocytes) in response to oral infection/ injury, and if the 
recruited cells differentiate into macrophages and accumulate they can lead to gingival tissue 
destruction and tooth loss (Miyauchi et al., 1998; Park et al., 2014; Silva et al., 2014; Kim & 
Amar., 2006).  
 
Therefore it would also be beneficial to deliver an agent with selective moderate toxicity 
towards macrophage cells to reduce their destruction and MCP-1 production as this could be 
effective in preventing gingival disease progression (Bettany & Wolowacz., 1998; Hanazawa 
et al., 1993). Anionic liposomes are known to preferentially target macrophages but their 
toxicity on the cell membrane is dependent on the aggregates physicochemical properties i.e. 
large liposomes are more toxic, and so swollen (+) α-TP structures would be expected to have 
enhanced selective macrophage toxicity via cell lysis (Kelly et al., 2011). 
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The aim of this Chapter was to assess how the architecture of the (+) α-TP planar bilayer islands 
in simple Tris environments (150 mM) would change when dispersed in complex solute 
systems (i.e. cell culture media which contains: 103-110 mM sodium chloride, 25 mM glucose 
and 18 mM sodium bicarbonate ect.) that resemble the complex systems in gum tissue in order 
to improve drug delivery and treat gingival disease. The nanostructure swelling properties of 
(+) α-T, (+) α-TP and (±) α-TP (8 isomer racemic mixture) were monitored to assess which 
vitamin E chemical parameters affected the swelling characteristics for drug delivery and 
subsequent gingival activity. Two cell lines HGF-1 and THP-1 were selected for cell viability 
and MCP-1, IL-6 and IL-8 expression studies (Melnyk & Morrison-Beedy., 2012). mRNA 
transcript expression assays were performed using q-PCR on HGF-1 cells for mechanistic 
understanding of MCP-1, IL-8 and IL-6 protein regulation by the three different vitamin E test 
agents. The inflammatory stimulus applied to the cells was heat killed bacteria from human 
saliva in an attempt to mimic the inflammatory environment found in vivo (Segura et al., 1999; 




(+) α-T (type (VI, ~ 40%), (±) α-TP (≥ 97%), chlorhexidine digluconate (CHX) (20% w/v 
aqueous solution), cetylpyridinium chloride monohydrate (CPC) (99.0-102%), Hanks balanced 
salt solution (HBSS) (Cat No H6648), 2-mercaptoethanol (99%), Dulbecco's phosphate 
buffered saline (PBS) (cat No D8537), trypan blue (0.4%), phorbol 12-myristate 13-acetate 
(PMA) (≥ 99%, film), trypsin-EDTA (0.25%) and TRI-Reagent® (Ambion) were purchased 
from sigma Aldrich, UK. Isopropanol, dimethyl sulfoxide (DMSO), hydrochloric acid, sodium 
hydroxide, heat-inactivated fetal bovine serum (FBS), penicillin G-streptomycin, MagMax™-
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96 for Microarrays Kit (Ambion, AM1839), High-Capacity RNA-to-cDNA™ Kit (Applied 
Biosystems) and TaqMan universal PCR master mix (Applied Biosystems) were purchased 
from Fisher Scientific Ltd, UK. De-ionised water was used from laboratory supply. Dulbecco’s 
modified Eagle’s medium (DMEM) (ATCC 30-2002) cell culture medium and HGF-1 (ATCC 
CRL-2014) cells were purchased from the American type culture collection (ATCC) (USA). 
Roswell park memorial institute (RPMI) -1640 Medium (ATCC 30-2001) and the immortalised 
human peripheral blood monocyte cell line THP-1 (ATCC TIB-202) was sourced from LGC 
standards (UK). A colorimetric one step cell viability assay using a novel tetrazolium 
compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt; MTS] and an electron coupling reagent (phenazine methosulfate; PMS) 
was purchased from Promega, USA. This has been previously used to assess toxicity of zinc 
oxide nanoparticles (Dechsakulthorn et al., 2007). Commercial enzyme-linked immunosorbent 
assays (ELISA’s) including human MCP-1/ CCL2, human IL-8 and human IL-6 max deluxe 
sets were purchased from Biolegend, USA. Tissue culture flasks (25 and 75 cm2 with ventilated 




5.3.1 Characterisation of (+) α-T, (+) α-TP, (±) α-TP aggregates in cell culture 
medium  
 
The volume median diameters of (+) α-T, (±) α-TP and (+) α-TP were measured using a laser 
diffraction technique (Mastersizer X, version 2.15, Malvern Instruments, UK). The vitamin E 
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derivatives were formulated by dissolving the appropriate amount in ethanol, diluting with 
water, then Tris (0.5 M) with pH adjustment to 7.4 using sodium hydroxide or hydrochloric 
acid (2M) before being made to the mark with water to generate 20% ethanol, 80% water 
vehicles with 150 mM Tris, 3 mM sample concentrations. Samples were aliquoted and 
dispersed into 12 ml of stirring (max RPM) cell culture medium (either DMEM or RPMI 
without phenol red, FBS, or pen strep) liquid volume dispersing unit of the Malvern 
Mastersizer until the connected circulating cell reached an obscuration of 10% to 30% using a 
180 µm size range lense. The volume median diameters were recorded as an average of three 
measurements and swelling monitored every 3 minutes for 15 minutes after dispersion of the 
formulation in the relevant cell culture media. Mathematical model was fitted to the data.  
 
5.3.2 Gingival fibroblast and peripheral blood monocyte cell culture 
 
HGF-1 cells were cultured in DMEM which included 10% FBS, and 1% of penicillin G-
streptomycin (complete media A). The immortalised human peripheral blood monocyte cell 
line THP-1 was cultured in RPMI-1640 medium which included 10% FBS, 1% of penicillin 
G-streptomycin and 50 μM 2-mercaptoethanol (antioxidant) (complete media B). Both cell 
lines were initially cultured in 25 cm2 tissue culture flasks and on subsequent subcultures 75 
cm2 flasks. Both cell lines were incubated at 37°C in a 5% CO2, humidified atmosphere until 
HGF-1 cells reached confluence or until THP-1 monocytes reached 1x106 cell/ mL. HGF-1 
cells were adherent and so where subcultured using trypsin-EDTA (0.25%) (5 mL). The trypsin 
was then inactivated by adding complete media A (5 mL). The cells were harvested by 
centrifugation (500g for 5 min), resuspended in complete media A and reseeded at 50% of the 
initial confluent cell density. THP-1 monocytes where non-adherent and where subcultured 
Chapter 5: Engineering of Swellable (+) Alpha Tocopheryl Phosphate Nanostructures 155 
for use as Monocyte Control Agents to Treat Gingival Disease  




every 2-3 days by centrifugation (125 g for 5 min) and resuspended to achieve a seeding density 
of 2 x 105 cells/ mL complete media B. THP-1 cells were not allowed to exceed 1 x 106 cell/ 
mL during their flask culturing. HGF-1 and THP-1 cells used for experiments were between 
passages 3-8. There is not an ideal limit to cell passages and each cell line varies but value of 
18 and 25 have been described as ‘low’ passage counts (ATCC., 2010).  
 
5.3.3 Inflammatory stimuli preparation 
 
The human saliva (0.1 mL per well, e.g. 10 wells was 1 mL) (1 donor) was collected and stored 
at 4°C. Saliva was inverted to form a homogenous solution and was added to falcon tubes (15 
mL). The saliva was centrifuged (170 g, 10 min, Thermo Microlite RF temperature controlled 
microcentrifuge, Thermo Fisher Scientific, UK) and supernatant was removed and added to 
micro centrifuge tubes (1 mL/ tube). The supernatants were centrifuged (12,868 g, 10 min, 
Eppendorf 5810R temperature controlled centrifuge, Eppendorf UK Ltd, UK) to form bacterial 
pellets. Supernatants were discarded. Bacterial pellets were re-suspended in cell culture media 
(1 mL) (DMEM or RPMI-1640). Re-suspended bacteria were heat killed using a heating block 
(Grant, QBA1 series), UK) at 80 °C for 10 min followed by vortexing (Whirlimixer, 
Fisherbrand, UK). Samples were combined under sterile conditions and vortexed. The 
combined heat killed bacteria solution (200 μL) was added to one well in a 96 well plate and 
assessed by UV absorbance at 620 nm (iEMS Incubator/Shaker, Thermo Scientific, UK). The 
heat killed bacteria solution was diluted to 0.18 OD620 with cell culture medium under sterile 
conditions followed by a 1/100 dilution of the solution in cell culture medium. This was the 
inflammatory stimuli. 
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5.3.4 Determination of the HGF-1 and THP-1 cell line viability 
 
The effects of (+)/ (±) α-TP, (+) α-T and heat killed human saliva bacteria, individually and in 
combination, were tested on HGF-1 and THP-1 cells. CHX and CPC were also tested on THP-
1 macrophages as controls. To perform these assessments HGF-1 cells (passages 3-8) were 
seeded (1 x104 cells/ well) (Bedran  et al., 2014) in 96 well microplates (100 µL/ well)  and 
were incubated for 24 h at 37°C in a 5% CO2 atmosphere to allow cell adhesion. The culture 
medium was then aspirated, and the cells were treated for 4 h with (+) α-TP (0.05, 0.5, 5, 50, 
500, 5000 μM), (+) α-T (500, 5000 μM) or (±) α-TP (500 μM) (100 μL/ well) after which the 
test samples were aspirated, and the cells washed with HBSS (200 μL/ well). Either complete 
media or heat killed human bacteria from human saliva in complete media (1/100 dilution) 
were applied (100 μL/ well) and incubated for an additional 15 h at 37°C in a 5% CO2 
atmosphere to determine the cell viability of the vitamin derivatives alone and in with 
subsequent incubation with inflammation stimuli. The THP-1 monocytes were seeded (1 x104 
cells/ well) with PMA (5 ng/ mL) (PMA films were diluted in DMSO to 5 mM stock solution 
then diluted to 200 ng/ mL aliquots and stored at -20: the 5 ng/ mL PMA solutions were 
prepared by thawing the 200 ng/ mL stocks and dispersing in RPMI cell culture media as 
appropriate) to allow monocyte differentiation and subsequent cell adhesion in 96 well 
microplates and were incubated for 48 h at 37°C in a 5% CO2 atmosphere (Park et al., 2007). 
The culture medium was then aspirated, washed with HBSS and cultured in serum free media 
for 3 h before the cells were treated for 2 h (the time was reduced from 4 h to reduce the time 
the cells were starved from FBS) (Makon-Sébastien  et al., 2014)  with (+)  α-TP (0.05, 0.5, 5, 
50, 500, 5000 μM),  (±) α-TP (500 μM), (+) α-T (500, 5000 μM), CHX (50, 100, 150, 500, 
5000 μM) or CPC (0.05, 0.5, 5, 50, 500 μM )(100 μL/ well)  after which the test samples were 
aspirated, and the cells washed with HBSS (200 μL/ well). Either complete media or heat killed 
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human bacteria from human saliva in complete media (1/100 dilution) were applied (100 μL/ 
well) and incubated for an additional 15 h at 37°C in a 5% CO2 atmosphere. The 15 h 
supernatants were removed and used for ELISA assays and fresh complete media (100 μL) was 
added to the wells the colorimetric MTS cell viability assay (20 μL) was then added to each of 
the wells. Plates were then incubated at 37°C in a 5% CO2 atmosphere for 4 h after which time 
absorbance’s at 490 nm (iEMS Incubator/Shaker, Thermo Scientific, UK) were measured with 
reference subtractions at 650 nm. Untreated control cells were assigned a value of 100% 
viability (negative control), cell treated with 1% triton X (dispersed in cell culture media) were 
assigned a value of 0% viability (positive control). All the other conditions were compared to 
the controls using equation 5.1.: were As is the sample absorbance, Anc is the negative control 
absorbance and Apc is the positive control absorbance. Results are expressed as means ± 
standard deviations of triplicate assays from three different experiments. Lethal dose 50% 
(LD50) values were calculated using the dose response model in origin 2016. 
 
 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =  
𝐴𝑠−𝐴𝑝𝑐
𝐴𝑛𝑐−𝐴𝑝𝑐
𝑋100                         [Equation 5.1.] 
 
5.3.5 Determination of cytokine secretion using ELISA assays 
 
ELISA’s were used to quantify MCP-1, IL-8 and IL-6 concentrations in the cell-free 
supernatants as follows. 1X capture antibody was diluted in coating buffer, added 100 µL/ well 
and was incubated for 18 h at 4 ˚C. Reagents were brought to room temperature and washed 4 
times with wash buffer (300 µL/ well) and dried by firmly tapping on absorbent paper. To 
block non-specific binding and reduce background, 200 μL/ well of 1X Assay Diluent A was 
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added. Plates were sealed and incubated at RT for 1 hour. While plates were being blocked, 
the appropriate sample dilutions and standards were prepared. The cell-free supernatant 
samples were diluted 1/4 with 1X assay diluent A for MCP-1 and IL-8 quantification 
experiments and 1/40 for IL-6 quantification experiments in order for the concentrations of 
chemokines in the supernatants to be within the range of the generated calibration curve. These 
dilutions where found to be optimal in preliminary experiments. Top standards (1000 pg/ mL 
for IL-8 and 500 ng/ mL for IL-6 and MCP-1) were prepared from stock solutions in 1X Assay 
Diluent A (1000 µL). Six twofold serial dilutions of the top standards were performed with 1X 
Assay Diluent A in separate tubes. 1X Assay Diluent A served as the zero standard (0 pg/mL). 
The 1 h incubated plates were then washed 4 times with wash buffer before adding 100 μL/ 
well of standards or samples to the appropriate wells. Plates were sealed and incubated at RT 
for 2 hours. Plates were then washed 4 times with wash buffer before adding 100 μL of diluted 
detection antibody solution to each well. Plates were sealed and incubated at RT for 1 hour. 
Plates were washed 4 times with wash buffer before adding 100 μL of diluted Avidin-HRP 
solution to each well. Plates were sealed and incubated at RT for 30 minutes. Plates were 
washed 5 times with wash buffer before adding 100 μL of freshly mixed TMB substrate 
solution and incubated in the dark for 15 minutes. Positive wells turned blue in colour. The 
reaction was stopped by adding 100 μL of 2N sulphuric acid. Positive wells turned from blue 
to yellow. At the end of the experiment the absorbance’s at 450 nm (iEMS Incubator/Shaker, 
Thermo Scientific, UK) were recorded using a microplate reader with the wavelength 
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5.3.6 mRNA expression assay 
 
The HGF-1 cells were cultured and treated using the same method as the cell viability assay 
with the exception that after the 15 h incubation with the inflammatory stimuli supernatants 
were removed, the cells washed with PBS (100 µL/ well) and then harvested with TRI-
Reagent® (100 μL/ well). Cell treatments groups were in quintuplet and were combined in 
micro centrifuge tubes at this stage (500 µL, 50,000 cells) (N = 3).   
 
Total RNA was extracted using MagMax™-96 for Microarrays Kit following the Spin 
procedure. In summary, cells were homogenised in TRI- Reagent® for 5 minutes at room 
temperature. The homogenate was mixed 1–bromo–3–chloropropane (BCP) (50 µL) and 
centrifuged (12,000 g at 4°C for 10 minutes, Eppendorf 5810R temperature controlled 
centrifuge, Eppendorf UK Ltd, UK). The aqueous phase was collected and mixed with 100% 
isopropanol (50 µL). RNA was bound to RNA Binding Beads. The Beads were washed twice, 
total RNA was then eluted using Elution buffer. RNA was quantified using the NanoDrop 
(Thermo Scientific, UK). RNA integrity was analysed using the Bioanalyzer (Agilent, UK).  
 
50 ng of total RNA per sample was converted to cDNA using High-Capacity RNA-to-cDNA™ 
Kit. Expressions of MCP-1, IL-6 and IL-8 were analysed using probes from the Universal 
Probe Library (UPL, Roche). Actin beta (ACTB), Selenocysteine lyase (SCLY) and tRNA-yW 
synthesizing protein 1 homolog (TYW1) were used as reference genes (for primer sequence 
and probe selection, see Tables 5.1 and 5.2). Assays were designed following instructions from 
the Universal Probe Library Assay Design Centre (Online). Quantitative PCR (qPCR) was 
performed using TaqMan Universal PCR Master Mix, following manufacturer’s protocol. Each 
10 µL reaction contained 0.2 µM forward primer and reverse primer and 0.1 µM UPL probe. 
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cDNA was diluted 10-fold, and 4 µL of diluted cDNA was used per reaction. qPCR was 
performed on Applied Biosystems 7900HT Real-Time PCR System under the following 
cycling conditions: 50°C for 2 minutes, 95°C for 10 minutes, followed by 40 cycles of 95 °C 
for 15 seconds and 60 °C for 1 minute. Data was collected at the end of each cycle and 
graphically expressed as the change in DNA threshold cycle (ΔCT) when (+) α-TP was 
incubated with the HGF-1 cells prior to the heat killed bacteria incubation over the ΔCT of the 
media treated cells prior to the heat killed bacteria incubation to provide a gene fold change 
ratio by were numbers greater than 1 showed a mRNA inhibition.    
 
Gene name F primer R primer UPL probe 
MCP1 agtctctgccgcccttct gtgactggggcattgattg 40 
IL6 gatgagtacaaaagtcctgatcca ctgcagccactggttctgt 40 
IL8 gagcactccataaggcacaaa atggttccttccggtggt 72 
 
 
Table 5.1. Forward (F) and reverse (R) primer sequence and Universal Probe Library (UPL) 
probes for genes of interest.        
 
Gene name F primer R primer UPL probe 
ACTB agagctacgagctgcctgac cgtggatgccacaggact 9 
SCLY gctgcgggaaacacaact gctgaatacgggctgctg 1 
TYW1 agccttggcagtcaagca gcagtaggtaacgcccttca 1 
                           
 
Table 5.2. Forward (F) and reverse (R) primer sequence and Universal Probe Library (UPL) 
probes for reference genes. 
 
5.3.7 Data analysis 
 
All error values/ bars were expressed as their mean ± standard deviation (SD). Statistical 
analysis of data was performed using Levine’s homogeneity test before statistical significance 
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between the sample groups was assessed by one way analysis of variance (ANOVA) tests with 
post-hoc Tukey analysis in Origin 2016 (Silverdale scientific ltd, UK). Statistically significant 




5.4.1 Aggregate characterisation in cell culture media   
 
(+) α-TP was found to swell from nano sized bilayer planer fragments to micron sized 
structures when aliquoted into both DMEM and RPMI cell culture media. (+) α-TP was shown 
to swell at a faster rate when dispersed into the RPMI media as at the first time point (T = 0) 
the aggregates were 16.4 ± 1.0 µm whilst those in DMEM were 0.65 ± 0.04 µm (Figure 5.1 A). 
Although the aggregates in the RPMI media always had a mean volume diameter larger than 
those in DMEM there was not statistical significance after 3 minutes (P > 0.05) or 15 minutes 
(24.0 ± 4.9 µm and 28.52 ± 6.46 µm). The (+) α-T nano sized liposomes also swelled but to a 
lesser extent than the (+) α-TP. However, this was not observed in either DMEM or RPMI over 
the 15 minute time period (generated sizes of 3.7 ± 0.7 µm and 3.8 ± 0.6 µm at the 15 minute 
time point) as the swelling had already occurred at the ‘0’ time point. The (±) α-TP aggregates 
(liposomes, 104 nm ± 1.3 nm, -38.7 ± 7.0 mV – obtained by personal communication) were 
found to swell faster as they were already micron size at time ‘0’and swelled to a greater extent 
compared to the (+) isomer in DMEM with a size of 19.7 ± 2.6 µm at 15 minutes (Figure 5.1 
B) (not statistically different (P > 0.05) to (+) α-TP); The (±) α-TP isomer reduced in size over 
the 15 minute in both cell culture media which suggested the liposome was breaking down 
after it initial swelling. 
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Figure 5.1. The swelling of stereo-pure alpha tocopheryl phosphate ((+) Alpha TP) (3 mM) 
(A), (+) alpha tocopherol ((+) Alpha T) (3 mM) (A) and racemic alpha tocopheryl phosphate 
((±) Alpha TP) (B) in 20% ethanol, 80% water, 150 mM Tris at pH 7.4 when added into either 
Dulbecco's Modified Eagle's Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 
1640 medium. Data represented mean ± standard deviation (n = 3).  
B 
A 
Chapter 5: Engineering of Swellable (+) Alpha Tocopheryl Phosphate Nanostructures 163 
for use as Monocyte Control Agents to Treat Gingival Disease  













































































































5.4.2 HGF-1 cellular response to the aggregates 
 
(+) α-TP was well tolerated by HGF-1 until 5000 µM (0.25% w/v) where the cell viability was 
75.5 ± 7.9% (Figure 5.2). The (+) α-TP LD50 in HGF-1 cells could not be calculated because 
at the maximum solubility of (+) α-TP in DMEM 50% of cell death was not achieved. Both the 
(±) and the (+) α-TP isomer (500 µM) were found to have the same effects on cell viability (P 
> 0.05) which suggested the stereochemistry was not a factor in toxicity. At 5 mM (+) α-T was 
shown not to be toxic, against HGF-1 cells (96.7 ± 6.1%) showing that the addition of the 
















Figure 5.2. Cell viability of human gingival fibroblast cells (HGF-1) when treated with various 
(+) alpha tocopheryl phosphate (alpha TP) concentrations, (±) alpha TP (500 µM) or alpha 
tocopheryl (alpha T) (5000 µM), diluted in Dulbecco's modified eagle's cell culture medium 
(without FBS) at 37 °C for 4 hours. Data represented mean ± standard deviation (n = 3).  
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The inflammatory model developed using heat killed bacteria from human saliva was shown 
to be effective in upregulating MCP-1 from HGF-1 cells, the cells only treated with media 
throughout the experiment generated 21.6 ± 15.6 pg/ mL MCP-1, whilst those incubated with 
heat killed bacteria generated 673.5 ± 133 pg/ mL (Figure 5.3). Preliminary experiments 
showed there was no detectable amounts of MCP-1 in the heat killed bacteria itself showing 
that MCP-1 in the supernatant was generated from the HGF-1 cells. The reproducibility of this 
assay was considered acceptable as the relative standard deviation of the positive control was 
below 20% (DeSilva et al., 2003). As 500 μM concentrations of the test solutions where not 
toxic against HGF-1 cells, this concentration was used in the MCP-1 quantification to prevent 
MCP-1 release due to HGF-1 cell death. Pre-treatment with α-T (500 μM) was found not to 
inhibit MCP-1 production when the pre-treated HGF-1 cells where subsequently exposed to 
heat killed bacteria (619 ± 63 pg/ mL, P > 0.05). HGF-1 cells pre-treated with the (±) α-TP 
(500 µM) isomer were found not to statistically reduce MCP-1 generation compared to the 
non-pre-treated positive control (568 ± 107 pg/ mL, P > 0.05). However, (+) α-TP (500μM) 
was found to inhibit MCP-1 production (463.9 ± 68.9 pg/ mL) compared to the non-pre-treated 
positive control (P = 0.007), (+) α-T (P = 0.005) and (±) α-TP (P = 0.04). The inflammatory 
stimuli used was also found to produce IL-8 (8601 ± 600 pg/ mL) and IL-6 (18310 ± 896 pg/ 
mL). However, none of the vitamin E derivatives were found to have an inhibitory effect on 
IL-8 and IL-6 production (Figure 5.4) and so the (+) α-TP (500 μM) was MCP-1 specific in its 
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Figure 5.3. Quantity of monocyte chemoattractant protein-1 (MCP-1) secreted from human 
gingival fibroblast cells when pre-incubated with (+) alpha tocopheryl phosphate (alpha TP), 
(±) alpha TP or (+) alpha tocopherol (alpha T) samples for 4 h followed by 15 hours exposure 
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Figure 5.4. Quantity of interlukin-8 (IL-8) (A) and interlukin-6 (IL-6) (B) secreted from human 
gingival fibroblast cells when pre-incubated with (+) alpha tocopheryl phosphate (alpha TP), 
(±) alpha TP or (+) alpha tocopherol (alpha T) samples for 4 h followed by 15 hours exposure 
to inflammatory stimuli.   
B 
A 
Chapter 5: Engineering of Swellable (+) Alpha Tocopheryl Phosphate Nanostructures 167 
for use as Monocyte Control Agents to Treat Gingival Disease  










































































































The selective inhibition of MCP-1 protein generation in HGF-1 cells by (+) α-TP was found 
not to be caused by a selective inhibition of MCP-1 mRNA transcription mechanism (Figure 
5.5). This was because the pre-treatment of the HGF-1 cells with (+) α-TP before inflammatory 
stimulation did not statistically significantly reduce the transcription of MCP-1, IL-6 or IL-8 
after data processing with the reference genes and comparison to the stimulated cells not pre-













Figure 5.5. (+) Alpha tocopheryl phosphates ability to inhibit the mRNA transcription of MCP-
1, IL-6 and IL-8 genes in HGF-1 cells when applied before stimulation with heat killed bacteria 
(HKB). Plotted with ActB, SCLY and TYW1 reference gene subtractions and the gene fold 
change (gene expression, ratio of mRNA (ΔCT)) as a function of that of the HKB stimulated 
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5.4.3 THP-1 macrophage cellular response to the aggregates 
 
 (+) α-TP was less well tolerated by the differentiated THP-1 monocytes (macrophages) 
compared to the HGF-1 cells (Figure 5.6). The (+) α-TP LD50 against the macrophages was 
calculated to be 304 μM (20.0 ± 4.4% cell viability at 500 μM). Again (+) α-T (5 mM) was 
found to be well tolerated by the THP-1 macrophages at high concentrations (120.3 ± 33.6 %) 
but the (±) α-TP isomer was found to have a similar toxic effect to the (+) isomer (7.7 ± 4.6 % 




















Figure 5.6. Lethal dose 50 of (+) alpha tocopheryl phosphate on THP-1 macrophages when 
diluted in Roswell Park Memorial Institute (RPMI) 1640 medium (without FBS) and incubated 
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Figure 5.7. Lethal dose 50’s of chlorhexidine (A) and cetylpyridinium chloride (B) on THP-1 
macrophages when diluted in Roswell Park Memorial Institute (RPMI) 1640 medium (without 
FBS) and incubated at 37 °C for 2 hours. Data represented mean ± standard deviation (n = 3). 
A 
B 
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The inflammation model using the THP-1 macrophages showed a good upregulation of MCP-
1 even though the concentration produced was much lower than that produced by HGF-1 cells 
(Figure 5.8). The media negative control was found to produce 6.0 ± 2.9 pg/ mL of MCP-1 
whilst the macrophages treated with heat killed bacteria generated 57.3 ± 18.1 pg/ mL MCP-1 
(Figure 5.8). (+) α-T was found not to inhibit MCP-1 generated from the THP-1 macrophages, 
55.3 ± 31.7 pg/ mL was produced in the presence of the test agent. The (±) and (+) α-TP (500 
µM) were both shown to inhibit the generation of MCP-1 from THP-1 macrophages (16.1 ± 
5.1 pg/ mL for (±) isomer and 6.5 ± 3.2 pg/ mL for (+) isomer, p = 0.003) ((+) isomer, p > 0.05 
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Figure 5.8. Comparison of monocyte chemoattractant protein (MCP-1) secretion from THP-1 
macrophages when pre-incubated with (+) alpha tocopheryl phosphate (alpha TP), (±) alpha 






In Chapter 3, it was shown that the (+) α-TP forms thread-like micelles in water which 
transition into nano sized planar bilayer islands in the presence of Tris. However, when 
suspended in cell culture medium these nanostructures swelled to form micron sized 
aggregates; this was triggered due to the interactions with the cell culture electrolytes i.e. the 
sodium chloride and glucose in the complex electrolyte system. The swelling of the (+) α-TP 
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influences the assembly of the aggregate structures. The swelling process in this self-assembled 
system was attributed to a transition from planar bilayer islands to multi-lamella liposomes. 
These changes in aggregate characteristics were thought to be potentially beneficial for (+) α-
TP’s biological activity because it acts intracellularly and swelling would destabilise the 
extracellular system and release more free molecules to provide a more effective cellular 
bioactivity (Gao et al., 2010). The (+) α-TP aggregates are not taken up into the cells rather the 
free α-TP is sequestered by the organic anionic transporter proteins (Negis et al., 2007). 
 
It is unknown if the aggregates swelled and if so to what extent in the previous biofilm studies 
but they have been shown to have penetrated and killed the residing bacteria shown by the 
confocal microscopy. It is likely the Tris was present at high concentrations throughout the 
biofilms due to ion pairing with the EPS, dismantling the biofilms, whereas the Tris would be 
less likely to enter the gingiva in such high concentration but this needs to be proved. In any 
case the (+) α-TP nanostructure architecture would most likely be different between the biofilm 
and gingival penetration and hence would have different destabilising properties. In addition, 
the swelling mechanism may not be required for (+) α-TP uptake into bacterial cells as the 
Langmuir data showed the molecules inserted into the membranes and hence may be up taken 
through membrane diffusion in bacteria rather than uptake by organic anionic transporter 
proteins as in mammalian cells. (+) α-T swelled less than the (+) α-TP aggregates which could 
explain why (+) α-T had a lower biological activity compared to (+) α-TP. The (±) α-TP 
aggregates were also destabilised in both the cell culture media but in a different manner to the 
(+) isomer, they were destabilised more and hence showed that the chemical structure of (+) α-
TP was specific to its action. 
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(+) α-TP was well tolerated by HGF-1 cells and it reduced MCP-1 production upon exposure 
to an inflammatory stimuli. As (+) α-TP has previously been shown to have anti-inflammatory 
properties (Libinaki et al., 2010) and in Chapter 3 it adhered to teeth, it was anticipated that 
this molecule could help to prevent gingival destruction in the mouth by being present during 
the introduction of an inflammatory stimuli and control the recruitment of monocytes and 
accumulation of macrophages. α-TP has been reported to influence enzymes such as acid and 
alkaline phosphatases, adenosinetriphosphatase and diphosphopyridine nucleotidase, it has 
signal transduction properties in regulating cytokine synthesis and can effect gene expression 
by directly binding and regulating mRNA encoding enzymes involved in their biosynthesis 
(Zingg et al., 2010; Zingg et al., 2012). In this work (+) α-TP has been found to inhibit MCP-
1 upregulation, adding another biological function to this molecules activity. In addition the 
phosphate group was essential its activity as the (+) α-T analogue was not active. Interestingly 
the (±) α-TP racemic mixture was also not effective in supressing MCP-1 inhibition from HGF-
1 but (+) α-TP was. Stereochemistry is known to have a major impact on the effectiveness of 
anti-inflammatory agents, for example it is known that Ibuprofen is most active in its S 
configuration (Wolf., 2007). α-TP has three chiral centres which result in 8 possible 
stereoisomers of which only the RRR configuration is natural. Each of these stereoisomers 
could have a different potency for inhibiting MCP-1, and racemic mixture (8 stereoisomers) 
may have diluted the overall activity such that it did not have statistically significant activity 
compared to the controls. The MCP-1 production pathway begins with the microbial 
recognition by cells via receptor activation; the cell then starts the process of producing the 
protein by transcribing the mRNA, releasing it from the nucleus and is then transcribed using 
tRNA and ribosomes, generating the protein (Madianos et al., 2005). Therefore if (+) α-TP was 
inhibiting MCP-1 production by acting as an antagonist on the microbial recognition receptors 
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the MCP-1 mRNA would not be generated but in this study it was and hence (+) α-TP does not 
appear to be a microbial recognition receptor antagonist.   
 
When other cytokines in the HGF-1 cell free supernatants were tested i.e. IL-6 and IL-8, there 
was found to be no inhibition by (+) α-TP. This was surprising as previous literature found α-
TP to inhibit these cytokines in atherosclerosis (Libinaki et al., 2010). The specificity of the 
(+) α-TP species to inhibit only MCP-1 was similar to the molecule Bindarit which has 
previously been shown to selectively inhibit MCP-1 through the inhibition of mRNA for MCP-
1 (Sironi et al., 1999). There are chemical similarities between the molecules of Bindarit and 
(+) α-TP in that they both display fused rings and both display amphiphilic properties. 
However, (+) α-TP was found not to inhibit mRNA transcript expression, therefore (+) α-TP 
had a post mRNA transcription inhibitory activity on a downstream mechanism, perhaps 
inhibiting the mRNA translocation, translation into protein or signalling regulation at the 
protein level (for any of the enzymes employed in the protein synthesis post mRNA 
transcription) (Eskan et al., 2008).   
 
The selective (+) α-TP toxicity against THP-1 macrophages was considered to be a desirable 
trait for a molecule that aims to treat gingival disease as it can control the excessive macrophage 
burden during an immune response in a similar way to tetracycline derivatives (Bettany & 
Wolowacz., 1998). However, it is not desirable to kill all macrophages as they perform a 
beneficial role of engulfing microbes and preventing the spread of systemic infection. (+) α-
TP was found to be less toxic than two commercially used antimicrobial agents CHX and CPC 
and so it was thought capable of regulating macrophage accumulation without complete 
depletion. In addition MCP-1 generation was completely inhibited from THP-1 macrophages 
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treated with (+) α-TP (500 μM) and this would hopefully reduce the further recruitment of 
monocytes (Hanazawa et al., 1993). (+) α-T displayed no toxicity or MCP-1 inhibition towards 
THP-1 macrophages. The (±) α-TP racemic mixture had the similar effects on THP-1 
macrophages as the stereo-pure α-TP isomer in terms of cell toxicity and MCP-1 inhibition 
suggesting that it may be an interaction with the macrophage cell membrane leading to lysis 
that kills the macrophages (Zingg et al., 2010). An instant cell lysis mechanism was presumably 
the reason why the THP-1 macrophages did not generate MCP-1 as this would not give the 
cells time to generate the MCP-1 inflammatory proteins before cell death. However, the effect 
of killing the macrophages on the overall periodontal inflammatory response need to be 




The (+) α-TP nanostructures became swollen and transitioned into macrostructures when 
dispersed in cell culture media. The phosphate moiety was found to enhance the swelling 
process. The swollen (+) α-TP structures were found to selectively inhibited MCP-1 (not IL8 
or IL-6) generation in inflamed HGF-1 cells more so than both (+) α-T and (±) α-TP through a 
non-toxic post mRNA mechanism. The phosphate moiety in the swollen α-TP structures was 
also essential for introducing moderate toxicity to macrophages which inhibited their MCP-1 
generation. Therefore in addition to (+) α-TP’s moderate antimicrobial and anti-biofilm 
properties it is now thought to be a good candidate for professional applications in treating 
gingival disease i.e. oral psoriasis and periodontal disease through controlling the monocyte 
burden and hence prevent gingival destruction due to its swellable properties making it a novel 
multi-purpose agent for oral health applications. In addition, a lot of the oral care products to 
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date have focussed on antimicrobial agents to reduce the bacterial burden in the mouth to 
reduce the risk of gingival inflammation occurring, although there are some wound healing 
mouth rinses. A selection of these mouth rinse products have been applied to HGF-1 cells for 
30 seconds and had cell viability monitored. It was found that a number of the commercial 
products had high toxicity towards these fibroblast cells which is undesirable (Bowen et al., 













6 General discussion 
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The use of novel therapeutic compounds in denitrifies and mouthwash products to prevent oral 
disease is a growing area of research because of its economic value (Mintel., 2013). In addition, 
the fact that oral disease is now also being linked with serious systemic illnesses is increasing 
its importance (Kamera et al., 2008; Meurman et al., 2004; Abbayya et al., 2015; Ionel et al., 
2016). As a consequence there have been a vast range of oral health compounds that target 
different components/ processes in the mouth; i.e. though controlling the bacterial burden by 
antimicrobial mechanisms (cell lysis/ enzyme inhibition), prevention of bacterial attachment, 
biofilm disruption, preventing the demineralisation of enamel, controlling biofilm pH and 
treating inflammation, reported in the literature (Wilson., 1996; Gallob et al., 2015; Huang et 
al., 2016; Serafini et al., 2012). However, oral health remains a significant problem and this 
suggests the ideal therapeutic solution has not yet been discovered (World Health 
Organisation., 2012).   
 
Nanomaterials can be employed to improve the administration of therapeutic compounds 
through enhanced substantivity and/ or penetration and hence they are now being explored for 
dental applications (Narang & Narang., 2015; Ozak & Ozkan., 2013), but as yet they are not 
used clinically. In this work I explored the opportunity of using an amphiphilic natural 
biologically active molecule (+) α-TP as a novel nanomedicine to improve oral health. 
 
(+) α-TP was employed because it is a natural anti-inflammatory agent with physicochemical 
properties that made it highly likely to self-assemble into nanosized aggregates when dispersed 
in aqueous environments (Ogru et al., 2003). The aim of the thesis was to assess if (+) α-TP 
formed nanostructures that had antimicrobial activity via membrane lysis, could bind to HA 
and have gingival anti-inflammatory properties related to its biophysical characteristics.   
Chapter 6: General Discussion  179 
  




As a starting point, (+) α-TP was synthesised from (+) α-T in Chapter 2 because it was neither 
commercially available nor easy to extract from natural sources. It was also the naturally 
occurring stereoisomer that had the most biologically active form. Importantly (+) α-TP from 
this synthesis was still classified as natural due to the natural origin of the starting material 
(Moddresi., 2010). A method was developed from Nishio et al (2011), which generated the 
stereo-pure isomer in a 27% yield with ≥ 99% purity. Phosphorus, carbon, proton NMR, FTIR, 
mass spectrometry, HPLC and elemental analysis all confirmed the pure structure was 
successfully made. This synthesis procedure adds to the two published α-T phosphorylation 
reactions, but gives a more detailed description of the method and more extensive product 
characterisation ((Nishio et al., 2011; Gianello et al., 2005). In future work an attempt to scale 
up this reaction and make it commercially viable could be perused. This could be attempted by 
removing the immiscible solvent (+) α-TP extraction steps and directly purifying the 24 h 
water/ THF reaction mixture using column chromatography. This would reduce solvent usage 
making the reaction more ‘green’, reduce experiment time and it could improve the synthesis 
yield. 
 
The CD data which was employed primarily to confirm the stereochemistry of the (+) α-TP 
product suggested the molecules were aggregating. The cotton effect signals seen in the spectra 
are a characteristic of supramolecular interactions (Cassim & Yang., 1967). Both the (+) α-T 
and (+) α-TP molecules were found to aggregate (light scattering), but the phosphorylation 
altered the aggregate architecture with the (+) α-T molecules self-assembling into 563 ± 1 nm, 
-10.5 ± 0.2 mV nanostructures and the (+) α-TP molecules self-assembling into 175 ± 21  nm, 
-14.9 ± 3.5  mV nanostructures showing the charged phosphate group was at the surface of the 
nanostructures. This analytical data was imperative to understand how the phosphorylation 
event altered the vitamins physical chemistry and how the agent would present itself to 
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bacterial biofilms, bacterial membranes, HA surfaces and soft oral tissue upon administration. 
The CAC of the (+) α-TP molecules was 5.5 ± 0.2 μM (18 h after preparation) and once the 
aggregates formed they did not change in diameter size or PDI upon concentration increased 
(up to 1.5 mM) or over time (8 days) showing the aggregates were physically stable (Wanga et 
al., 2012). However, the high PDI values (above 2) suggested the nano-assembly process 
generated a varierty of sizes. The (+) α-TP CAC was slightly lower than the vitamin E 
derivative (+) α-TS, which has previously been found to have a critical micelle concentration 
of 20 μM (Sadoqi et al., 2009; Muthu et al., 2012). This showed the (+) α-TP nanostructures 
had a superior physical stability compared to (+) α-TS when dispersed in the Tris vehicle. 
 
The HPLC chemical stability method for (+) α-T and (+) α-TP was considered ‘fit for purpose’ 
based on the methods LOD, LOQ, precision and linearity. This assay provided a quick and 
reliable method for determining the chemical degradation of (+) α-T and (+) α-TP over time as 
well as subsequent analytical studies to determine the adsorption of the (+) α-TP nanostructures 
to HA. The (+) α-TP degradation rate was 1.2 μg/ mL/ week confirming that chemical 
degradation did not influence the biological results and that it was a commercially viable 
molecule. This was because it was within the industrial chemical degradation tolerance (10% 
degradation of a 0.05% w/v (500 µg/ mL) solution over 12 weeks at 40°C) and samples were 
only stored refrigerated for a maximums of 8 days. Interestingly (+) α-TP was much more 
chemically stable than (+) α-T, suggesting (+) α-TP was less susceptible to oxidation due to its 
inability to form a hydroxyl radical (Sabliov et al., 2009). Therefore the (+) α-TP was 
presumably hydrolysed back to (+) α-T for the established vitamin E degradation pathway to 
proceed. 
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Chapter 3 showed that the addition of a phosphate group not only improved the chemical 
stability of the molecules but it also generated antimicrobial nanostructures that inhibited the 
biofilm growth time to inflection point and maximum population density of the gram-positive 
bacteria S. oralis in a more potent manner compared to the (+) α-T nanostructures. This was 
considered to be beneficial to maintain good oral health as S. oralis is a highly proficient 
pioneering coloniser species. S. oralis provides a surface for the later bacterial colonisers to 
adhere to and is considered a major factor in the initialization of biofilm development (Dorkhan 
et al., 2013; Fujiwara et al., 2000). The controls used in this assay gave similar results to other 
bacterial growth curve data, which gave confidence this was a robust method and that (+) α-
TP was a mildly active antimicrobial material (Gan., 2010; Mackay et al., 1984; Zahner et al., 
2011; Fine et al., 1996).  
 
The anti-biofilm activity of (+) α-TP was shown to be linked to the nanostructures having a 
substantive effect on the S. oralis biofilms. When a charge neutralising solution was used 
instead of saline to rinse off the (+) α-TP from the biofilms, both the inhibition of growth time 
to inflection points and the inhibition of the maximum population densities were reduced. The 
known substantive agent CHX (Elworhy et al., 1996; Koontongkaew & Jitpukdeebodintra., 
1995) was found to have the same trend as (+) α-TP, but was more potent. This showed that 
the negatively charged phosphate group was allowing an interaction with the bacterial cell wall, 
tethering it in a similar way to the positive charge of CHX. It was surprising that the negatively 
charged (+) α-TP was interacting with the negatively charged cells walls of S. oralis so 
successfully as the physicochemical properties of the aggregate and the membrane were 
expected to repel. It was therefore suspected that the positively charged Tris molecules in the 
administration vehicle were influencing the (+) α-TP activity by interacting with all the 
negatively charged bacterial cell walls.   
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The (+) α-TP antimicrobial activity was found to influenced by the species of bacteria it was 
applied to; it was much less potent against the cariogenic bacterium S. mutans (Nobbs et al., 
2009), unlike CHX, which displayed increased potency against this strain. This could be 
explained as S. mutans is known to have different cell wall architecture to S. oralis; it is more 
negatively charged and is more hydrophilic (Saito et al., 1997). This made it more prone to 
interacting with the cationic antimicrobial CHX whilst seemingly evading the antimicrobial 
effect of anionic (+) α-TP.  
 
The MBC of (+) α-TP against S. oralis was found to be 1 µg/ mL which was more potent than 
CHX (Wang et al., 2012).  This reversal in potency trend was considered to be a result of the 
(+) α-TP planar bilayer islands swelling and becoming disrupted when dispersed in BHI in a 
similar way to when the nanostructures were dispersed in cell culture media in Chapter 5. 
However, in future work, the MBC test should be performed on a wide range of other oral 
bacterial strains to fully understand its antimicrobial potential. 
 
Chapter 3 found that the addition to the phosphate group also provided the vitamin with 
substantive anti-biofilm properties as it also facilitated the molecules ability to adsorb to HA. 
The mechanism of adsorption was considered to be the binding of the (+) α-TP phosphate group 
to the positively charged Ca2+ binding sites, a property observed with other organic phosphate 
species (Ganesan., 2008). This then reduced the extent of attachment of bacteria to the HA 
surface and inhibited salivary biofilm formation, but did not eradicate it. This was considered 
beneficial as controlling the oral micro-organisms, rather than completely eradicating them, is 
the goal (March., 2000). The (+) α-TP nanostructures antimicrobial interactions with S. oralis 
were likely a factor in delaying the salivary plaque maturation which could inhibit the 
attachment of the later pathogenic colonizing bacteria, which cause gum disease. Future work 
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should include assessing which micro-organisms were prevented from attaching to the HA/ 
pellicle surface, i.e., S. oralis, S. mitis, S. gordonii ect in order to better understand the 
mechanism of action in the prevention of plaque development/ maturation i.e. whether it was 
due to a change is HA physicochemical properties (hydrophobicity change) or an antimicrobial 
mechanism (controlled release of the (+) α-TP bilayer fragments). 
 
The AFM images in Chapter 3 suggested that the differences in (+) α-T and (+) α-TP 
nanostructure shape contributed to the increased antimicrobial activity of (+) α-TP (Figure 6.1). 
The addition of the phosphate group reduced the aggregate size, increased negative charge, 
transitioned the shape from spherical liposomes and introduced viscoelastic properties. The 
phosphate group also made the vitamin E molecule sensitive to the presence of electrolytes 
(also seen in Chapter 5) as Tris transitioned the (+) α-TP from thread-like micelles to planar 
bilayer islands, increasing surface area and viscoelasticity whereas the architecture of the (+) 
α-T liposomes was unaffected by the presence of Tris. These shape transitions are observed 
when ionic surfactant like molecules are formulated with a high ratio of salt (in this case Tris) 
due to reduced head group repulsion (Nagarajan., 2002). The ability to manipulate and engineer 
the (+) α-TP nanostructures by carefully selecting electrolytes and/ or changing vehicle 
hydrophobicity could be used to optimise the compounds antimicrobial properties and should 
be investigated in future work i.e. application of the (+) α-TP macrostructures formed in cell 
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Figure 6.1. Correlation of (+) alpha tocopherol and (+) alpha tocopheryl phosphates 
nanostructure biophysical properties with their activity against S. oralis biofilm growth time to 
inflection points and salivary biofilm growth inhibition.    
 
 
Chapter 3 also showed that the (+) α-TP substantive antimicrobial activity was related to the 
aggregates biophysical properties but the exact mechanism of action was not known. Therefore, 
in Chapter 4 the mechanism of action was investigated by monitoring the (+) α-TP membrane 
interactions. CHX and CPC are both positively charged antimicrobial species that disrupt cell 
wall stability and cause cell lysis (McBain et al., 2003; Haps et al., 2008). Negatively charged 
sodium lauryl sulphate micelles have been found to have bactericidal effects by solubilising 
cell membrane proteins again resulting in cell lysis (Wang et al., 2012; Mohamad., 2011). It 
was thought that (+) α-TP could also induce cell lysis. However, its membrane interactions 
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suggested otherwise. (+) α-TP is endogenous in cells and it appears in ultralow concentrations. 
It is a potent signalling molecule that targets enzymes including acid and alkaline phosphatases, 
adenosinetriphosphatase and diphosphopyridine nucleotidase to name just a few (Zingg et al, 
2010) and or transcription factors (Gianelo et al., 2005). Moreover it has been suggested that 
(+) α-TP acts in a similar way to thiamine di-phosphate in bacteria which directly binds and 
regulate mRNAs encoding enzymes involved in its biosynthesis controlling gene expression. 
Therefore, (+) α-TP was thought to be acting via enzyme inhibition rather than cell lysis. Future 
work should involve selecting a number of enzymes that are known to play a part in the S. 
oralis metabolism and observe if (+) α-TP inhibits any of their activities to confirm its 
antimicrobial mechanism of action.  
 
The antimicrobial properties of the (+) α-TP nanostructures were tested by altering the co-
formulated counter ions. The (+) α-TP aggregates were influenced by phosphate and Tris in 
different manners according to the fluorescence emission spectra’s. Nanostructure size, charge 
and chemical stability were all affected differently by co-formulation with either phosphate or 
Tris electrolyte species and this influenced the antimicrobial activity. The electrolyte selected 
was also found to have a huge effect on the packing of gram-positive bacterial membranes as 
the limiting equilibration pressure of the monolayer when formed on the Tris subphase was 
more than twice that of the pressure achieved on the phosphate subphase. This showed the Tris 
was ion-pairing with the phosphate head groups of the artificial bacterial membrane, becoming 
inserted into the surface of the monolayer, increasing pressure which could make the 
monolayer more permeable (Hamouda & Baker., 2000; Irvin et al., 1981; Ban  et al., 2012;  
Asbell & Eagon., 1966;  Vaara., 1992; Lambert., 2002). This was found to be vital for (+) α-
TP’s antimicrobial activity as only the monolayer formed on the Tris subphase allowed an 
instant interaction of the (+) α-TP planar bilayer islands. The monolayer pressure increase of 
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2.7 mN/ m when the (+) α-TP planar bilayers were injected into the subphase was considered 
to show that the structures were becoming inserted into the monolayer and not rupturing it as 
this is the monolayer pressure increase when polypeptides insert into monolayers (Posada et 
al., 2014). 
 
In addition, the more negatively charged (+) α-TP aggregates formulated with phosphate did 
not interact with the monolayer, inhibit S. oralis growth time to inflection point or kill salivary 
bacteria were as the (+) α-TP planar bilayer islands did. This suggested that Tris was enabling 
the uptake of the (+) α-TP molecules and was inhibiting an intracellular process in a similar 
way to how Tris has been observed to increase the antibiotic properties of tetracycline (Mecheri 
et al., 2004) and antimicrobial supramolecular structures (Hancock & Wong., 1984). The 
internalisation of (+) α-TP molecules should in future be assessed by synthesising (+) α-TP 
using P31 and tracking its signal.  
 
Unfortunately an AFM image of the (+) α-TP nanostructure in the phosphate buffer could not 
be obtained due to the way the phosphate buffer precipitated upon drying and so future work 
should include using transmission electron microscopy to observe the shape of these 
aggregates. Also, antimicrobial and AFM images of the (±) α-TP isomer should be investigated 
to understand if there are differences in antimicrobial isomer activity and if so whether they 
are related to physical and/ or chemical differences.   
 
The positively charged Tris molecules were found to affect the architecture of the oral biofilms 
in a manner that allowed the (+) α-TP bilayer planer islands to penetrate the salivary biofilms, 
interact with and kill the residing bacteria (Figure 6.2). The bulk of biofilms are known to 
consist of negatively charged EPS, which has been shown to inhibit the diffusion of positively 
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charged oral antimicrobial agents i.e. CHX though electrostatic attraction (Shen et al., 2016) 
and presumably hindered the diffusion of negatively charged (+) α-TP nanostructures through 
























Figure 6.2. Interaction of (+) alpha tocopheryl phosphate nanostructures with an artificial 
gram-positive bacterial monolayer, salivary biofilm penetration and salivary bacterial kill when 
formulated with phosphate or Tris ions. 
 
 
Another important area of oral health that has been explored in this thesis (Chapter 5) was the 
ability of (+) α-TP to target macrophages in the gingival tissue to maximise its anti-
inflammatory properties (Nishio et al 2011; Munteanu et al., 2004; Kato et al., 2011; Libinaki 
et al., 2010). Chapters 3 and 4 showed that the variation in electrolyte presence effected 
nanostructure architecture and biological activity. When the (+) α-TP planar bilayer islands 
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were dispersed in DMEM and RPMI which simulated the environment of gum tissue they were 
found to rapidly swell from nanostructures to microstructures. The swelling was found to be a 
result of the phosphate group’s sensitivity to electrolytes as the (+) α-T swelled less than the 
(+) α-TP aggregates. Interestingly the stereochemistry of α-TP also had an effect on the 
swelling process as the (±) α-TP aggregates were also destabilised but in a different manner to 
the (+) isomer, a characteristic that could have contributed to the observed biological activity 
differences. In future work the swelling process should be observed by environmental scanning 
electron microscopy and the effect of temperature change assessed i.e. 37 °C.These changes in 
aggregate architecture were thought to be beneficial for (+) α-TP’s biological activity because 
it acts intracellularly and swelling would disrupt the system allowing the organic anionic 
transporter proteins to sequester more free α-TP providing a more effective cellular bioactivity 
(Gao et al., 2010; Negis et al., 2007) (Figure 6.3). In addition, it could help phagocytosis by 
macrophages.  
 
Upon understanding the physical changes to the (+) α-TP nanostructures its gingival biological 
activity was assessed. The micron sized structures were found to be well tolerated by the HGF-
1 cells, which are the major composition of gingival tissue. This was beneficial as the small 
selection of wound healing mouth rinse commercial products available have shown to be highly 
toxic against HGF-1 cells when applied for 30 seconds (Bowen et al., 2015). For future work 
it would be beneficial undertake these experiments in house for a more reliable comparison of 
the data as well as comparing them to the toxicity of CHX and CPC which are expected to have 
a higher toxicity to (+) α-TP due to their cationic interactions with membranes.  
 
The phosphate group and the stereochemistry of (+) α-TP was found to have important 
biological activity as this microstructure was found to selectively inhibit the generation of 
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MCP-1 whilst (+) α-T did not and (±) α-TP had reduced activity. The sensitive relationship 
between structure and activity are commonly observed in cell signalling molecules (Wolf., 
2007). However, the specificity of (+) α-TP to inhibit MCP-1 and not IL-8 or IL-6 was thought 
to due to the mRNA inhibition of MCP1-1 like that of the drug Bindarit (Sironi et al., 1999), 
but our studies found that the production of MCP-1 mRNA was not inhibited. Therefore the 
(+) α-TP post mRNA transcription inhibitory activity should be tested on downstream 
mechanisms in future work. (Eskan et al., 2008). In addition, the lack of activity against IL-6 
and IL-8 was surprising as previous literature found α-TP to inhibit these cytokines in 
atherosclerosis (Libinaki et al., 2010). This may be due the (+) α-TP molecule having specific 
activity between mammalian cell types in a similar way to the differences in antimicrobial 
properties seen between the different species of bacteria. In addition the inflammatory stimuli 
(concentration, type and application time), the (+) α-TP effect on other cell lines (i.e. gingival 
epithelium cells) and other secreted cytokine species could be investigated to gain more 
understanding  of the (+) α-TP anti-inflammatory properties for oral applications.  
 
The stereochemistry of α-TP was found not to affect the moderate toxicity towards THP-1 
macrophages (lesser than CHX and CPC), only the amphiphilic properties were required 
(phosphate group). The literature has already shown that phospholipids can lyse macrophages 
(Zingg et al., 2010). This toxicity profile was considered to be a desirable trait for a molecule 
that aims to treat periodontal disease as it can control the macrophage burden during chronic 
immune response (Bettany & Wolowacz., 1998). In a similar way to the biofilm burden it is 
not desirable to kill all macrophages in gum disease as they are beneficial in engulfing microbes 
and preventing the spread of infection into the systemic system; the aim was just to control the 
recruitment and accumulation which was achieved. The (+) α-TP toxicity to the macrophages 
was thought to be instant as they did not generate any MCP-1; dying macrophages can still 
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produce MCP-1 (Hanazawa et al., 1993), and so the α-TP MCP-1 inhibition was not likely to 
be enzymatic based but rather cell lysing. An LDH time response assay should be developed 
















Figure 6.3. Swellability of (+) α-TP nanostructures upon gum uptake, their toxicity against  
human gingival fibroblast (HGF-1) cells/ THP-1 macrophages and their biological activity 
against inhibiting pro-inflammatory protein secretion from HGF-1 cells.   
  
 
Overall, the data gathered in this thesis has shown that the vitamin E derivative (+) α-TP can 
be used as a multi-functional nanomedicine for topical oral health applications and should be 
tested in a commercial mouthwash product. This work has demonstrated that (+) α-TP 
nanostructure architectures are sensitive to their environment and can be used to manipulate 
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their anti-biofilm and gum disease treatment activity. This work provides a platform to explore 
this self-assembling biologically active molecule in vivo and hence its clinical therapeutic 
potential. For example, it may have activity against other gram-positive bacteria i.e. MRSA 
and gram-negative bacteria i.e. E.coli. Its actual specific antimicrobial mechanism of action 
still needs to be ascertained, upon doing so a library of bacterial strains that it would likely to 
effective against could be assembled and its activity tested to assess if it could be used in other 
body sites other than the mouth. Furthermore, it’s inhibition of MCP-1 could be tested as a 
treatment for psoriasis (oral and skin) as these conditions are immune-mediated chronic 
inflammatory diseases linked to high expressions of the chemokine MCP-1 which leads to poor 
skin and oral health (Zablotna et al., 2016; Fatahzadeh & Schwartz., 2016). Additionally, (+) 
α-TP could be used synergistically as a nanocarrier encapsulating other therapeutic agents and 
have targeted controlled release in the mouth, this would increase the multifunctional capability 
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